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A B S T R A C T
Background
The use of anaesthetics in the elderly surgical population (more than 60 years of age) is increasing. Postoperative delirium, an acute
condition characterized by reduced awareness of the environment and a disturbance in attention, typically occurs between 24 and 72
hours after surgery and can affect up to 60% of elderly surgical patients. Postoperative cognitive dysfunction (POCD) is a new-onset
of cognitive impairment which may persist for weeks or months after surgery.
Traditionally, surgical anaesthesia has beenmaintained with inhalational agents. End-tidal concentrations require adjustment to balance
the risks of accidental awareness and excessive dosing in elderly people. As an alternative, propofol-based total intravenous anaesthesia
(TIVA) offers a more rapid recovery and reduces postoperative nausea and vomiting. Using TIVA with a target controlled infusion
(TCI) allows plasma and effect-site concentrations to be calculated using an algorithm based on age, gender, weight and height of the
patient.
TIVA is a viable alternative to inhalational maintenance agents for surgical anaesthesia in elderly people. However, in terms of postop-
erative cognitive outcomes, the optimal technique is unknown.
Objectives
To compare maintenance of general anaesthesia for elderly people undergoing non-cardiac surgery using propofol-based TIVA or
inhalational anaesthesia on postoperative cognitive function, mortality, risk of hypotension, length of stay in the postanaesthesia care
unit (PACU), and hospital stay.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 11), MEDLINE (1946 to November 2017),
Embase (1974 to November 2017), PsycINFO (1887 to November 2017). We searched clinical trials registers for ongoing studies, and
conducted backward and forward citation searching of relevant articles.
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Selection criteria
We included randomized controlled trials (RCTs) with participants over 60 years of age scheduled for non-cardiac surgery under general
anaesthesia. We planned to also include quasi-randomized trials. We compared maintenance of anaesthesia with propofol-based TIVA
versus inhalational maintenance of anaesthesia.
Data collection and analysis
Two review authors independently assessed studies for inclusion, extracted data, assessed risk of bias, and synthesized findings.
Main results
We included 28 RCTs with 4507 randomized participants undergoing different types of surgery (predominantly cardiovascular, la-
paroscopic, abdominal, orthopaedic and ophthalmic procedures). We found no quasi-randomized trials. Four studies are awaiting
classification because we had insufficient information to assess eligibility.
All studies compared maintenance with propofol-based TIVA versus inhalational maintenance of anaesthesia. Six studies were multi-
arm and included additional TIVA groups, additional inhalational maintenance or both. Inhalational maintenance agents included
sevoflurane (19 studies), isoflurane (eight studies), and desflurane (three studies), and was not specified in one study (reported as an
abstract). Some studies also reported use of epidural analgesia/anaesthesia, fentanyl and remifentanil.
We found insufficient reporting of randomization methods in many studies and all studies were at high risk of performance bias because
it was not feasible to blind anaesthetists to study groups. Thirteen studies described blinding of outcome assessors. Three studies had a
high of risk of attrition bias, and we noted differences in the use of analgesics between groups in six studies, and differences in baseline
characteristics in five studies. Few studies reported clinical trials registration, which prevented assessment of risk of selective reporting
bias.
We found no evidence of a difference in incidences of postoperative delirium according to type of anaesthetic maintenance agents
(odds ratio (OR) 0.59, 95% confidence interval (CI) 0.15 to 2.26; 321 participants; five studies; very low-certainty evidence); we noted
during sensitivity analysis that using different time points in one study may influence direction of this result. Thirteen studies (3215
participants) reported POCD, and of these, six studies reported data that could not be pooled; we noted no difference in scores of
POCD in four of these and in one study, data were at a time point incomparable to other studies. We excluded one large study from
meta-analysis because study investigators had used non-standard anaesthetic management and this study was not methodologically
comparable to other studies. We combined data for seven studies and found low-certainty evidence that TIVA may reduce POCD (OR
0.52, 95% CI 0.31 to 0.87; 869 participants).
We found no evidence of a difference in mortality at 30 days (OR 1.21, 95% CI 0.33 to 4.45; 271 participants; three studies; very
low-certainty evidence). Twelve studies reported intraoperative hypotension. We did not perform meta-analysis for 11 studies for this
outcome. We noted visual inconsistencies in these data, which may be explained by possible variation in clinical management and
medication used to manage hypotension in each study (downgraded to low-certainty evidence); one study reported data in a format
that could not be combined and we noted little or no difference between groups in intraoperative hypotension for this study. Eight
studies reported length of stay in the PACU, and we did not perform meta-analysis for seven studies. We noted visual inconsistencies
in these data, which may be explained by possible differences in definition of time points for this outcome (downgraded to very low-
certainty evidence); data were unclearly reported in one study. We found no evidence of a difference in length of hospital stay according
to type of anaesthetic maintenance agent (mean difference (MD) 0 days, 95% CI -1.32 to 1.32; 175 participants; four studies; very
low-certainty evidence).
We used the GRADE approach to downgrade the certainty of the evidence for each outcome. Reasons for downgrading included:
study limitations, because some included studies insufficiently reported randomization methods, had high attrition bias, or high risk
of selective reporting bias; imprecision, because we found few studies; inconsistency, because we noted heterogeneity across studies.
Authors’ conclusions
Weare uncertainwhethermaintenancewith propofol-basedTIVAorwith inhalational agents affect incidences of postoperative delirium,
mortality, or length of hospital stay because certainty of the evidence was very low. We found low-certainty evidence that maintenance
with propofol-based TIVA may reduce POCD. We were unable to perform meta-analysis for intraoperative hypotension or length
of stay in the PACU because of heterogeneity between studies. We identified 11 ongoing studies from clinical trials register searches;
inclusion of these studies in future review updates may provide more certainty for the review outcomes.
2Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-
cardiac surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
P L A I N L A N G U A G E S U M M A R Y
Injected versus inhaled medicines to maintain general anaesthesia during non-cardiac surgery for cognitive outcomes in elderly
people
Background
Anaesthesia during surgery in elderly people (more than 60 years of age) is increasing.
Traditionally, general anaesthesia is maintained with an inhaled drug (a vapour which the patient breathes in) which needs to be adjusted
to ensure that the patient remains unconscious during surgery without receiving too much anaesthetic. An alternative method is to use
propofol which is injected into a vein throughout the anaesthetic procedure; this is called total intravenous anaesthesia (TIVA).
Elderly people are more likely to experience confusion or problems with thinking following surgery, which can occur up to several days
postoperatively. These cognitive problems can last for weeks or months, and can affect the patients’ ability to plan, focus, remember,
or undertake activities of daily living. We looked at two types of postoperative confusion: delirium (a problem with awareness and
attention which is often temporary) and cognitive dysfunction (a persistent problem with brain function).
TIVA with propofol may be a good alternative to inhaled drugs, and it is known that patients who have TIVA experience less nausea
and vomiting, and wake up more quickly after anaesthesia. However, it is unknown which is the better anaesthetic technique in terms
of postoperative cognitive outcomes.
Review question
To compare maintenance of general anaesthesia for elderly people undergoing non-cardiac surgery using TIVA or inhalational anaes-
thesia on postoperative cognitive function, number of deaths, risk of low blood pressure during the operation, length of stay in the
postanaesthesia care unit (PACU), and hospital stay.
Study characteristics
The evidence is current to November 2017. We included 28 randomized studies with 4507 participants in the review. We are awaiting
sufficient information for the classification of four studies.
All studies included elderly people undergoing non-cardiac surgery and compared use of propofol-based TIVA versus inhalational
agents during maintenance of general anaesthesia.
Key results
We found little or no difference in postoperative delirium according to the type of anaesthetic maintenance agents from five studies
(321 participants). We found that fewer people experienced postoperative cognitive dysfunction when TIVA with propofol was used
in seven studies (869 participants). We excluded one study from analysis of this outcome because study authors had used methods to
anaesthetize people which were not standard.
We found little or no difference in the number of deaths from three studies (271 participants). We did not combine data for low
blood pressure during the operation or length of stay in the PACU because we noted differences in studies, which may be explained
by differences in patient management (for low blood pressure), and differences in how length of stay in the PACU is defined in each
study . We found little or no difference in length of hospital stay from four studies (175 participants).
Quality of the evidence
Many studies did not report randomization methods adequately and all studies were at high risk of bias from anaesthetists, who needed
to be aware of which anaesthetic agent they used. Outcome assessors in some studies were aware of which study group participants were
in. We noted a large loss of participants in three studies, and some studies had differences between groups in the types of drugs used for
pain, the types of monitors used to assess how deeply-unconscious the patients were, and participant characteristics at the start of the
studies; these factors may have influenced the results. Few studies had reported clinical trials registration. We found few studies for two
outcomes (mortality and length of hospital stay), which made the results less precise. We judged evidence for postoperative delirium,
number of deaths, length of stay in the PACU, and length of hospital stay to be very low certainty, and evidence for postoperative
cognitive dysfunction, and low blood pressure during the operation to be low certainty.
TIVA with propofol may reduce postoperative cognitive dysfunction. We are uncertain whether the choice of anaesthetic agents (TIVA
with propofol, or inhalational agents) affects postoperative delirium, mortality and length of hospital stay. We found 11 ongoing studies
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in database and clinical trials register searches. Inclusion of these studies in future review updates will provide more certainty for the
review outcomes.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Intravenous maintenance of anaesthesia compared with inhalational maintenance of anaesthesia in elderly people undergoing non-cardiac surgery
Participants: elderly people, aged 60 years and above, undergoing non-cardiac surgery under general anaesthesia
Settings: hospitals in: Belgium, Canada, China, Egypt, France, Germany, Greece, Ireland, Japan, Norway, South Korea, Spain, Sweden, Turkey, UK, USA
Intervention: intravenous maintenance of anaesthesia with: propofol
Comparison: inhalat ional maintenance of anaesthesia with: sevof lurane, isof lurane, or desf lurane












(One study used DRS,
three studies used CAM
and in one study diag-
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(9 studies used MMSE,
and 2 of these stud-
ies used addit ional di-
agnost ic tools; 1 study
used Trail Making Test
and addit ional diagnos-
t ic tools; 3 studies did
not report diagnost ic
tools)
Time points were up to
30 days postoperat ively
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(3215 part icipants) re-




We excluded 1 large
study f rom this analysis
which used non-stan-
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not be combined. Of
these 5: we noted no
apparent dif f erences in
mean MMSE scores in
3 studies; 1 study re-
ported sim ilar scores in
each group; 1 study in-
cluded data at 2 years
and was not compara-
ble with our other data








very lowc Overall, 4 studies re-
ported mortality. We did
not include 1 study in
analysis because num-
ber of deaths (3 in to-
tal) were not reported
by group




(def ined by study au-
thors as change in MAP
f rom baseline)
- See comment - 1145 (12 studies) lowd Overall, 12 studies
(1145 part icipants) re-
ported intraoperat ive
hypotension. 1 study re-
ported data in a format
that could not be com-
bined with other study
data (we noted lit t le or
no apparent dif f erence
in hypotension in this
study)
We did not pool data
in 11 studies; we noted
inconsistencies in vi-
sual inspect ion of the
data which could be



























































































































































and medicat ion used to
manage hypotension in
each study
Length of stay in PACU
(measured in minutes)
- see comment - 567 (8 studies) very lowe We did not pool data in
seven studies: we noted
inconsistencies in vi-
sual inspect ion of the
data and we expected
that studies used dif fer-
ent def init ions of t ime
points to assess length
of t ime in the PACU
Data were unclearly re-
ported in one study
Length of hospital stay
(measured in days)
- MD 0 days higher




very lowf Overall, 6 studies (375
part icipants) reported
data for this outcome.
Of 4 combined studies,
mean scores in the in-
halat ional maintenance
group ranged f rom 1.
3 days to 15 days. 2
studies reported data
that could not be com-
bined with other stud-
ies (we noted lit t le or
no dif ference in median
length of stay between
groups)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CAM: Confusion Assessment Method; CI: conf idence interval; DRS: Delirium Rating Scale; MAP: mean arterial pressure; MD: mean dif ference; MMSE: Mini-Mental State


























































































































































GRADE Working Group grades of evidence
High certainty: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aWe downgraded by one level for study lim itat ions; we noted few included studies for this outcome had suf f icient ly reported
methods of randomizat ion and we were concerned by high risk of attrit ion bias in two studies and high risk of select ive
outcome report ing bias in one study. We downgraded by two levels for inconsistency; we could not be certain whether
measurements of delirium, and t ime points of measurement, were equivalent between studies, and we used sensit ivity
analysis to show that choice of t ime point in one study may inf luence direct ion of this result
bWe downgraded by one level for study lim itat ions; we noted that some studies had insuf f icient ly reported methods of
randomizat ion and we were concerned by high risk of attrit ion bias in one study. We downgraded by one level for inconsistency;
we noted a moderate level of stat ist ical heterogeneity (I² = 41%) which we were unable to explain in subgroup analysis
cWe downgraded by one level for study lim itat ions; we noted that some studies had insuf f icient ly reported methods of
randomizat ion. Analysis included few studies with few part icipants and, because deaths due to anaesthesia are rare we would
require a large sample size to show evidence of a dif ference; we downgraded by two levels for imprecision.
dWe downgraded by one level for study lim itat ions; we noted some studies reported insuf f icient methods of randomizat ion.
We downgraded by one level for inconsistency because of stat ist ical heterogeneity (I² = 63%) and noted dif ferences in visual
inspect ion of results; this could be explained by possible variat ion in clinical management and medicat ion used to manage
hypotension in each study
eWe downgraded by one level for study lim itat ions; we noted some studies reported insuf f icient methods of randomizat ion.
We downgraded by two levels for inconsistency; we noted substant ial stat ist ical heterogeneity (I2 = 94%) and dif ferences in
visual inspect ion of results which may be explained by likely dif f erences in study designs related to def init ions of t ime points
of measurement for this outcome
f Few studies with few part icipants; we downgraded by two levels for imprecision. We noted a moderate level of stat ist ical


























































































































































B A C K G R O U N D
Description of the condition
There are an estimated 187 million to 281 million surgical pro-
cedures worldwide each year (Weiser 2008). Alongside an aging
population, the global use of anaesthetics in the elderly (> 60
years of age) is increasing (Mandal 2009). Surgery and anaesthesia
have a pronounced effect on elderly people, which can result in
an increased risk of postoperative confusion and functional de-
cline (Rundshagen 2014). Complications such as these have ad-
verse effects on postoperative recovery and are associated with an
increased length of hospital stay and an increased risk of mortality.
It is hypothesized that the direct effect of anaesthesia on the brain,
hypotension, and hypoxia may all have an influence on their de-
velopment (Ballard 2012; Wang 2015).
Postoperative delirium is an acute condition, characterized by re-
duced awareness of the environment and a disturbance in atten-
tion (Deiner 2009). It typically occurs between 24 and 72 hours
after surgery, following an initial lucid phase (Ballard 2012). It
is thought to occur in around 10% of elderly patients (Rudolph
2011), although this can rise to 60% following certain types of
surgery, such as hip fracture fixation (Ansaloni 2010; Bitsch 2004).
Postoperative delirium is a defined condition according to the In-
ternational Classification of Diseases (WHO 2016a), and there
are a number of validated tools to assist in diagnosis and severity
scoring, such as the confusion assessment method (CAM) (Inouye
1990).
Postoperative cognitive dysfunction is characterized by a chronic
reduction in cognitive function, lasting weeks or months, com-
pared with an individual’s normal cognitive state (Newman 2007).
It presents a diagnostic challenge as it has not been formally de-
fined and diagnostic criteria are yet to be developed, but can in-
clude changes to circadian rhythm, psychomotor state, and mem-
ory deficit. The incidence of postoperative cognitive dysfunction
varies depending on the surgery type and the definition of postop-
erative cognitive dysfunction used (Krenk 2011); it is associated
with an inability to return to normal lifestyle following surgery
(Monk 2005; Steinmetz 2016).
Description of the intervention
There are three phases involved in the provision of general anaes-
thesia: induction, maintenance, and emergence. Induction of
anaesthesia is often undertaken using intravenous (IV) agents, typ-
ically propofol. This has the advantage of rapid onset, and therefore
airway control can be quickly obtained. Inhalational induction of
anaesthesia (which may be given at high or low initial concentra-
tions; Boonmak 2016), using a non-irritant volatile agent such as
sevoflurane is an alternative which, though slower in onset, offers
benefits in terms of the maintenance of spontaneous ventilation
and increased cardiovascular stability. In many patients, anaesthe-
sia is maintained by the inhalation of volatile agents (typically
sevoflurane, desflurane, or isoflurane, historically also enflurane
and halothane). The alternative technique for the maintenance
of anaesthesia is the continuous administration of an IV infusion
of an anaesthetic drug, typically propofol. This is known as total
intravenous anaesthesia (TIVA). Neither maintenance technique
provides analgesia, and this may be co-administered through a
variety of techniques which may be used in combination. These
include boluses or an infusion of opioid medication, the inhala-
tion of nitrous oxide, or regional anaesthetic techniques. In this
review, wewill compare inhalational anaesthesia involvingmainte-
nance with sevoflurane, desflurane, isoflurane, or halothane, with
or without nitrous oxide (Hounsome 2016), (referred to as in-
halational anaesthesia) with propofol-based TIVA (referred to as
TIVA).
How the intervention might work
The mechanism of action of anaesthetic agents has not been fully
elucidated. However, it is known that both IV and inhalational
agents act at multiple receptor sites within the central nervous
system to reduce neuronal activity (Koblin 2000). Both propofol
and volatile agents are thought to act predominantly though the
activation of the gamma-aminobutyric acid (GABA)-A receptor,
with variable effects on other receptors. Of these, the nicotinic
acetylcholine receptormay be of particular relevance to the subject
of this review, as it has a role in cognition, and is inhibited by
volatile agents at therapeutic levels, but by propofol only in high
doses (Fodale 2010).
Inhalational anaesthesia has been associated with lower rates
of postoperative cognitive dysfunction in the setting of cardiac
surgery (Royse 2011; Schoen 2011), and inhalational induction
has been shown to induce less hypotension than IV induction
(Luntz 2004;Thwaites 1997). In inhalational anaesthesia, the end-
tidal concentration of anaesthetic agent is measured and this can
be compared to a known value at which 50% of patients move in
response to a standard surgical stimulus, known as the minimum
alveolar concentration (MAC). In order to prevent awareness, it is
suggested that the end-tidal volatile concentration should exceed
0.7 MAC (Pandit 2013). MAC is age-dependant, decreasing with
advancing age, and should therefore be adjusted using nomograms
or algorithms in order to reduce the risk of excessive dosing in the
elderly population (Griffiths 2014).
There are a number of proposed benefits to the use of TIVA, in-
cluding a more rapid recovery and a decreased incidence of post-
operative nausea and vomiting (Weilbach 2005).However, propo-
fol is associated with hypotension, thought to be mediated by the
inhibition of sympathetic outflow, and this may be particularly
pronounced in the elderly or those with cardiovascular disease
(Robinson 1997). In TIVA, the anaesthetic agent is not measured,
but the plasma and effect-site concentration may be calculated
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using an algorithm built in to the infusion pump; the anaesthetic
can then be administered to a target effect-site concentration, and
this is known as a target-controlled infusion (TCI). The algorithm
is dependant on the gender, age, height, and weight of the pa-
tient, but is less reliable in certain patient groups, including the el-
derly. As the concentration of anaesthetic agent is calculated rather
than measured, it has been proposed that the depth of anaesthe-
sia should bemonitored using electroencephalogram (EEG)-based
devices in patients undergoing TIVA in order to reduce the risk
of accidental awareness (Checketts 2016).
Monitors of anaesthetic depth have been widely available for some
years. They enable titration of dose of general anaesthetic both
to avoid unnecessarily high doses and also the risk of accidental
awareness if too little anaesthetic is given (Chhabra 2016;Messina
2016; Punjasawadwong 2014). The use of EEG-based depth of
anaesthesia monitoring in the elderly population, in order to min-
imize the risk of the administration of excessive doses of sedative
or anaesthetic agents, has been shown to reduce the incidence of
postoperative cognitive complications and hypotension (Ballard
2012; Chan 2013; Sieber 2010). As a result of this, its use is ad-
vocated for general anaesthesia for the elderly, regardless of tech-
nique, in national and international guidelines (Griffiths 2014;
NICE 2012).
Why it is important to do this review
Traditionally, surgical anaesthesia has been maintained with in-
halational agents, however the introduction of new technologies
has made IV maintenance a viable alternative technique which
presents a number of possible advantages. In terms of postopera-
tive cognitive outcomes, the optimal technique remains unknown.
This review aims to help identify the anaesthetic technique that
is optimal for elderly surgical patients in terms of postoperative
cognitive function, cardiovascular stability, mortality, and length
of stay in hospital in order to optimize the use of healthcare re-
sources and reduce the overall healthcare costs.
O B J E C T I V E S
To compare maintenance of general anaesthesia for elderly peo-
ple undergoing non-cardiac surgery using propofol-based TIVA
or inhalational anaesthesia on postoperative cognitive function,
mortality, risk of hypotension, length of stay in the postanaesthe-
sia care unit (PACU), and hospital stay.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomized controlled trials (RCTs), and aimed
to include quasi-randomized studies (for example, in which the
method of assignment is by alternation, date of birth, or medical
record number).
Types of participants
The United Nations defines the older population as 60 years of
age and above (WHO 2016b). We therefore included participants
aged 60 years and above, undergoing surgery under general anaes-
thesia. We excluded participants undergoing cardiac surgery due
to the differences in the provision of general anaesthesia whilst on
bypass, and the additional risk of postoperative cognitive compli-
cations associated with extracorporal support. If studies included
participants less than 60 years of age, we included the study if it
was possible to identify the ratio of participants who were more
than 60 years of age; if the ratio was more than 75%, and this
was distributed evenly between intervention groups, we included
these studies.
Types of interventions
We included studies that compared maintenance of anaesthesia
with propofol-based TIVA versus inhalational anaesthesia. Com-
parisons of inhalational maintenance anaesthesia included both
inhalational and IV induction of anaesthesia.
Types of outcome measures
We aimed to establish if one type of maintenance of anaesthesia re-
duces postoperative delirium and postoperative cognitive dysfunc-
tion in participants, as these are associated with both an increased
length of hospital stay and risk of mortality. Our secondary out-
comes establish if one method reduces the incidence of hypoten-
sion (a proposed cause of postoperative delirium and postopera-
tive cognitive dysfunction), mortality, length of stay in the PACU,
and overall hospital admission time, as these have significant cost
implications to healthcare settings.
We excluded studies that did not measure any of the review out-
comes. See Differences between protocol and review.
Primary outcomes
1. Postoperative delirium; as measured by a validated tool or
diagnostic criteria, e.g. Diagnostic and Statistical Manual of
Mental Disorders (DSM-5 2013), confusion assessment method
(CAM) (Inouye 1990), International Classification of Diseases-
10 (WHO 2016a).
2. Postoperative cognitive dysfunction; as defined and
measured by the study authors.
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Secondary outcomes
1. Mortality at 30 days.
2. Intraoperative hypotension as defined by the study authors
(for example, mean arterial pressure (MAP) < 65 mmHg, drop in
MAP > 20% from baseline value).
3. Length of stay in the PACU (measured as minutes).
4. Length of hospital stay (measured as days).
Search methods for identification of studies
Electronic searches
We identified RCTs through literature searching with systematic
and sensitive search strategies as outlined in Chapter 6.4 of the
Cochrane Handbook of Systematic Reviews of Interventions (Higgins
2011).We applied no restrictions to language or publication status.
We searched the following databases for relevant trials.
1. Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 11)
2. MEDLINE (Ovid SP, 1946 to 20 November 2017)
3. Embase (Ovid SP, 1974 to 20 November 2017)
4. PsycINFO (EBSCO, 1887 to 21 November 2017)
We developed a subject-specific search strategy in MEDLINE
and used that as the basis for the search strategies in the other
listed databases. The search strategy was developed in consultation
with the Information Specialist. Search strategies can be found in
Appendix 1, Appendix 2, Appendix 3, Appendix 4.
We scanned the following trials registries for ongoing and unpub-
lished trials (20 November 2017).
1. The World Health Organization International Clinical




We carried out citation searching of identified included studies in
Web of Science ( apps.webofknowledge.com), and Google Scholar
( scholar.google.co.uk), on 23 November 2017 and conducted a
search of grey literature through ’Opengrey’ ( www.opengrey.eu./),
on 5 December 2017. We carried out backward citation searching
of key reviews identified from the searches.
Data collection and analysis
Two review authors (SRL and DM, OSR, or MP) independently
assessed trial quality and extracted data. Consensus was reached
through discussion. We used standard Cochrane methodological
procedures, including assessment of risk of bias for all studies.
Selection of studies
We used reference management software to collate the results of
the searches and to remove duplicates (Endnote 2011). We used
Covidence software to screen the results of the search from the
titles and abstracts and identify any potentially relevant studies
from this information alone (Covidence 2016). We sourced the
full texts of all those potentially relevant studies and considered
whether they met the inclusion criteria. We included abstracts at
this stage. However, we only included these in the review if they
contained sufficient information and relevant results that included
denominator figures for each intervention/comparison group. We
recorded the number of papers retrieved at each stage and reported
this using a PRISMA flow chart (Moher 2009). We reported brief
details of closely-related, but excluded papers in the review.
Data extraction and management
WeusedCovidence software to extract data from individual studies
(Covidence 2016). A basic template of the data extraction forms
are available at www.covidence.org. We adapted the template to
include the following information.
1. Methods: type of study design, setting, dates of study,
funding sources.
2. Participants: number randomized to each group, baseline
characteristics (age, urgency of surgery, American Society of
Anesthesiologists (ASA) grade and type of surgery).
3. Intervention: details of anaesthetic techniques (induction
technique, type of volatile agents used, use of depth of
anaesthesia monitoring, dose of anaesthetic agents given (i.e.
minimum alveolar concentration (MAC)/target-controlled
infusion (TCI)/manual infusion), use and dose of concomitant
drugs (i.e. analgesics, anticholinergics, antiemetics, hypnotics,
vasoactive drugs), use of regional anaesthesia in addition to
general anaesthesia).
4. Outcomes: data for all reported review outcomes to include
study author definitions, measurement tools, and time points.
We considered the applicability of information from individual
studies and generalizability of the data to our intended study pop-
ulation (i.e. the potential for indirectness in our review). If there
were associated publications from the same study, we created a
composite data set from all the eligible publications.
Assessment of risk of bias in included studies
We assessed study quality, study limitations, and the extent of
potential bias using the Cochrane ’Risk of bias’ tool (Higgins
2011). We considered the following domains.
1. Sequence generation (selection bias).
2. Allocation concealment (selection bias).
3. Blinding of participants, personnel, and outcomes assessors
(performance and detection bias).
4. Incomplete outcome data (attrition bias).
5. Selective outcome reporting (reporting bias).
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6. Other - use of concomitant drugs.
It is not feasible to blind personnel to the study intervention, and
we acknowledge that this introduces an unavoidable risk of per-
formance bias in any eligible study. However, it is feasible for out-
come assessors to be blinded for all outcomes, except hypotension.
In addition to the standard risk of bias domains, we also collected
data on the use of concomitant drugs such as opiate analgesics, an-
ticholinergics, antiemetics, and benzodiazapines, which are known
or suspected to increase the risk of delirium (Clegg 2011).
For each domain, two review authors (SRL and DM, OSR, or
MP) judged whether study authors made sufficient attempts to
minimize bias in their study design. We made judgements using
three measures - high, low, or unclear risk of bias. We recorded
this in ’Risk of bias’ tables and presented a summary ’Risk of bias’
figure.
Measures of treatment effect
We collected dichotomous data for 30-day mortality. We antici-
pated that postoperative delirium and postoperative cognitive dys-
function would be measured using a scale, either validated (e.g.
CAM) or determined by the study authors. We planned to es-
tablish an appropriate cut-off on such scales (delirium versus no
delirium), so that the data could be recorded as dichotomous. We
recorded data for hypotension as dichotomous using cut-offs de-
fined by the study authors. We collected length of recovery in the
PACU and length of hospital stay as continuous data.
Unit of analysis issues
It was possible that studies may have compared TIVA against dif-
ferent anaesthetic induction and maintenance strategies in multi-
arm study designs. For example, TIVA could be compared against
an IV inductionwith inhalationalmaintenance, and also against an
inhalational induction with inhalational maintenance within the
same study. For our primary analysis, we combined the two com-
parison groups for comparison with TIVA. In subgroup analysis,
however, we analysed these comparison groups separately against
TIVA, and used the ’halving’ method for the TIVA group to en-
sure that no double-counting occurred (Higgins 2011).
Dealing with missing data
In the event that study authors reported loss of participants during
follow-up, we did not impute values but reported data as analysed
by study authors. We used sensitivity analysis to explore the effect
of including studies with high risk of attrition bias. SeeDifferences
between protocol and review, and sensitivity analysis in Effects of
interventions.
Assessment of heterogeneity
We assessed whether there was evidence of inconsistency within
our results through consideration of heterogeneity. We assessed
clinical heterogeneity by comparing similarities between the par-
ticipants, the interventions, and outcomes in our included stud-
ies. We assessed statistical heterogeneity by calculation of the Chi
2 (with an associated P value) or I2 statistic (with an associated
percentage). We judged any heterogeneity above 60% as a reason
not to pool the data, unless we considered the heterogeneity to be
not clinically important.
As well as looking at the statistical results, we considered the point
estimates and the overlap of confidence intervals (CIs). If the CIs
overlap, then the results are more consistent. However, it is also
possible for combined studies to show a large consistent effect,
but with significant heterogeneity. We therefore interpreted het-
erogeneity with caution (Guyatt 2011a).
Assessment of reporting biases
We attempted to source published protocols for each of our in-
cluded studies using clinical trials registers. We compared pub-
lished protocols with published study results to assess the risk of
selective reporting bias. If there were sufficient studies, i.e. more
than 10 (Higgins 2011), we planned to generate a funnel plot to
assess the risk of publication bias in the review; an asymmetric
funnel plot may indicate potential publication of only positive re-
sults (Egger 1997).
Data synthesis
We completed a meta-analysis for outcomes for which we had
comparable effect measures from more than one study, and where
measures of heterogeneity indicated that pooling of results was
appropriate. We used the statistical calculator in Review Manager
5 (Review Manager 2014).
For dichotomous outcomes, for example, mortality rate, we cal-
culated the odds ratio (OR) using the summary data presented
in each trial. We used the Mantel-Haenszel effects model, un-
less events were extremely rare (1 per 1000), in which case we
planned to use the Peto method (Higgins 2011). For continuous
outcomes, for example, length of hospital stay, we used mean dif-
ference (MD). We used a random-effects statistical model which
allowed for differences between studies (for example, because of
different types of surgery (Borenstein 2010).
We calculated CIs at 95% and used a P value of 0.05 or below to
judge if a result was statistically significant.We consideredwhether
there was imprecision in the results of analysis by assessing the CI
around the relative effects measure; a wide CI suggested a higher
level of imprecision in our results. A small number of studies may
also reduce the precision (Guyatt 2011b).
Subgroup analysis and investigation of heterogeneity
Weundertook a subgroup analysis when there were sufficient stud-
ies that reported the relevant characteristic (Higgins 2011). We
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used RevMan 5 to calculate differences in subgroups, based on the
test for heterogeneity Chi2 statistics (Review Manager 2014); we
used a P value ≥ 0.05 to indicate a statistically significant differ-
ence between subgroups.
TheUnitedNations’ definition of old age is over 60 years, however
many surgical patients in early old age (under 80 years of age) are fit
with few comorbidities, whilst patients 80 years of age and over are
at an increased risk of adverse outcomes (NCEPOD 2010). Other
sources of potential heterogeneity include the urgency of surgery,
with non-elective surgery being associated with an increased risk
of postoperative cognitive problems (Raats 2015), and the use of
depth of anaesthesia monitoring, which is associated with a re-
duction in intra- and postoperative complications (Ballard 2012;
Chan 2013). We also used subgroup analysis to explore differ-
ences in results for the inhalational maintenance group, in which
induction was undertaken using either inhalational or IV agents.
We only conducted a subgroup analysis based on information pre-
sented in the written paper. In summary, subgroups were:
1. elderly (60 to 79 years of age) versus late elderly (80 years of
age or older);
2. elective versus non-elective surgery;
3. inhalational induction versus IV induction (as a subgroup
of inhalational maintenance only);
4. TCI versus non-TCI maintenance of anaesthesia (as a
subgroup of TIVA only); and
5. use of depth of anaesthesia monitoring.
Sensitivity analysis
We explored the potential effects of decisions made as part of the
review process in the following way.
1. We excluded all studies that we judged to be at high or
unclear risk of selection bias.
2. We excluded studies that we judged to have a high risk of
attrition bias because of missing data for a large number of
participants that were unevenly distributed or unclearly reported
between groups. See Differences between protocol and review.
3. We conducted a meta-analysis using the alternate meta-
analytic effects model (fixed-effect or random-effects).
We compared effect estimates from the above results with effect
estimates from the main analysis. We reported differences that
altered interpretation of the effect.
’Summary of findings’ tables and GRADE
The GRADE Working Group approach incorporates assessment
of indirectness, study limitations, inconsistency, publication bias,
and imprecision (Atkins 2004). We made these assessments at
each stage of our analysis detailed above (Data collection and
analysis; Assessment of risk of bias in included studies; Assessment
of heterogeneity; Assessment of reporting biases; Data synthesis).
This approach gives an overall measure of how confident we can
be that our estimate of effect is correct (Guyatt 2008).
We used the principles of the GRADE system to give an overall
assessment of the evidence relating to each of the following out-
comes: postoperative delirium, postoperative cognitive dysfunc-
tion, mortality within 30 days, intraoperative hypotension, length
of stay in the PACU, and overall hospital length of stay. We as-
sessed the certainty of the evidence using one of four judgements
(high, moderate, low, and very low).
One review author (SL) used the GRADEpro software to create
a ’Summary of findings’ table for each comparison (GRADEpro
GDT). Consensus was reached with a second author (MP) who
checked the table and approved judgements.
R E S U L T S
Description of studies
Results of the search
We screened 12,313 titles and abstracts from database searches,
results from clinical trials register searches, grey literature searches,
and forward and backward citation searches. We carried out full-
text review of 440 articles. We excluded 397 studies, and reported
details of 46 of these excluded studies. We identified 28 eligible
studies, and 11 ongoing studies. We found four studies awaiting
classification; we had insufficient information to assess review eli-
gibility for these studies. See Figure 1.
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Figure 1. Study flow diagram
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Included studies
We included 28 parallel design randomized controlled trials
(Ammar 2016; Biboulet 2012; Cai 2012a; Celik 2011; Chan
1996; Demeere 2006; Egawa 2016; Epple 2001; Geng 2017;
Gursoy 2015; Ishii 2016; Jellish 2003; Juvin 1997; Kim 2015a;
Lindholm 2013; Liu 2013; Longas 2004; Luntz 2004; Micha
2016; Moffat 1995; Nishikawa 2004; Rohan 2005; Tan 2009;
Tanaka 2017; Tang 2014; Trembach 2012; Tylman 2011; Zhang
2015). We sourced no quasi-randomized studies. Included stud-
ies had an assumed total of 4507 randomized participants; two
studies reported number of participants unclearly and we assumed
totals from other data in the study reports (Jellish 2003; Longas
2004).One included studywas an abstractwith sufficient informa-
tion regarding number of participants in each group and relevant
outcome data (Trembach 2012). See Characteristics of included
studies.
Study population and setting
Twenty-one studies specifically included elderly participants (
Biboulet 2012; Cai 2012a; Celik 2011; Chan 1996; Epple 2001;
Geng 2017;Gursoy 2015; Ishii 2016; Juvin 1997; Kim2015a; Liu
2013; Luntz 2004; Micha 2016; Moffat 1995; Nishikawa 2004;
Rohan 2005; Tan 2009; Tanaka 2017; Tang 2014; Trembach
2012; Zhang 2015). Seven studies did not report inclusion of el-
derly participants and we used mean ages reported in the baseline
characteristics table to ascertain that more than 75% of partici-
pants were > 60 years of age (Ammar 2016; Demeere 2006; Egawa
2016; Jellish 2003; Lindholm 2013; Longas 2004; Tylman 2011).
All participants were undergoing surgery which were typical of
elderly patients. Surgery types were:
1. vascular surgery: abdominal aortic aneurysm (AAA)
(Ammar 2016); open abdominal aortic surgery (Lindholm
2013); carotid endarterectomy (Jellish 2003; Longas 2004);
2. laparoscopic surgery: laparoscopic surgery
(choledocholithotomy, colectomy, sigmoidectomy) (Nishikawa
2004); laparoscopic cholecystectomy (Geng 2017; Trembach
2012);
3. abdominal surgery: abdominal surgery (Tan 2009);
laparotomy (Gursoy 2015); radical rectal resection surgery (Tang
2014); colorectal surgery (Tylman 2011); gastrectomy,
colectomy, or rectectomy (Ishii 2016);
4. orthopaedic surgery: total hip replacement (Biboulet 2012;
Chan 1996; Demeere 2006); hip arthroplasty, knee arthroplasty,
laminectomy, other orthopaedic surgery (Juvin 1997); hip
replacement, knee replacement, long bone fracture fixation,
spinal surgery (Kim 2015a); spinal surgery (Liu 2013); total knee
arthroplasty (Tanaka 2017);
5. ophthalmic surgery: cataract surgery (Epple 2001), cataract
extraction and lens implantation (Moffat 1995); ophthalmic
surgery (Luntz 2004); and
6. mixed surgery to include: oesophagectomy, gastrectomy,
nephrectomy and fracture reduction (Cai 2012a); urological
surgery (Celik 2011); one-lung surgery (Egawa 2016); minor
urological or gynaecological surgery (Rohan 2005); tumour
resection (Micha 2016); radical surgery (Zhang 2015).
We noted American Society of Anesthesiologists (ASA) status re-
ported in studies. Four studies recruited participants with ASA I
to II and did not report breakdown per group (Ammar 2016; Ishii
2016; Liu 2013; Tan 2009). Four studies recruited participants
with ASA I to II (Juvin 1997; Kim 2015a; Nishikawa 2004; Zhang
2015), and most participants in these studies were ASA II. Eight
studies recruited participants with ASA I to III; in four studies
most participants were ASA II (Celik 2011; Chan 1996; Egawa
2016; Epple 2001), in one study most participants were ASA II
and III (Micha 2016), and four studies did not report breakdown
per group (Gursoy 2015; Luntz 2004; Moffat 1995; Tang 2014).
One study recruited participants who were ASA II and III; in one
studymost participantswereASA II (Geng 2017), and in one study
ASA status was evenly distributed (Tanaka 2017). Three studies
recruited participants who were all ASA III (Jellish 2003; Longas
2004; Trembach 2012), and one study recruited participants who
were ASA II, III, and IV, andmost were ASA III (Lindholm 2013).
One study recruited participants who were ASA III and IV, and
most were ASA III (Biboulet 2012); this study recruited partici-
pants > 75 years of age. Four studies reported no ASA status (Cai
2012a; Demeere 2006; Rohan 2005; Tylman 2011). One study
recruited participants with a body mass index (BMI) > 30 kg/m².
Whilst some studies excluded patients who had existing neurolog-
ical, psychiatric or cognitive disorders, or had dementia symptoms
(Cai 2012a; Egawa 2016; Geng 2017; Gursoy 2015; Kim 2015a;
Lindholm 2013; Micha 2016; Nishikawa 2004; Rohan 2005; Tan
2009; Tanaka 2017), we noted two studies included only partic-
ipants who had existing mild cognitive impairment (Liu 2013;
Tang 2014).
Interventions and comparators
All studies compared total intravenous anaesthesia (TIVA) using
propofol versusmaintenance anaesthesia using inhalational agents.
Six studies were multi-arm studies and included additional TIVA
groups or additional inhalational maintenance or both (Demeere
2006; Geng 2017; Juvin 1997; Longas 2004; Luntz 2004; Zhang
2015).
Ten studies described propofol anaesthesia using target-controlled
infusion (TCI) (Biboulet 2012; Demeere 2006; Egawa 2016;
Geng 2017; Kim 2015a; Moffat 1995; Nishikawa 2004; Rohan
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2005; Tylman 2011; Zhang 2015).
Nineteen studies compared TIVA versus maintenance using
sevoflurane (Ammar 2016; Biboulet 2012; Celik 2011; Demeere
2006; Egawa 2016; Geng 2017; Gursoy 2015; Ishii 2016; Kim
2015a; Lindholm 2013; Liu 2013; Longas 2004; Luntz 2004;
Micha 2016; Nishikawa 2004; Rohan 2005; Tang 2014; Tylman
2011; Zhang 2015). Eight studies compared TIVA versus main-
tenance using isoflurane (Cai 2012a; Chan 1996; Epple 2001;
Geng 2017; Jellish 2003; Juvin 1997; Moffat 1995; Tan 2009).
Three studies compared TIVA versus maintenance using desflu-
rane (Demeere 2006; Juvin 1997; Tanaka 2017). One study de-
scribed the comparator as volatile induction and maintenance
anaesthesia (VIMA) and did not report details of the anaesthetic
agents (Trembach 2012).
Seven studies used inhalation agents during induction of partic-
ipants in the inhalational maintenance groups (Biboulet 2012;
Nishikawa 2004; Rohan 2005; Tang 2014; Trembach 2012;
Tylman 2011; Zhang 2015). Twenty studies used intravenous
agents during induction of participants in the inhalational mainte-
nance groups (Ammar 2016; Cai 2012a; Celik 2011; Chan 1996;
Demeere 2006; Egawa 2016; Epple 2001; Geng 2017; Gursoy
2015; Ishii 2016; Jellish 2003; Juvin 1997; Lindholm 2013; Liu
2013; Longas 2004; Luntz 2004; Micha 2016; Moffat 1995; Tan
2009; Tanaka 2017). Two studies used propofol and inhalation
agents during induction of participants in the inhalational mainte-
nance groups (Kim 2015a; Luntz 2004); Luntz 2004 was a multi-
arm study that included a group that used only inhalation agents
during induction.
Six studies reported use of epidural for anaesthesia and postoper-
ative analgesia in addition to general anaesthesia (Ammar 2016;
Egawa 2016; Ishii 2016; Lindholm 2013;Nishikawa 2004; Zhang
2015). We noted 13 studies administered fentanyl (Ammar 2016;
Cai 2012a; Chan 1996; Egawa 2016; Ishii 2016; Juvin 1997;
Longas 2004;Micha 2016; Rohan 2005; Tan 2009; Tanaka 2017;
Tang 2014; Zhang 2015), and three studies administered remifen-
tanil (Biboulet 2012; Celik 2011; Luntz 2004) during induc-
tion or maintenance or both. One study administered fentanyl
at induction, and remifentanil during maintenance (Geng 2017).
Two studies administered remifentanil in only the TIVA group
(Gursoy 2015; Kim 2015a), and one study administered fentanyl
in only the TIVA group (Trembach 2012). Two studies admin-
istered remifentanil to participants in the TIVA group, and fen-
tanyl to participants in the inhalational maintenance group (Epple
2001; Jellish 2003), and two studies administered fentanyl and
remifentanil in the TIVA group and only fentanyl in the inhala-
tional maintenance group (Lindholm 2013; Tylman 2011). Two
studies administered sufentanil (Demeere 2006; Liu 2013). We
have included details of other analgesics and agents as part of
routine anaesthetic management in Characteristics of included
studies.
Fourteen studies described use of bispectral index (BIS) for moni-
toring of depth of anaesthesia (Ammar 2016; Biboulet 2012; Cai
2012a; Demeere 2006; Egawa 2016; Geng 2017; Ishii 2016; Kim
2015a; Lindholm 2013; Liu 2013; Longas 2004; Micha 2016;
Tang 2014; Zhang 2015), and one study used Sedline for moni-
toring of depth of anaesthesia (Tanaka 2017). Other studies used
standard care (e.g. clinical assessment, vital signs, and end-tidal
concentration of anaesthetic agent (for inhalational agents) or cal-
culated concentrations of anaesthetic agent (for TCI TIVA)), or
did not describe monitoring and we assumed standard care was
used.
We noted that one study (Cai 2012a) used anaesthetic methods
that differed from standard practice. Participants were exposed
to a disproportionately high dose of isoflurane (2% to 3% end-
tidal concentration; equivalent to 2.06 to 3.09 minimum alveo-
lar concentration (MAC) at age 70 years) compared to propofol
(target concentration 3 µg/mL; a conventional dose for this age
group (Al-Rifai 2016)). This methodological criticism was raised
by Deiner 2012, who postulated that participants in Cai 2012a
had been exposed to a toxic dose of isoflurane; this was not dis-
puted in the study authors’ subsequent response (Cai 2012b).
Funding sources
Ten studies reported department funding or external funding
sources that we assumed to be independent (Ammar 2016;
Biboulet 2012; Cai 2012a; Egawa 2016; Geng 2017; Kim 2015a;
Lindholm 2013; Liu 2013; Rohan 2005; Tang 2014). Four studies
reported support from pharmaceutical companies (Epple 2001;
Juvin 1997; Luntz 2004; Tanaka 2017). The remaining 14 studies
reported no details of funding sources (Celik 2011; Chan 1996;
Demeere 2006; Gursoy 2015; Ishii 2016; Jellish 2003; Longas
2004; Micha 2016; Moffat 1995; Nishikawa 2004; Tan 2009;
Trembach 2012; Tylman 2011; Zhang 2015).
Excluded studies
We excluded 397 articles following review of full texts where avail-
able. See Figure 1.
We excluded 24 articles because they were not RCTs (for example:
commentaries; editorials; observational or cohort studies). Many
studies did not report participant age within the abstract and there-
fore, we considered participant age from full texts. We excluded
292 studies inwhich participants had amean age less than 60 years,
or the study inclusion criteria was 18 to 65 years of age (in which
case, these studies had participants with a mean age less than 60
years), or we calculated that fewer than 75% of participants were
more than 60 years of age. We excluded five articles that reported
details of retracted studies and three studies for which we were
unable to access full texts and information in abstracts was insuf-
ficient. We excluded 27 studies that did not compare a propofol-
based TIVA versus an inhalational maintenance anaesthetic agent.
We did not include references for these studies in the review.
We excluded 46 RCTs that compared propofol-based TIVA ver-
sus an inhalational maintenance anaesthetic agent and did not
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measure any of our review outcomes (Arar 2005; Arnaoutoglou
2007; But 2003; Carles 2008;Doe 2016; Filipovic 2007; Fredman
2002; Gasowska 1999; Gauger 2008; Guedes 1988; Halberg
1996; Holst 1993; Hosseinzadeh 2013; Ionescu 2009; Ito 2012;
Kadoi 2009a; Kim 2015b; Konstantopoulos 2013a; Kvarnstrom
2012; Malcharek 2015; Manolescu 2012; Mets 1992; Murray
1994; Mutch 1995; Ohe 2014; Oikkonen 1992; Passot 2005;
Pirttikangas 1996; Polarz 1995; Sal’nikov 2003; Schäfer 2002;
Schilling 2007; Schilling 2011; Shao 2013; Sohn 2008; Sugata
2012; Trifu 2011; Tufano 2000; Ueda 1999; Wakabayashi
2014; Weilbach 2005; Wen 2010; Wormald 2005; Yu 2010a;
Zabolotskikh 2013; Zhang 2014). It was a post-hoc decision to
exclude studies that did not measure the review outcomes and we
have included references and additional details for these 46 studies
in Characteristics of excluded studies.
Awaiting classification
We found four studies for which we had insufficient informa-
tion to assess eligibility or extract data (IRCT2015112925277N1;
McDonagh 2012; NCT02766062; Shen 2011). Two studies were
described as completed in clinical trials registers; study results were
not posted in the register and we were unable to source a published
full-text reports for these studies (IRCT2015112925277N1;
NCT02766062). One study was published as an abstract and re-
ported insufficient information to assess eligibility (McDonagh
2012). One study requires translation from Chinese to assess
eligibility (Shen 2011). See Characteristics of studies awaiting
classification.
Ongoing studies
We found 11 ongoing studies from clinical trials regis-
ter searches, with an estimated 3704 participants. All stud-
ies compare TIVA with inhalation anaesthetic agents. Eight
studies specifically include older participants (ChiCTR-IOR-
16009851; NCT01809041; NCT01995214; NCT02133638;
NCT02301676; NCT02458547; NCT02662257;
NCT03165396); remaining studies do not specify age and we will
ascertain mean age of participants once the studies are completed.
Nine studies aim to report data for our postoperative delirium
or postoperative cognitive dysfunction (POCD) (ChiCTR-IOR-
16009851; NCT01809041; NCT01995214; NCT02107170;
NCT02133638; NCT02301676; NCT02662257;
NCT03165396; NCT03194074). See Characteristics of ongoing
studies.
Risk of bias in included studies
See Figure 2 and Figure 3, and Characteristics of included studies.
Figure 2. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Thirteen studies reported adequate randomization methods and
we judged these studies to have low risk of selection bias (Ammar
2016; Cai 2012a; Chan 1996; Egawa 2016; Epple 2001; Geng
2017; Jellish 2003; Kim 2015a; Liu 2013; Luntz 2004; Tanaka
2017; Tang 2014; Zhang 2015). Remaining studies reported in-
sufficient details of randomization methods to judge risk of selec-
tion bias.
Only three studies reported adequate methods to conceal alloca-
tion andwe judged these to have low risk of allocation bias (Ammar
2016; Egawa 2016; Rohan 2005). Remaining studies reported no
details and we were unable to judge risk of selection bias.
Blinding
It was not feasible to blind personnel to anaesthetic management
and we judged all studies to have high risk of performance bias.
For studies that reported data for more than one outcome we
judged risk of detection bias for our primary outcomes. For stud-
ies that did not report our primary outcomes, we judged risk of
detection bias on our secondary outcomes. Thirteen studies had
adequately reported whether personnel responsible for outcome
assessment were blinded to the intervention and we judged these
studies to have low risk of detection bias (Ammar 2016; Cai 2012a;
Celik 2011; Chan 1996; Egawa 2016; Geng 2017; Ishii 2016;
Juvin 1997; Micha 2016; Nishikawa 2004; Rohan 2005; Tanaka
2017; Tang 2014). Attempts to blind assessors was not described
in Liu 2013; the only review outcome of interest was mortality and
we believed assessment of this outcome had low risk of detection
bias.
One study reported that assessment of discharge from PACU was
completed by personnel aware of group allocation and we judged
this study to have high risk of detection bias (Epple 2001).
Remaining studies reported insufficiently whether outcome asses-
sors were blinded to group allocation.
Incomplete outcome data
Twenty-two studies reported no losses or few losses that were
clearly reported and balanced between groups and we judged these
studies to have a low risk of bias (Ammar 2016; Biboulet 2012;
Celik 2011;Chan 1996;Demeere 2006; Egawa 2016; Epple 2001;
Geng 2017; Gursoy 2015; Ishii 2016; Jellish 2003; Juvin 1997;
Kim 2015a; Lindholm 2013; Longas 2004; Luntz 2004; Moffat
1995; Nishikawa 2004; Rohan 2005; Tan 2009; Trembach 2012;
Zhang 2015). We noted a large number of losses (> 10%) in three
studies and were unclear whether risk of attrition bias could influ-
ence outcome data (Cai 2012a; Liu 2013; Tang 2014).
We judged three studies to have high risk of attrition bias (Micha
2016; Tanaka 2017; Tylman 2011). Micha 2016 reported loss of
participants at nine months but did not include data for these
participants at an earlier time point of seven days. Tanaka 2017
reported a large number of losses and reasons for losses were not
clearly reported by group. Tylman 2011 reported a post-hoc de-
cision to exclude participants due to particular conditions; these
lost participants belonged to only the inhalational maintenance
group.
Selective reporting
Three studies reported retrospective clinical trials registration
(Ammar 2016; Geng 2017; Tanaka 2017). It was not feasible to
assess risk of selective outcome reporting bias from these docu-
ments. We judged Ammar 2016 and Geng 2017 to have unclear
risk of bias. In Tanaka 2017, however, we noted that one outcome
was listed in the methods section but not reported in the results,
and some outcome data were inconsistently reported; therefore,
we judged this study to have high risk of selective outcome report-
ing bias.
Two studies reported prospective clinical trials registration (Kim
2015a; Lindholm 2013). We judged Kim 2015a to have a low risk
of selective reporting bias, although we noted that secondary out-
comes were not reported as described in the clinical trials register
documents (i.e. MAP was reported, rather than hypotension). It
was not feasible to assess risk of selective outcome reporting bias in
Lindholm 2013 because the clinical trials registration documents
did not report intended outcomes.
Remaining studies did not report clinical trials registration or
prospectively published study protocols and it was not feasible to
assess risk of selective reporting bias for these studies.
Other potential sources of bias
Wenoted no other sources of bias in 12 studies and judged these to
have low risk of other biases (Ammar 2016; Biboulet 2012; Celik
2011; Chan 1996; Gursoy 2015; Liu 2013; Longas 2004; Luntz
2004; Micha 2016; Nishikawa 2004; Tang 2014; Zhang 2015).
Six studies reported differences between groups in administration
of fentanyl or remifentanil and it is unclear whether these dif-
ferences may influence outcome data (Epple 2001; Jellish 2003;
Kim 2015a; Lindholm 2013; Trembach 2012; Tylman 2011). We
noted baseline imbalances between groups, or differences in length
of surgery or durationof anaesthesia in five studies (Demeere 2006;
Egawa 2016; Geng 2017; Juvin 1997; Tanaka 2017).
Four full-text study reports and one abstract contained limited
information in the report and it is unclear whether other sources
of bias were present (Demeere 2006; Ishii 2016; Rohan 2005; Tan
2009; Trembach 2012).
We noted differences in study design in Moffat 1995, which used
a different airway management technique in each group. This
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difference was related to the study aim which compared the use
of neuromuscular blockade in addition to anaesthetic agents for
maintenance. We were uncertain whether this may influence data.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings TIVA versus inhalational maintenance of anaesthesia
Primary outcomes
1. Postoperative delirium
Five studies reported postoperative delirium (Chan 1996; Ishii
2016; Micha 2016; Nishikawa 2004; Tanaka 2017).
Chan 1996 did not report the diagnostic tool used to assess delir-
ium which was reported nine hours postoperatively in one partici-
pant (associated with a transient episode of cerebral ischaemia), on
the second postoperative day in one participant,and on the fourth
postoperative day in one participant (associated with pneumonia).
Three studies used the Confusion Assessment Method (CAM) to
diagnose postoperative delirium (Ishii 2016; Micha 2016; Tanaka
2017). Micha 2016 made assessments at 48 hours postoperatively,
and Ishii 2016 did not report the time point of assessment. Tanaka
2017 made assessments at one, six, 24, and 48 hours postoper-
atively, although time points for reported data are not clear. We
noted differences in data between the published report for Tanaka
2017, and outcome data in the clinical trials register documents;
for primary analysis we used the data as reported in the published
study report. Nishikawa 2004 used the Delirium Rating Scale
(DRS) on the first, second, and third postoperative day; in order
to avoid risk of double-counting participants in this study, we in-
cluded data only for the third postoperative day.
We noted no difference in postoperative delirium according to
whether total intravenous anaesthesia (TIVA )or inhalational
maintenance of anaesthesia was used (odds ratio (OR) 0.59, 95%
confidence interval (CI) 0.15 to 2.26; 321 = participants; I2 =
17%; Analysis 1.1).
We used the GRADE approach to judge the certainty of the evi-
dence for postoperative delirium to be very low. We downgraded
by one level for study limitations; we noted few included studies
for this outcome had sufficiently reported themethods of random-
ization and we were concerned by high risk of attrition bias in two
studies and high risk of selective outcome reporting bias in one
study. We downgraded by two levels for inconsistency; we could
not be certain whether measurements of delirium, and time points
of measurement, were equivalent between studies, and we used
sensitivity analysis to show that choice of time point in one study
may influence direction of this result. See Summary of findings
for the main comparison.
2. Postoperative cognitive dysfunction (POCD)
Thirteen studies reported on POCD (Cai 2012a; Egawa 2016;
Geng 2017; Gursoy 2015; Juvin 1997; Lindholm 2013; Liu 2013;
Micha 2016;Moffat 1995; Rohan 2005; Tan 2009; Tanaka 2017;
Tang 2014). Nine studies used the Mini-Mental State Examina-
tion (MMSE) or Mini Mental Test (MMT) (Cai 2012a; Egawa
2016; Geng 2017; Gursoy 2015; Juvin 1997; Liu 2013; Micha
2016; Rohan 2005; Tan 2009); two of these studies used ad-
ditional tools, which are reported in Characteristics of included
studies (Egawa 2016; Geng 2017). Tanaka 2017 assessed post-
operative cognitive function with the Digit Symbol Substitution
Test (DSST), Digit Span, and Trail Making tests.The remaining
studies did not report diagnostic tools used to measure POCD.
Seven studies (2869 participants) reported data as number of par-
ticipants who had POCD: Cai 2012a at three days postopera-
tively; Egawa 2016 at five days postoperatively; Geng 2017 at one
and three days postoperatively, and we used data at three days;
Lindholm 2013 up to 30 days postoperatively; Micha 2016 and
Tanaka 2017 at 48 hours postoperatively; Rohan 2005 on the day
following surgery; Tang 2014 at seven days postoperatively. Geng
2017 reported data for two inhalational maintenance arms (isoflu-
rane and sevoflurane) and we combined data for these groups. In
Tanaka 2017, we used data provided from study authors (follow-
ing email communication) for Trail Making (part A). Owing to
concern about methodology in Cai 2012a, in particular that par-
ticipants may have been exposed to a toxic dose of inhalational
agent, we did not include this large study in the primary analysis.
We found fewer incidences of POCD in participants following
use of TIVA (OR 0.52, 95% CI 0.31 to 0.87; 869 participants; I
2 = 41%; Analysis 1.2).
Three studies (160 participants) reported data as mean (standard
deviation (SD)), or mean (range), scores for POCD and we re-
ported these data in Table 1; we used time points at 24 hours post-
operatively (Gursoy 2015; Tan 2009), and two hours postopera-
tively (Moffat 1995). We noted no apparent differences in these
scores from visual inspection.
One study reported data in a figure, which we were unable to in-
terpret for this outcome; study authors reported that postopera-
tive psychometric evaluations were similar in each groups (Juvin
1997).
One study included participants with amnesic mild cognitive im-
pairment (aMCI) and assessed progression at two years postoper-
atively using the MMSE; we did not include data for this study in
the analysis because this time point was not comparable to other
included studies (Liu 2013). Study authors reported that 30/55
participants in the sevoflurane group had aMCI at two years, and
17/52 participants in the propofol group had aMCI.
We used the GRADE approach to judge the certainty of the evi-
dence for POCD to be low. We downgraded by one level for study
limitations; we noted that some studies had insufficiently reported
methods of randomization and we were concerned by high risk of
attrition bias in one study. We downgraded by one level for incon-
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sistency; we noted a moderate level of statistical heterogeneity (I²
= 41%) which we could not explain. See Summary of findings for
the main comparison.
Secondary outcomes
1. Mortality at 30 days
Four studies reported on mortality (Ammar 2016; Biboulet 2012;
Lindholm 2013; Liu 2013). Liu 2013 reported the number of
participants who were lost to follow-up because of death; three
participants died but these deaths were not reported by group.
We included Ammar 2016, Biboulet 2012 and Lindholm 2013
in the analysis which demonstrated no difference in the number
of deaths at 30 days according to whether TIVA or inhalational
maintenance of anaesthesia was used (OR 1.21, 95% CI 0.33 to
4.45; 271 participants; I2 = 0%; Analysis 1.3).
We used the GRADE approach to judge certainty of the evidence
for mortality to be very low. We downgraded by one level for study
limitations because we noted that some studies had insufficiently
reportedmethods of randomization.We downgraded by two levels
for imprecision because the analysis included only three studies
with few participants and, because deaths due to anaesthesia are
rare, we would require a large sample size to show evidence of a
difference. See Summary of findings for the main comparison.
2. Intraoperative hypotension
Twelve studies reported data for intraoperative hypotension (
Biboulet 2012; Chan 1996; Geng 2017; Jellish 2003; Lindholm
2013; Longas 2004; Luntz 2004; Micha 2016; Nishikawa 2004;
Tang 2014; Trembach 2012; Zhang 2015). We included data for
11 studies in the analysis; one study (Lindholm 2013), reported
data as median number of episodes lasting more than two minutes
and we reported these data in Table 1.
We included hypotension as defined by study authors, which was
reported as a change from baseline in mean arterial pressure.
We included three multi-arm studies in analysis (Longas 2004;
Luntz 2004; Zhang 2015). For Luntz 2004, we combined data
from the two inhalational maintenance groups (one that used total
sevoflurane anaesthesia, and one that used propofol inductionwith
sevoflurane maintenance). For Longas 2004, we combined data
from the two inhalational maintenance groups (one used sevoflu-
rane 1 MAC, and one used sevoflurane 1.5 MAC). For Zhang
2015, we combined the two TIVA groups (one used additional
epidural anaesthesia) versus combined data for the two sevoflurane
groups (one used additional epidural anaesthesia).
We noted a high level of statistical heterogeneity (I2 = 63%), and
because we expected that studies had clinical variation in theman-
agement strategy and medication used to manage hypotension,
we did not combine data in a meta-analysis. Visual inspection of
data demonstrated inconsistencies in results and we could not be
certain whether TIVA or inhalational maintenance anaesthesia re-
duces episodes of intraoperative hypotension. Unpooled data for
11 studies (945 participants) are presented in Analysis 1.4.
We used the GRADE approach to judge certainty of the evidence
for intraoperative hypotension to be low. We downgraded by one
level for study limitations; we noted some studies reported insuf-
ficient methods of randomization. We downgraded by one level
for inconsistency because of possible variation in clinical manage-
ment of participants in each study. See Summary of findings for
the main comparison.
3. Length of stay in the postoperative anaesthesia care unit
(PACU)
Eight studies reported the length of stay in the PACU (Celik
2011; Chan 1996; Demeere 2006; Epple 2001; Jellish 2003;
Juvin 1997; Kim 2015a; Tanaka 2017). Two of these studies were
multi-arm studies and reported data for TIVA versus maintenance
using sevoflurane and TIVA versus maintenance using desflurane
(Demeere 2006), and TIVA versus maintenance using isoflurane
and TIVA versus maintenance using desflurane (Juvin 1997). For
the primary analysis, we included data for the sevoflurane and
isoflurane groups; we assessed this decision in a sensitivity analysis
using data for the desflurane groups in each study. Data for length
of stay in the PACU were not clearly reported in Tanaka 2017,
and we noted discrepancies between the published study report
and the clinical trials registration documents; we did not report
data for this study.
We noted a substantial level of statistical heterogeneity between
studies (I2 = 94%), and we expected that there were differences
in study methods for this outcome (e.g. whether length of stay
in the PACU was reported as time until ready for discharge or
time until discharge occurred). We did not conduct meta-analysis
for this outcome because of these differences. Visual inspection
of data demonstrated inconsistencies in results and we could not
be certain whether TIVA or inhalational maintenance anaesthesia
reduces length of time in the PACU. Unpooled data for seven
studies (467 participants) are presented in Analysis 1.5.
We used the GRADE approach to judge the certainty of the evi-
dence for length of time in the PACU to be very low. We down-
graded the evidence by one level for study limitations; we noted
some studies reported insufficient methods of randomization. We
downgraded the evidence by two levels because of inconsistency;
we expected likely differences in study methods related to defini-
tions of time points ofmeasurement of this outcome. See Summary
of findings for the main comparison.
4. Length of hospital stay
Six studies reported length of hospital stay (Ammar 2016;
Demeere 2006; Jellish 2003; Juvin 1997; Lindholm 2013; Tylman
2011). Two of these studies were multi-arm studies and reported
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data for TIVA versus maintenance using sevoflurane and TIVA
versus maintenance using desflurane (Demeere 2006), and TIVA
versusmaintenance using isoflurane andTIVAversusmaintenance
using desflurane (Juvin 1997). For the primary analysis we in-
cluded data for the sevoflurane and isoflurane groups; we assessed
this decision in sensitivity analysis using data for the desflurane
groups in each study. Two studies reported data as median val-
ues with little or no difference between median number of days
in each group, therefore we did not include these data in analy-
sis (Lindholm 2013; Tylman 2011); data for these studies are re-
ported in Table 1.
We included four studies in meta-analysis and noted no difference
between participants given TIVA and participants given inhala-
tional maintenance anaesthesia in length of hospital stay (mean
difference (MD) -0.00, 95% CI -1.32 to 1.32; participants = 175;
I2 = 41%; Analysis 1.6).
We used the GRADE approach to judge the certainty of the evi-
dence for length of hospital stay to be very low. We downgraded
by two levels for imprecision because we included few studies with
few participants, and we downgraded by one level for inconsis-
tency because we noted moderate statistical heterogeneity and vi-
sual differences in the results. See Summary of findings for the
main comparison.
Subgroup analysis
We performed pre-planned subgroup analysis as follows.
1. Elderly (60 to 79 years of age) versus late elderly (80 years
of age or older)
We included no studies recruiting participants whowere > 80 years
of age.
2. Elective versus non-elective surgery
We identified no studies that described surgery as non-elective.
3. Inhalational induction versus intravenous (IV) induction
(as a subgroup of inhalational maintenance only)
Postoperative delirium: one study used inhalational agents at in-
duction (Nishikawa 2004), and four studies used propofol at in-
duction (Chan 1996; Ishii 2016; Micha 2016; Tanaka 2017). We
noted little or no difference in postoperative delirium in partici-
pants who had anaesthesia with TIVA versus anaesthesia induction
with propofol and inhalational maintenance (OR 0.42, 95% CI
0.11 to 1.67; 271 participants; 4 studies; Analysis 2.1). We noted
little or no difference between subgroups according to agents used
during induction (P = 0.27).
POCD: two studies used inhalational agents at induction (Rohan
2005; Tang 2014), and this analysis showed little or no difference
in incidences of POCD between groups (OR 0.87, 95% CI 0.50
to 1.50; 230 participants). Five studies used intravenous agents at
induction andwe found less POCDinparticipants when IV agents
had been used (OR 0.38, 95% CI 0.20 to 0.75; 639 participants).
We noted little or no difference between subgroups according to
agents used during induction (P = 0.07). See Analysis 2.2.
Mortality: one study used inhalational agents at induction (
Biboulet 2012) and two studies used propofol for induction
(Ammar 2016; Lindholm 2013). We noted little or no difference
between subgroups according to agents used during induction (P
= 0.53). See Analysis 2.3.
Intraoperative hypotension: we noted visual inconsistencies in the
data during our primary assessment of this outcome, which we
expected could be explained by differences in the clinical man-
agement of hypotension between studies and we did not conduct
meta-analysis. We used pre-planned subgroup analysis to assess
whether induction agents may explain inconsistencies in data be-
tween studies. However, we noted visual inconsistencies in one
of the subgroups (when induction was given with inhalational
agents), and expected that differences in clinical management be-
tween studies continued to affect the data such that subgroup anal-
ysis was not appropriate. See Analysis 2.4.
Length of stay in the PACU: we could not perform subgroup
analysis because we included no studies using inhalational agents
for induction.
Length of hospital stay: we could not perform subgroup analysis
because we included no studies using inhalational agents for in-
duction.
4. Target-controlled infusion (TCI) versus non-TCI
maintenance of anaesthesia (as a subgroup of TIVA only)
Postoperative delirium: one study used TCI (Nishikawa 2004),
and four studies did not report use of TCI for maintenance of
TIVA (Chan 1996; Ishii 2016; Micha 2016; Tanaka 2017). We
noted no difference in postoperative delirium when TCI had not
been used (OR 0.42, 95% CI 0.11 to 1.67; 271 participants;
Analysis 2.1). We noted little or no difference between subgroups
according to whether TCI had been used (P = 0.27).
POCD: we noted little or no difference between subgroups (P =
0.38). Whilst effect estimates in each subgroup favoured use of
TIVA, we found little or no difference in POCD when studies
used TCI (OR 0.31, 95% CI 0.07 to 1.38; 294 participants), or
when studies did not use TCI (OR 0.63, 95% CI 0.36 to 1.10;
575 participants). We noted a high level of statistical heterogeneity
(I² = 71%) between the studies that used TCI which we could not
explain. See Analysis 2.5.
Mortality: one study used TCI for maintenance of anaesthesia
(Biboulet 2012). We noted no difference between subgroups ac-
cording to whether TCI had been used (P = 0.53). See Analysis
2.3.
Intraoperative hypotension: we noted visual inconsistencies in the
data during our primary assessment of this outcome, which we
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expected could be explained by differences in the clinical manage-
ment of hypotension between studies and therefore, we did not
conduct meta-analysis. We used pre-planned subgroup analysis to
assess whether use of TCI maintenance may explain inconsistence
in data between studies. However, we noted visual inconsistencies
in each subgroup (TCI, and non-TCI) and expected that differ-
ences in clinical management between studies continued to af-
fect the data such that subgroup analysis was not appropriate. See
Analysis 2.6.
Length of stay in the PACU: we noted visual inconsistencies in
the data during our primary assessment of this outcome, which
we expected could be explained by differences in the definition
of time point for length of stay in PACU between studies and
we did not conduct meta-analysis. We used pre-planned subgroup
analysis to assess whether use of TCI maintenance may explain
inconsistence in data between studies. However, we noted visual
inconsistencies in one of the subgroups (non-TCI) and expected
that possible differences in time point definitions between studies
continued to affect the data such that subgroup analysis was not
appropriate. See Analysis 2.7.
Length of hospital stay: no studies used TCI for maintenance of
anaesthesia.
5. Use of depth of anaesthesia monitoring
We considered the use of any processed electroencephalogram
(EEG) for depth of monitoring. Fourteen studies described use
of bispectral index (BIS) for monitoring of depth of anaesthesia
(Ammar 2016; Biboulet 2012; Cai 2012a; Demeere 2006; Egawa
2016; Geng 2017; Ishii 2016; Kim 2015a; Lindholm 2013; Liu
2013; Longas 2004; Micha 2016; Tang 2014; Zhang 2015), and
one study used Sedline for monitoring of depth of anaesthesia
(Tanaka 2017). We compared studies that reported use any pro-
cessed EEG versus studies that used standard care for monitoring
(e.g. clinical assessment, vital signs, and end-tidal concentration
of anaesthetic agent (for inhalational agents) or calculated concen-
trations of anaesthetic agent (for TCI TIVA)).
Postoperative delirium: three studies used processed EEG (Ishii
2016; Micha 2016; Tanaka 2017) and when combined, we noted
little or no difference in whether anaesthesia was maintained with
TIVA or inhalation agents (OR 0.56, 95% CI 0.04 to 7.44;
211 participants). Two studies used standard care (Chan 1996;
Nishikawa 2004) and when combined we noted little or no differ-
ence in whether anaesthesia was maintained with TIVA or inhala-
tion agents (OR 1.00, 95%CI 0.14 to 7.06; 110 participants). We
noted no differences between subgroups (P = 0.73). See Analysis
3.1.
POCD: one study used standard care (Rohan 2005); this sin-
gle study showed no difference in POCD depending on whether
anaesthesia was maintained with TIVA or inhalation agents (OR
1.00, 95% CI 0.24 to 4.20; 30 participants). Six studies used pro-
cessed EEG or Sedline for depth of monitoring and when com-
bined we noted that fewer participants had experiences of POCD
when TIVA was used (OR 0.47, 95% CI 0.27 to 0.84; 839 par-
ticipants). We noted little or no difference between subgroups (P
= 0.35). See Analysis 3.2.
Mortality: all included studies used processed EEG for depth of
anaesthesia monitoring.
Intraoperative hypotension: we noted visual inconsistencies in the
data during our primary assessment of this outcome, which we
expected could be explained by differences in the clinical man-
agement of hypotension between studies and we did not conduct
meta-analysis. We used pre-planned subgroup analysis to assess
whether use of processed EEG may explain inconsistence in data
between studies. However, we noted visual inconsistencies in each
subgroup and expected that differences in clinical management
between studies continued to affect the data such that subgroup
analysis was not appropriate. See Analysis 3.3.
Length of stay in the PACU: we noted visual inconsistencies in
the data during our primary assessment of this outcome, which we
expected could be explained by differences in the definition of time
point for length of stay in PACU between studies and we did not
conduct meta-analysis. We used pre-planned subgroup analysis to
assess whether use of processed EEG may explain inconsistence
in data between studies. However, we noted visual inconsistencies
in one of the subgroups (use of processed EEG) and expected
that possible differences in time point definitions between studies
continued to affect the data such that subgroup analysis was not
appropriate. See Analysis 3.4.
Length of hospital stay: one study used processed EEG, and for
studies which used standard care; we noted little or no difference
in length of hospital stay depending on whether anaesthesia was
maintained with TIVA or inhalation agents (OR -0.27 minutes,
95% CI -1.40 to 0.86; 138 participants; Analysis 3.5). We noted
little or no difference between subgroups (P = 0.10).
Sensitivity analysis
1. Risk of bias judgements. In sensitivity analysis, we excluded
studies that we judged to be at high or unclear risk of selection
bias. We performed sensitivity analysis on studies that were pooled
in primary analysis.
1. Postoperative delirium: we excluded three studies from the
analysis, which did not alter interpretation of the effect (Ishii
2016; Micha 2016; Nishikawa 2004).
2. POCD: we excluded three studies from analysis, which did
not alter interpretation of the effect (Lindholm 2013; Micha
2016; Rohan 2005).
3. Mortality: we excluded two studies from analysis (Biboulet
2012; Lindholm 2013), the remaining study reported no deaths
in either group.
4. Length of hospital stay: we excluded two studies (Demeere
2006; Juvin 1997). We noted that the effect remained the same
but statistical heterogeneity was reduced (I² = 0%).
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2. Decisions made for missing data. In sensitivity analysis, we
excluded studies that we judged to be at high risk of attrition bias.
1. Postoperative delirium: we excluded two studies which did
not alter interpretation of the effect (Micha 2016; Tanaka 2017).
2. POCD: we excluded one study from analysis which did not
alter interpretation of the effect (Micha 2016).
3. Effectsmodel. In sensitivity analysis, we used the alternatemeta-
analytic effectsmodel for those outcomes in whichwe pooled data.
1. Postoperative delirium: we used a fixed-effect model which
did not alter interpretation of the result.
2. POCD: we used a fixed-effect model which did not alter
interpretation of the result.
3. Length of hospital stay: we used a fixed-effect model which
did not alter interpretation of the result.
Additional sensitivity analysis
We made decisions during the review process that may have in-
fluenced our review results. In sensitivity analysis, we assessed the
following decisions for each outcome.
1. In primary analysis, we included studies in which we used mean
ages reported in the baseline characteristics table to ascertain that
> 75% of participants were > 60 years of age (Ammar 2016;
Demeere 2006; Egawa2016; Jellish2003; Lindholm2013; Longas
2004; Tylman 2011). It was feasible that some participants in these
studies were not elderly.
1. Postoperative delirium: we included no studies in primary
analysis that may have included participants that were not elderly.
2. POCD: in sensitivity analysis, we removed Egawa 2016 and
Lindholm 2013 from analysis and this did not alter
interpretation of the effect.
3. Mortality: in sensitivity analysis, we removed Ammar 2016
and Lindholm 2013. One remaining study reported one death in
the TIVA group.
4. Length of hospital stay: in sensitivity analysis, we removed
three studies (Ammar 2016; Demeere 2006; Jellish 2003); it was
not possible to pool data because only one study remained.
2. In primary analysis, we included studies in which participants
had an existing neurological impairment at baseline (Liu 2013;
Tang 2014).
1. Postoperative delirium: we included no studies in primary
analysis that recruited participants with an existing neurological
impairment.
2. POCD: in sensitivity analysis, we removed Tang 2014 from
analysis. This did not alter our interpretation of the effect.
3. Mortality: we included no studies in primary analysis that
recruited participants with an existing neurological impairment.
4. Length of hospital stay: we included no studies in primary
analysis that recruited participants with an existing neurological
impairment.
3. In primary analysis, we made decisions to include data for
one time point when the study reported different time points
(Nishikawa 2004 reported postoperative delirium for the first and
second postoperative day, which we did not include in primary
analysis; Geng 2017 reported POCD for the first postoperative
day that we did not include in analysis).
1. Postoperative delirium: in sensitivity analysis, we used data
for the first postoperative day in Nishikawa 2004 and, whilst we
found no statistically significant difference in incidences of
delirium between groups, we noted a change in the direction of
effect and a reduced level of statistical heterogeneity (OR 0.41,
95% CI 0.13 to 1.29; 321 participants; 5 studies; I² = 11%).
This result was similar when we used data for the second
postoperative day in Nishikawa 2004 (OR 0.54, 95% CI 0.19 to
1.50; participants = 321; studies = 5; I² = 17%).
2. POCD: in sensitivity analysis, we used data for the first
postoperative day in Geng 2017.This did not alter interpretation
of the effect.
3. Mortality: we included no studies in which different time
points were reported.
4. In primary analysis, we made decisions to manage data for
multi-arm studies. We combined groups for POCD and intra-
operative hypotension (Geng 2017; Longas 2004; Luntz 2004;
Zhang 2015), and we used one inhalational maintenance group
for length of PACU stay, and length of hospital stay (sevoflurane
in Demeere 2006; isoflurane in Juvin 1997).
1. Postoperative delirium: we included no multi-arm studies
in analysis of this outcome.
2. POCD: in sensitivity analysis, we included data separately
for each inhalational maintenance group for Geng 2017. This
did not alter interpretation of the effect.
3. Mortality: we included no multi-arm studies in analysis of
this outcome.
4. Length of hospital stay: in sensitivity analysis, we included
data for the desflurane groups in Demeere 2006 and Juvin 1997.
We noted a change in the effect estimate which showed that
participants who had anaesthesia maintained with inhalational
agents had a shorter length of hospital stay (MD 0.10 days, 95%
CI 0.00 to 0.20; 175 participants; I² = 9%). However, this result
demonstrated only a small change in time and is unlikely to be
clinically important.
5. In primary analysis, we excluded one large study (because
of methodological differences that were inconsistent with usual
anaesthetic practice) in analysis of POCD (Cai 2012a).
1. POCD: in sensitivity analysis, we included Cai 2012a. This
increased statistical heterogeneity from I² = 41% to I² = 90%.
The direction of effect was not altered by including this study in
analysis (OR 0.32, 95% CI 0.11 to 0.93; 2869 participants; I2 =
90%).
D I S C U S S I O N
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Summary of main results
We included 28 studies with 4507 randomized participants. Four
studies are awaiting classification because we had insufficient in-
formation to assess eligibility. All included studies comparedmain-
tenance with propofol-based total intravenous anaesthesia (TIVA)
versus inhalational maintenance of anaesthesia.
We found little or no evidence of a difference in incidences of
postoperative delirium according to type of anaesthetic mainte-
nance agents from five studies (Chan 1996; Ishii 2016; Micha
2016; Nishikawa 2004; Tanaka 2017). We used sensitivity anal-
ysis to explore including different time points of outcome assess-
ment reported by one study (Nishikawa 2004), which may influ-
ence direction of effect for postoperative delirium. We found that
fewer people may experience postoperative cognitive dysfunction
(POCD) with propofol-based TIVA in seven studies. We excluded
one large study from analysis for POCD because study investiga-
tors had used a non-standard method of anaesthetic management.
Five additional studies reported data for POCD, which we were
unable to pool and we noted little or no difference in scores of
POCD in five of these studies, and in the remaining study the
time point was not comparable to other studies.
We found little or no evidence of a difference in mortality from
three studies (Ammar 2016; Biboulet 2012; Lindholm 2013). We
did not combine data in meta-analysis for intraoperative hypoten-
sion or length of stay in the postanaesthesia care unit (PACU); we
noted visual inconsistencies in the data and expected that these
might be explained by clinical differences between studies in the
management of hypotension and methodological differences in
definition of time points before discharge from the PACU. We
found little or no evidence of a difference in length of hospital
stay according to type of anaesthetic maintenance agent from four
studies.
Overall completeness and applicability of
evidence
We included studies that recruited participants who were more
than 60 years of age, and studies in which we calculated that more
than 75% participants were more than 60 years of age.
The included studies recruited people scheduled for non-cardiac
surgery under general anaesthesia. The surgery types were typical
of elderly patients but varied between studies to include: cardio-
vascular, laparoscopic, abdominal, orthopaedic, ophthalmic, and
mixed surgery (oesophagectomy, gastrectomy, nephrectomy, uro-
logical surgery, one-lung surgery, gynaecological surgery, tumour
resection, and radical surgery). The ASA status differed between
the included studies. Most studies included a majority of partici-
pants who were classed as ASA II; however, some studies included
only participants who were ASA III, and two studies also included
participants with an ASA status up to ASA IV (Biboulet 2012;
Lindholm 2013).
Anaesthetic management differed between studies, for example
with use of different intraoperative and postoperative analgesic
management, use of epidurals, or use of premedication. We also
noted differences in studies that used target-controlled infusion
(TCI) for TIVA, that used processed electroencephalogram (EEG)
for monitoring of depth of anaesthesia (bispectral index (BIS) or
Sedline), and that used inhalation agents only for induction and
maintenance.
These differences may introduce inconsistency and reduce the
overall applicability of the evidence.
Quality of the evidence
We found insufficient reporting of randomization methods in
many studies and all studies were at high risk of performance bias
because it was not feasible to blind anaesthetists for this study de-
sign. Thirteen studies had described blinding of outcome asses-
sors. Three studies had a high of risk of attrition bias, and we noted
differences in use of analgesics between groups in six studies, and
differences in baseline characteristics, which may have influenced
results in five studies. Few studies reported clinical trials registra-
tion and we could not assess risk of selective outcome reporting
bias.
We used the GRADE approach and considered study limitations
noted during ’Risk of bias’ assessment which may influence the
certainty of the evidence for each outcome. In addition, we iden-
tified few studies with few participants for two outcomes (mor-
tality, and length of hospital stay) which introduced imprecision.
We noted visual differences in some results which might be ex-
plained by differences in clinical management or methodologi-
cal designs which prevented pooling of data in meta-analysis and
introduced inconsistency. We judged evidence for postoperative
delirium, mortality, length of stay in the PACU, and length of
hospital stay to be very low certainty, and evidence for POCD,
and intraoperative hypotension to be low certainty.
We explored potential explanations for this heterogeneity in sub-
group analysis, in particular with consideration of whether in-
travenous agents were used during induction in the inhalational
maintenance group, whether TIVA was given using TCI, and
whether depth of anaesthesia was monitored. Results of subgroup
analyses did not appear to explain heterogeneity and we noted that
high levels of statistical heterogeneity remained in one or both
subgroups in each analysis. We were not confident that these sub-
groups alone could explain the differences between studies and the
levels of heterogeneity that prevented meta-analysis; we did not
explore this in additional subgroup analyses.
Potential biases in the review process
We conducted our reviewusingCochranemethodology, using two
review authors to select studies, extract data, and assess risk of bias
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according to our published protocol (Miller 2016).We conducted
a thorough search that included clinical trials registers, forward
and backward citation searching, and grey literature.
We reported changes from the protocol in Differences between
protocol and review. In particular, we found that studies did not
always define ’elderly’ using a cut-off of 60 years (according to
WHO2016b), and studies typically used an included age category
of 18 to 65 years. We excluded studies that used an age category
of 18 to 65 years, but we found that these studies had a mean age
for participants of less than 60 years and therefore this decision
did not affect choice of included studies for this review.
We made a post-hoc decision to exclude studies that did not mea-
sure our review outcomes. We included references for these stud-
ies in the review in order to inform readers of other studies that
compare intravenous versus inhalational maintenance anaesthesia
for different purposes.
We were cautious to assess the impact of decisions that we made
during the review process and used sensitivity analysis for this
purpose.
In particular, some studies may have included participants that
were younger than 60 years of age.When sufficient studies allowed
sensitivity analysis, we considered whether results differed if we
excluded these studies; we found no differences in the interpreta-
tion of effect estimates. In addition, we considered the effect of
including studies in which participants had an existing cognitive
impairment, and, again, found excluding relevant studies did not
alter the effect.
We considered the effect of decisions regarding which time point
to use in studies that reportedmore than one time point. For delir-
ium, we noted that, whilst there remained no statistical evidence
of a difference according to type of anaesthetic maintenance agent,
direction of effect changed when we used different time points
reported in one study. We believed that our decisions on which
time point to use may have the potential to affect interpretation
of the data and we used GRADE to downgrade the certainty of
the evidence for postoperative delirium.
We noted one large study which had methodological differences
in anaesthetic management that were not consistent with standard
anaestheticmanagement (Cai 2012a). For this reason, we excluded
Cai 2012a from analysis of POCD.We assessed this decision dur-
ing sensitivity, by including the study in analysis of POCD. The
direction of effect was not altered and we believed that the deci-
sion to exclude Cai 2012a from primary analysis did not affect the
conclusion of the review.
Also, we were unable to assess eligibility of four studies (see Studies
awaiting classification); inclusion of these studies may have influ-
enced the results (IRCT2015112925277N1; McDonagh 2012;
NCT02766062; Shen 2011).
Agreements and disagreements with other
studies or reviews
We found no reviews that specifically looked at intravenous ver-
sus inhalational maintenance of anaesthesia in elderly surgical pa-
tients.
One Cochrane Review considered intravenous versus inhalation
agents for transabdominal robotic assisted laparoscopic surgery
(Herling 2017). This review did not specifically include elderly
patients and no included randomized controlled trials measured
cognitive function, mortality, or length of stay. Another Cochrane
Review compared the two types of anaesthetic for emergence from
anaesthesia after brain tumour surgery (Prabhakar 2016). Again,
the patients were not specifically elderly and the review authors did
not seek the outcomes specified in our review. Another Cochrane
Review considered general anaesthesia versus regional anaesthe-
sia for hip fracture (a surgery which would typically include an
older patient population), however this review did not measure
outcomes related to cognitive function (Guay 2016). This review
does serve to remind us, however, that general anaesthesia is not
the only option and can be avoided for many operations (Lewis
2015).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We are uncertain whether maintenance with propofol-based total
intravenous anaesthesia (TIVA) or with inhalational agents affect
incidences of postoperative delirium, mortality, or length of hos-
pital stay. We identified 28 studies which assessed the effects of
propofol-based TIVA versus inhalational maintenance in elderly
surgical patients. Few of the included studies reported the effect
on postoperative delirium.
We found no evidence of a difference in postoperative delirium
according to type of anaesthetic agents used and we judged this
evidence to be very low certainty. We found low-certainty evi-
dence that propofol-based TIVA may reduce postoperative cog-
nitive dysfunction (POCD). We were unable to ascertain any ef-
fects on length of stay in postanaesthesia care unit (PACU); we
judged this evidence to be very low certainty, and we were unable
to ascertain any effects on intraoperative hypotension for which
we judged the evidence to be low certainty. We found little or no
evidence of a difference in mortality and length of hospital stay,
but this evidence was very low certainty.
Implications for research
We identified a large number of ongoing studies (11), which assess
the effects of propofol-based TIVA versus inhalational agents in
elderly surgical patients. This demonstrates continuing interest in
this research field and including these studies in future review up-
dates would increase certainty of the effect. The studies included
in this review did not separate data for participants that were frail
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elderly (or more than 80 years of age), and no studies specifically
included non-elective surgical patients. These are important sub-
groups and evidence for these groups of patients in future research
would be useful. We focused our review outcomes on postopera-
tive cognitive outcomes and length of stay; however we propose
that future reviewupdates consider postoperative nausea and vom-
iting as an additional relevant outcome.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ammar 2016
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 50
Inclusion criteria
1. People who were ASA II or III, and scheduled for elective infrarenal AAA repair
Exclusion criteria
1. Needed concomitant procedures other than AAA repair
2. Had experienced an acute coronary syndrome within 3 months
3. > 85 years of age
Type of surgery: elective infrarenal AAA repair
Baseline characteristics
TIVA group
1. Age, median (range): 70 (65 to 79) years
2. Gender, M/F: 20/5
3. NYHA score, median (range): 1 (1 to 2)
Inhalational maintenance group
1. Age, median (range): 71 (67 to 79) years
2. Gender, M/F: 19/6




Participants: n = 25; 0 losses
Induction details: propofol 1.5 mg/kg to 2 mg/kg, fentanyl 3 µg/kg, cisatracurium 0.1
mg/kg
Maintenance details: continuous infusion of propofol 4 mg/kg/hour to 6 mg/kg/hour,
and cisatracurium 2 µg/kg/min. BIS kept between 45 and 55
Additional regional anaesthesia: epidural analgesia before starting anaesthesia at T8-
T10. Epidural block with 12 mL bupivacaine hydrochloride 0.25%. 4 mL bupivacaine
injected 2 hours later as maintenance and every hour thereafter for postoperative epidural
analgesia
Other information: fluid loading was performed with 1.0 L of 6% 130/0.4 hydroxyethyl
starch (Voluven) infusion. Fluid and blood replacements were adjusted to maintain par-
ticipant haematocrit value above 30%. Norepinephrine and nicardipine were used if re-
quired (if MAP changed by > 20%) tomaintain haemodynamic stability. Normothermia
maintained. Acetaminophen IV postoperatively if required
Inhalational maintenance group
Participants: n = 25; 0 losses
Induction details: propofol 1.5 mg/kg to 2 mg/kg, fentanyl 3 µg/kg, cisatracurium 0.1
mg/kg
Maintenance details: sevoflurane 1 MAC, cisatracurium 2 µg/kg/min. BIS kept between
45 and 55
Additional regional anaesthesia and other information: epidural analgesia, epidural block
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Ammar 2016 (Continued)
and all other fluid management etc. was the same as the TIVA group
Outcomes 1. Kidney specific proteins
2. Serum creatinine and cystatin
3. Serum pro-inflammatory cytokines
4. Blood loss
5. Blood transfusion
6. Length of ICU and hospital stay
7. 30-day mortality
Notes Funding/declarations of interest: university funding. No conflicts of interest
Study dates: February 2012 to April 2014
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of a computer-generated random number ta-
ble
Allocation concealment (selection bias) Low risk Quote: “an independent statistician was assigned
to perform central randomization to ensure proper
concealment of the study management from the
patients and investigators until the release of the
final statistical results.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “one analyst was blinded in respect to the
drug under study during the procedure by covering
the lines, infusion pump, gas analyzer, and by nu-
meric codes during the whole process of data eval-
uation. Furthermore, physicians who were charged
for postoperative care of patients and for their dis-
charges from intensive care unit (ICU) and hospi-
tal were effectively blinded to the study design.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Retrospective registration with clinical trials reg-
ister (PACTR201505001095139). Not feasible to
assess risk of selective outcome reporting bias with
these documents
Other bias Low risk No other sources of bias identified
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Biboulet 2012
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 30
Inclusion criteria
1. > 75 years of age, ASA III or IV with severe cardiac comorbidities, presenting for
hip fracture and undergoing hip nailing or partial hip replacement
Exclusion criteria
1. Contraindication to spinal anaesthesia
2. Allergy to any of the anaesthetic drugs used
3. Existing total hip replacement
Type of surgery: total hip replacement
Baseline characteristics:
TIVA group (characteristics for 14 participants)
1. Age, mean (SD): 86 (± 6) years
2. Gender, M/F: 4/10
3. ASA grade: ASA III: 8; ASA IV: 6
Inhalational maintenance group (characteristics for 15 participants)
1. Age, mean (SD): 85 (± 6) years
2. Gender, M/F: 5/10




Participants: n =15; 1 loss (change to surgical techniquewhichwarranted study exclusion)
; 14 analysed
Induction details: initial target plasma concentration 1.5 µg/mL propofol, gradually
increased by increments of 0.5 µg/mL every 2 minutes until BIS of 50. Remifentanil 0.
25 µg/kg for 2 minutes, with repeated boluses if required to maintain BIS of 50 or HR
and MAP no more than 20% of baseline
Maintenance details: after intubation, propofol TCI decreased to 0.5 µg/mL, and titrated
to maintain BIS of 50. Remifentanil infusion 0.1 µg/kg/min, preceded by bolus of 0.25
µg/kg for 2 minutes
Other information: femoral nerve block with 30 mL ropivacaine 0.5% on arrival in
operating theatre
Inhalational maintenance group
Participants: n = 15; 1 loss (cardiac arrest during induction); 14 analysed
Induction details: sevoflurane, initially at 6%, decreased to 3% when BIS fell to 50.
Remifentanil 0.25 µg/kg for 2 minutes, with repeated boluses if required to maintain
BIS of 50 or HR and MAP no more than 20% of baseline
Maintenance details: after intubation, sevoflurane decreased to FiO2 0.5%, to maintain
BIS of 50. Remifentanil infusion 0.1 µg/kg/min, preceded by bolus of 0.25 µg/kg for 2
minutes
Other information: femoral nerve block with 30 mL ropivacaine 0.5% on arrival in
operating theatre. 1 g paracetamol given in recovery room, and, if score on VAS > 3, 1
mg IV morphine given every 5 minutes up to 10 mg
Outcomes 1. Biological data (serum urea nitrogen, creatinine, haemoglobin, troponin)
2. Stroke
3. Acute heart failure (after 1 month)
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Biboulet 2012 (Continued)
4. MI (after 1 month)
5. Mortality (after 1 month)
6. Times for anaesthesia
7. Haemodynamic data (to include number of participants given ephedrine for
hypotension - defined as 30% decrease in MAP from baseline value, lasting > 1 minute)
Notes Funding/declarations of interest: Department of Anaesthsia and Critical Care Unit,
Lapeyronie University Hospital, France. Study authors declare no conflicts of interest
Study dates: not reported
Note: study includes a group with continuous spinal anaesthesia. We have not included
data for this group in the review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly divided into groups;
no additional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk Few losses, unlikely to influence outcome data
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Low risk No other sources of bias identified
Cai 2012a
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 2216
Inclusion criteria
1. Elderly Han patients (Chinese ethnic group) scheduled to undergo general
anaesthesia
Exclusion criteria
1. Did not consent to be enrolled
2. Dementia symptoms
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7. Participants who required postoperative intensive care (because of bleeding,
inflammation, respiratory failure, heart failure, anastomotic leaks etc.) or required
postoperative sedation were excluded from analysis
Type of surgery: oesophagectomy, gastrectomy, nephrectomy, fracture reduction
Baseline characteristics
TIVA group
1. Age, mean (SD): 71.2 (± 3.8) years
2. Gender, M/F: 570/430
3. ASA grade: not reported
Inhalational maintenance group
1. Age, mean (SD): 69.3 (± 5.1) years
2. Gender, M/F: 570/430




Participants: n = 1106; 106 losses (anastomotic leaks, bleeding, respiratory failure, heart
failure, inflammation); 1106 analysed using ITT: 1000 analysed PP
Induction details: loading doses of fentanyl 4 µg/kg, propofol 3 mg/kg and vecuronium
0.08 mg/kg
Maintenance details: fentanyl continuous infusion 0.03 µg/kg/min, propofol continuous
infusion at a rate of 53.8 µg/kg/min injected with gradual increases in concentration of
0.4 µg/mL with initial target level of 1 µg/mL. Continuous infusion of vecuronium 0.5
µg/kg/min. BIS maintained at 40 to 60
Other information: premedicationwith 10mgdiazepam, 0.5mg atropine im 30minutes
before GA
Inhalational maintenance group
Participants: n = 1110; 110 losses (anastomotic leaks, bleeding, respiratory failure, heart
failure, inflammation); 1110 analysed using ITT; 1000 analysed PP
Induction details: loading doses of fentanyl 4 µg/kg, propofol 3 mg/kg and vecuronium
0.08 mg/kg
Maintenance details: continuous inhalation 2% to 3% end-tidal concentration isoflu-
rane. Continuous infusion of vecuronium 0.5 µg/kg/min. BIS maintained at 40 to 60
Other information: premedication same as TIVA group
Outcomes 1. MMSE (tested every day for 10 days)
2. Frequency distribution of ApoE alleles and genotypes
Notes Funding/declarations of interest: supported by grants from National Nature Science
Foundation of China, and by Doctor funding
Study dates: 2005 to 2010
Risk of bias
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Cai 2012a (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of a computerized random number generator
and block randomization
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Postoperative assessment ofMMSEwas carried out
by psychiatrists who were blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Reasons for losses are described and balanced be-
tween group but number of losses is large (> 10%)
and we were unclear whether this could influence
outcome data
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk We noted a discrepancy between table 2 and the
text in results section of the study report. Table 2
reports a big difference in MMSE scores at base-
line, with very low scores in the inhalation group,
and text reports no difference at baseline. We have
assumed that table 2 has a typo, because baseline
MMSE score is unusually low. We noted that data
in this study differed from other studies. We did
not identify any differences that could explain this,
and we could not be certain whether other sources
of unidentified bias were present
Celik 2011
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 100
Inclusion criteria
1. ASA I to III, aged 65 to 80 years, scheduled for elective urological surgery
estimated to last > 1.5 hours
Exclusion criteria
1. Routine use of sedative drugs
2. Requirement of dialysis
3. Emergency surgery
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Celik 2011 (Continued)
4. Cardiac and respiratory failure
Type of surgery: urological surgery
Baseline characteristics
TIVA group
1. Age, mean (SD): 69.2 (± 4.8) years
2. Gender, M/F: 38/12
3. ASA grade: ASA I: 18; ASA II: 24; ASA III: 8
Inhalational maintenance group
1. Age, mean (SD): 69.8 (± 3.9)
2. Gender, M/F: 36/14




Participants: n = 50; 0 losses
Induction details: premedicated with 0.06 mg/kg midazolam 45 minutes before surgery.
Prior to induction 5 mL/kg of IV fluid. Bolus dose 1 µg/kg remifentanil (over 30 to 60
seconds), and infusion of remifentanil at rate of 0.5µg/kg/min added simultaneously.
Propofol starting dose of 0.5 mg/kg and titrated thereafter at 10 mg every 10 seconds
until participant was unresponsive to verbal commands. Rocuronium 0.6 mg/kg
Maintentance details: remifentanil 0.25 µg/kg/min. Propofol 2 mg/kg/hour to 8 mg/
kg/hour. Fresh gas flow with 4 L/min oxygen 35% in air. Depth of anaesthesia adjusted
according to haemodynamic parameters
Other: tramadol 2mg/kg administered for hyperalgesia 30minutes before end of surgery
Inhalational maintenance group
Participants: n = 50; 0 losses
Induction details: premedicated with 0.06 mg/kg midazolam 45 minutes before surgery.
Prior to induction 5 mL/kg of IV fluid. Bolus dose 1 µg/kg remifentanil (over 30 to 60
seconds), and infusion of remifentanil at rate of 0.5µg/kg/min added simultaneously.
Propofol starting dose of 0.5 mg/kg and titrated thereafter at 10 mg every 10 seconds
until participant was unresponsive to verbal commands. Rocuronium 0.6 mg/kg
Maintenance details: remifentanil 0.25 µg/kg/min. Sevoflurane end expiratory levels 0
to 4% and MAC values at 0.5 to 1. Fresh gas flow with 4 L/min oxygen 35% in air.
Depth of anaesthesia adjusted according to haemodynamic parameters
Other: tramadol 2mg/kg administered for hyperalgesia 30minutes before end of surgery
Outcomes 1. Doses of remifentanil
2. Emergence and recovery times (to include length of stay in the PACU)




Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
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Celik 2011 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly divided into groups;
no additional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants assessed in recovery room by an inves-
tigator who was blinded to group allocations
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent losses
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Low risk No other sources of bias identified
Chan 1996
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 60
Inclusion criteria
1. ASA I, II, and III, 65 to 85 years of age, scheduled for total hip replacement
surgery
Exclusion criteria
1. Significant cardiovascular, respiratory, hepatic, or renal disease
Type of surgery: total hip replacement
Baseline characteristics
TIVA group
1. Age, mean (SD): 68.6 (± 8) years; 15 participants were > 70 years of age
2. Gender, M/F: 9/20
3. ASA grade: ASA I: 1; ASA II: 22; ASA III: 6
Inhalational maintenance group
1. Age, mean (SD): 70.2 (± 8) years; 15 participants were > 70 years of age
2. Gender, M/F: 8/23
3. ASA grade: ASA I: 1; ASA II: 23; ASA III: 7
Country: Canada
Setting: hospital
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Interventions TIVA group
Participants: n = 29; 0 losses
Induction details: propofol at 0.75 mg/kg/min via electronic pump. Succinylcholine 1.
0 mg/kg to 1.5 mg/kg to facilitate tracheal intubation
Maintenance details: 60%N2O inO2. Propofol increased/decreased by 50% in response
to 25% change in baseline BP or HR. Fentanyl 1 µg/kg (to a maximum of 4 µg/kg)
with increase of propofol. Intraoperative muscle relaxation maintained with vecuronium.
Propofol discontinued 5 minutes before end of surgery, N2O and O2 continued until
end of surgery. Postoperative pain management with IV morphine as required. Use of
clinical parameters (HR and BP) to monitor depth of anaesthesia
Other information: evening before surgery, participants were given triazolam 0.125 mg
to 0.25 mg, if required. Participants usual medication was withheld on morning of
surgery. Then as premedication given 10 mL/kg IV crystalloid, then vecuronium 1 mg,
and fentanyl 0.75 µg/kg
Inhalational maintenance groups
Participants: n = 31; 0 losses
Induction details : bolus of 2 mg/kg thiopental, titrated to 4 mg/kg within 60 seconds
as necessary. Succinylcholine 1.0 mg/kg to 1.5 mg/kg to facilitate tracheal intubation
Maintenance details: 60%N2O inO2. 0.5% to 1.5% isoflurane end-tidal concentration
increased/decreased by 50% in response to 25% change in baseline BP or HR. Fentanyl
1 µg/kg (to a maximum of 4 µg/kg) with increase of propofol. Intraoperative muscle
relaxation maintained with vecuronium. Isoflurane discontinued 5 minutes before end
of surgery, N2O and O2 continued until end of surgery. Postoperative pain management
with IV morphine as required
Other information: premedication etc. same as TIVA group
Outcomes 1. Dose requirement
2. Duration of anaesthesia
3. Haemodynamics (to include hypotension)
4. Myocardial ischemias
5. Recovery (to include time in PACU)
6. Mental alertness
7. Adverse effects (PONV)
Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of a computer-generated random number list
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
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Chan 1996 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Discharge from the PACU was assessed by a
blinded independent investigator. Study authors
do not report whether assessment of hypotension
was done by a blinded investigator
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Low risk N2O in O2 used in both groups in addition to
other agents. However, unlikely to affect results
Demeere 2006
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 60
Inclusion criteria
1. undergoing hip replacement under GA
Exclusion criteria
1. Not reported
Type of surgery: total hip replacement surgery
Baseline characteristics (table reported by study authors appears to include data for
number analysed not number randomized)
TIVA group
1. Age, mean (SD): 68.6 (± 10.9) years
2. Gender: 50% male
3. ASA grade: not reported
Inhalational maintenance group (sevoflurane)
1. Age, mean (SD): 72.8 (± 6.9) years
2. Gender: 11% male
3. ASA grade: not reported
Inhalational maintenance group (desflurane)
1. Age, mean (SD): 70.7 (± 8.7) years
2. Gender: 24% male




Participants: n =20; 1 loss (reasons for losses described only as ’methodological problems’)
; 19 analysed
Induction details: propofol 1%50mL, TCI 4 µg/mL via aDiprivusor, 3 µg/kg sufentanil.
Atracurium 0.5 µg/kg
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Demeere 2006 (Continued)
Maintenance details: 50% N2O and 50% O2. Propofol TCI, 10 mL atracurium, and
10 µg sufentanil as necessary. To maintain BIS ’around 40’
Other information: oral premedication with 0.25 or 0.5 mg alprazolam. BP maintained
above 80 mmHg with ephedrine as required
Inhalational maintenance group (sevoflurane)
Participants: n = 20; 2 losses (reasons for losses described only as ’methodological prob-
lems’); 18 analysed
Induction details: propofol 1% 20 mL (1 mg/kg/body weight to 2 mg/kg/body weight)
, 3 µg/kg sufentanil. Atracurium 0.5 µg/kg
Maintenance details: 50% N2O and 50% O2. 10 mL atracurium, and 10 µg sufentanil
as necessary. Sevoflurane to maintain BIS ’around 40’
Other information: oral premedication with 0.25 mg or 0.5 mg alprazolam. BP main-
tained above 80 mmHg with ephedrine as required
Inhalational maintenance group (desflurane)
Participants: n = 20; 0 losses
Induction details: propofol 1% 20 mL (1 mg/kg/body weight to 2 mg/kg/body weight)
, 3 µg/kg sufentanil. Atracurium 0.5 µg/kg
Maintenance details: 50% N2O and 50% O2. 10 mL atracurium, and 10 µg sufentanil
as necessary. Desflurane to maintain BIS ’around 40’
Other information: oral premedication with 0.25 mg or 0.5 mg alprazolam. BP main-
tained above 80 mmHg with ephedrine as required
Outcomes 1. Cost-effectiveness data
2. Length of stay in PACU
3. Length of hospital stay
Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomized to groups; no addi-
tional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk Although reasons for losses are not well described,
loss is small and unlikely to influence outcome data
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Demeere 2006 (Continued)
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk Limited detail in paper - does not include inclu-
sion/exclusion criteria. We noted a difference in
gender balance between groups
Egawa 2016
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 148
Inclusion criteria
1. Scheduled for one-lung surgery, 20 to 85 years of age, ASA I to III, fluency in
Japanese, ability to read, and absence of serious hearing or visual impairments that
would preclude neuropsychological testing
Exclusion criteria
1. Interstitial lung disease or lung fibrosis
2. Pregnancy or possibility of pregnancy
3. History of neurological or mental illness
4. Baseline MMSE score < 24
5. Renal insufficiency
6. Active liver disease
7. Documented coagulopathy
Type of surgery: one-lung surgery
Baseline characteristics
TIVA group
1. Age, median (IQR): 69 (63 to 73) years
2. Gender, M/F: 48/23
3. ASA grade: ASA I: 25; ASA II: 42; ASA III: 5
Inhalational maintenance group
1. Age, median (IQR): 72 (63 to 72) years
2. Gender, M/F: 39/33




Participants: n = 74; 2 losses (1 withdrew prior to surgery; 1 had surgery cancelled); 72
analysed (at 5 days postoperatively)
Induction details: propofol TCI 3 µg/mL to 4 µg/mL, bolus of fentanyl 2.0 µg/kg, to 2.
5 µg/kg, Rocuronium 0.6 mg/kg to 0.9 mg/kg
Maintenance details: TCI propofol, plus fentanyl, and epidural
Other information: epidural inserted between thoracic 5 to 6 and 7 to 8 intervertebral
spaces. No additional details
Inhalational maintenance groups
Participants: n = 74; 2 losses (1 withdrew prior to surgery; 1 had unsuccessful jugular
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Egawa 2016 (Continued)
vein cannulation); 72 analysed (at 5 days postoperatively)
Induction details : propofol 1 mg/kg to 2 mg/kg and fentanyl 2.0 µg/kg to 2.5 µg/kg
Maintenance details: sevoflurane, plus fentanyl and epidural. To maintain BIS 40 to 60
Other information: epidural same as TIVA group
Outcomes 1. POCD (defined as a decline of > 20% from baseline) at baseline, 5 days
postoperatively, and 3 months postoperatively using MMSE, Trail Making Test (Parts
A and B), Digit Span (forward and backward), and Grooved Pegboard Test (dominant
and non-dominant hands)
2. Oxygen saturation measures
3. Cerebral desaturation measures
Notes Funding/declarations of interest: department funding. Study authors declared no con-
flicts of interest
Study dates: March 2007 to January 2013
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of a computer-generated randomization list
Allocation concealment (selection bias) Low risk Allocation concealment was assured by the use of
numbered sealed opaque envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome was assessed by the same anaesthesiolo-
gist blinded to group allocation and not involved
in intraoperative management
Incomplete outcome data (attrition bias)
All outcomes
Low risk Few losses which were well reported
Selective reporting (reporting bias) Unclear risk Study authors report that clinical trials registration
was not required in Japan at the time of the start
of the study. Not feasible to judge risk of selective
reporting bias
Other bias Unclear risk Participants in the sevoflurane groups appeared to
have shorter duration of surgery and anaesthesia
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Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 124
Inclusion criteria
1. Geriatric participants > 65 years of age, ASA I, II, or III, scheduled for elective
cataract surgery under GA
Exclusion criteria
1. History of allergic reaction to one of the study drugs
Type of surgery: cataract surgery
Baseline characteristics
TIVA group
1. Age, mean (SD): 77 (± 6) years; participants described as ’geriatric’
2. Gender, M/F: 17/45
3. ASA grade: ASA I: 3; ASA II: 40; ASA III: 19
Inhalational maintenance group
1. Age, mean (SD): 76 (± 6) years; participants described as ’geriatric’
2. Gender, M/F: 17/45
3. ASA grade: ASA I: 1; ASA II: 39; ASA III: 22
Country: Germany
Setting: PACU in hospital
Interventions TIVA group
Participants: n = 62; 0 losses
Induction details: propofol 1.5 mg/kg and remifentanil 1.5 µg/kg over 3 minutes, 0.15
mg/kg mivacurium
Maintenance details: continuous infusion of propofol 0.05 mg/kg/min to 0.1 mg/kg/
min and remifentanil 0.15 µg/kg/min to 0.3 µg/kg/min. Haemodynamic parameters
used to monitor depth of anaesthesia
Other information: received no medication before surgery
Inhalational maintenance group
Participants: n = 62; 0 losses
Induction details: etomidate 0.1 mg/kg to 0.3 mg/kg and fentanyl 1.5 µg/kg, 0.15 mg/
kg mivacurium
Maintenance details: isoflurane 0.8 to 2.5 MAC and bolus of 0.1 mg fentanyl. Haemo-
dynamic parameters used to monitor depth of anaesthesia
Outcomes 1. Cost-benefit analysis
2. Anaesthetic and surgical time intervals
3. Emergence times
4. Time to discharge from PACU
5. Postanaesthetic adverse events (to include hypertension, PONV, shivering, pain
requiring intervention)
6. Patient satisfaction
Notes Funding/declarations of interest: supported by a grant from Glaxo Wellcome GmbH
Co., Hamburg, Germany
Study dates: not reported
Note: we identified an associated reference for this study (Kubitz 2001)
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of a computer-generated randomization list
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Discharge from the PACU judged by unblinded
anaesthetist
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk Use of remifentanil and fentanyl differs between
groups
Geng 2017
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 150
Inclusion criteria
1. ASA II to III, ≥ 65 years of age, sufficient level of education to be capable of
completing neuropsychological tests
Exclusion criteria
1. History of allergy to anaesthetics
2. Dialysis-dependent renal failure
3. Liver transaminase level < 1.5 times the normal value
4. MMSE score ≤ 26
5. Pre-existing diagnosis of schizophrenia or dementia
6. Recent stroke
7. Known disorder affecting cognition
8. Mental dysfunction
9. History of cerebral surgery
10. Severe anxiety
11. Recent history of alcohol abuse
12. History of chronic opioid or other psychotropic drug use
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Type of surgery: laparoscopic cholecystectomy
Baseline characteristics
TIVA group
1. Age: not reported
2. Gender, M/F: 20/30
3. ASA grade: ASA II: 35; ASA III: 15
Inhalational maintenance group (isoflurane)
1. Age: not reported
2. Gender, M/F: 18/32
3. ASA grade: ASA II: 33; ASA III: 17
Inhalational maintenance group (sevoflurane)
1. Age: not reported
2. Gender, M/F: 22/28




Participants: n = 50; 0 losses
Induction details: 5 minutes of pre-oxygenation, then midazolam 0.05 mg/kg, fentanyl
4 µg/kg, rocuronium 0.6 mg/kg. TCI 3.0 µg/kg propofol
Maintenance details: propofol with target concentration 2.5 µg/mL to 3.0 µg/mL.
Remifentanil 0.2 µg/kg/min to 0.3 µg/kg/min. To maintain BIS 40 to 50
Other information: all patients given crystalloids as required. All patients were given
flurbiprofen 100 mg and granisetron 3 mg at beginning of operation, and 0.25% ropi-
vacaine via local infiltration for postoperative analgesia
Inhalational maintenance groups
Participants: n = 50; 0 losses
Induction details: 5 minutes of pre-oxygenation, then midazolam 0.05 mg/kg, fentanyl
4 µg/kg, rocuronium 0.6 mg/kg. TCI 3.0 µg/kg propofol
Maintenance details: isoflurane 1.0 MAC to 1.5 MAC. Remifentanil 0.2 µg/kg/min to
0.3 µg/kg/min. To maintain BIS 40 to 50
Other information: fluids and analgesics same as TIVA group
Inhalational maintenance groups
Participants: n = 50; 0 losses
Induction details: 5 minutes of pre-oxygenation, then midazolam 0.05 mg/kg, fentanyl
4 µg/kg, rocuronium 0.6 mg/kg. TCI 3.0 µg/kg propofol
Maintenance details: sevoflurane 1.0 MAC to 1.5 MAC. Remifentanil 0.2 µg/kg/min
to 0.3 µg/kg/min. To maintain BIS 40 to 50
Other information: fluids and analgesics same as TIVA group
Outcomes 1. POCD on postoperative day 1 and 3 (using MMSE, vision test, the Digit Symbol
Substitution Test, the Cumulative test, digit span, forward and backward, Trail Making
Test Part A, the RAVLT, Grooved Pegboard Test (dominant and non-dominant hand)).
POCD defined as decline > 20% in at least 2 tests compared to baseline
2. Plasma concentrations or protein biomarkers of POCD
3. Proinflammatory markers
4. Duration of anaesthesia and emergence times
5. Use of vasoconstrictors
51Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-
cardiac surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Geng 2017 (Continued)
6. Hypotension (number of participants, number of episodes, and duration)
Notes Funding/declarations of interest:no funding and authors declare no conflicts of interest
Study dates: December 2010 to June 2011
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of a computer-generated random number ta-
ble
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk A blinded anaesthetist evaluated cognitive scores
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses
Selective reporting (reporting bias) Unclear risk Retrospective clinical trials registration (ChiCTR-
OCC-11001411). Not feasible to assess risk of se-
lective reporting bias
Other bias Unclear risk Some differences in duration of anaesthesia,
surgery times, and time to emergence from anaes-
thesia. We were not certain whether these differ-
ences were clinically significant. Also note that no
ages were reported in baseline characteristics
Gursoy 2015
Methods RCT, parallel group, single-centre
Participants Total number of participants: 60
Inclusion criteria
1. > 65 years of age, ASA I to III, scheduled for laparotomy
Exclusion criteria
1. Neurological or psychiatric illnesses
2. Alcohol or substance misuse
3. Significant fluid loss or electrolyte impairment.
4. Participants were excluded during the study if they had respiratory or cardiac
arrest, ischaemia, cerebral haemorrhage or long-lasting episodes of hypotension
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Type of surgery: laparotomy
Baseline characteristics
TIVA group
1. Age, mean (SD): 73.17 (± 6.35) years
2. Gender, M/F: 15/15
3. ASA grade: not reported
Inhalational maintenance group
1. Age, mean (SD): 73.27 (± 6.15) years
2. Gender, M/F: 13/17




Participants: n = 30; 0 reported losses (study authors report use of ITT analysis)
Induction details: propofol 3 mg/kg to 6 mg/kg, remifentanil 1 µg/kg, vecuronium 0.1
mg/kg
Maintenance details: propofol infusion of 12 mg/kg/hour, then 9 mg/kg/hour, then 6
mg/kg/hour over 10 minutes. Remifentainil 0.15 µg/kg/hour to 0.30 µg/kg/hour. 67%
air and 33% O2
Inhalational maintenance group
Participants: n = 30; 0 reported losses (study authors report use of ITT analysis)
Induction details: thiopentone 3 mg/kg to 5 mg/kg, vecuronium 0.1 mg/kg IV
Maintenance details: 2% sevoflurane, with 67% N2O/33% O2
Outcomes 1. Changes in MAP
2. Cognitive dysfunction (measured at 1, 6, 12, 24 hours postoperatively with
MMT)
Notes Funding/declarations of interest: study authors report no conflict of interest
Study dates: not reported
Note: study report in Turkish. Review authors used Google translate to assist with trans-
lation of key paragraphs
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomized to groups; no addi-
tional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Low risk No other sources of bias identified
Ishii 2016
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 59
Inclusion criteria
1. ASA I to II, ≥ 70 years of age
Exclusion criteria
1. History of dementia, depression, alcoholism, and liver cirrhosis
2. History of using benzodiazepine, major tranquillizers, or steroids
3. An ineffective postoperative analgesia via epidural anaesthesia
4. Allergic reactions to local anaesthetics
Type of surgery: elective gastrectomy, colectomy, or rectectomy
Baseline characteristics
TIVA group
1. Age, mean (SD): 77.3 (± 4.6) years
2. Gender, M/F: 20/9
3. ASA grade: not reported
Inhalational maintenance group
1. Age, mean (SD): 76.5 (± 4.5) years
2. Gender, M/F: 20/10




Participants: n = 29; 0 losses
Induction details: insertion of epidural catheter, then induction with propofol 1 mg/kg
to 1.5 mg/kg
Maintenance details: propofol to maintain BIS 40 to 60
Other information: intraoperative analgesia given with injection of fentanyl or contin-
uous infusion of 0.25% ropivacaine (6 mL/hour)
Inhalational maintenance groups
Participants: n = 30; 0 losses
Induction details: insertion of epidural catheter, then induction with propofol 1 mg/kg
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to 1.5 mg/kg
Maintenance details: sevoflurane to maintain BIS 40 to 60
Other information: analgesia same as TIVA group
Outcomes 1. Incidence of postoperative delirium (using CAM)
Notes Funding/declarations of interest: not reported
Study dates: July 2009 to December 2010
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomized to groups; no addi-
tional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessment done by ICU nurses blinded to group
assignment
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent losses
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk No other sources of bias noted. However, report is
short with limited detail on anaesthetic regimen
Jellish 2003
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 60 (unclearly reported in paper, possibly
59 randomized participants)
Inclusion criteria
1. Undergoing unilateral carotid endarterectomy
Exclusion criteria
1. Undergoing emergency surgery
2. In atrial fibrillation
3. Significant renal or hepatic disease
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Type or surgery: carotid endarterectomy
Baseline characteristics
TIVA group
1. Age, mean (SD): 72.1 (± 1.5) years
2. Gender: 55% male
3. ASA grade: all patients were ASA III
Inhalational maintenance group
1. Age, mean (SD): 69.2 (± 1.7) years
2. Gender: 62% male




Participants: n = 30; 0 losses
Induction details : propofol 1.0 mg/kg to 1.5 mg/kg IV. Remifentanil infusion started at
0.25 µg/kg/min. Additional propofol 25 mg to 50 mg IV given if necessary to maintain
MAP within 10 % pre-induction values during intubation
Maintenance details: propofol 50 µg/kg/min to 75 µg/kg/min. Remifentanil 0.125 µg/
kg/min to 0.5 µg/kg/min. Adjusted to maintain haemodynamic parameters within 15%
pre-induction. N2O in O2 mix 60/40
Other information: hypertension non-responsive to anaesthesia treated with sodium
nitroprusside 0.5 µg/kg/min. Hypotension non-responsive to anaesthesia treated with
phenylephrine 40 µg to 80 µg IV. Tachycardia unresponsive to anaesthesia treated with
esmolol 10 mg to mg 20 mg IV, bradycardia treated with glycopyrrolate 0.2 mg IV
Inhalational maintenance group
Participants: number of randomized participants is unclearly reported.We have assumed
that 30 participants were randomized, with 1 loss (owing to technical difficulties with
transoesophageal probe), and 29 participants were analysed
Induction details: propofol 1.5 mg/kg to 2 mg/kg IV, fentanyl 2 µg/kg. Additional
propofol 25 mg to 50 mg IV given if necessary to maintain MAP within 10 % pre-
induction values during intubation
Maintenance details: isoflurane 0.5% to 2% end-tidal. Titrated to maintain MAP 15%
pre-induction values. N2O in O2 mix 60/40
Other information: other drugs to maintain stability same as TIVA group
Outcomes 1. Haemodynamic variables (hypertension, hypotension, tachycardia, bradycardia)
2. Emergence and recovery data to include length of time in PACU, time to hospital
discharge, cardiac performance (using TEE)
Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of computer generated randomization
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Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk One participant lost from inhalation group, which
is unclearly reported.Wehave assumed that 30par-
ticipants were randomized to the inhalation group,
with one loss. We were not concerned by risk of
attrition bias because losses were few and unlikely
to influence outcome data
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk Study includes comparison of remifentanil with
fentanyl, which introduces methodological differ-
ences between groups. Also note differences in
amount of propofol given at induction
Juvin 1997
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 45
Inclusion criteria
1. ASA I or II, > 70 years of age, scheduled for major orthopedic surgery expected to
last > 60 minutes. No participants had any clinical condition that might influence the
assessment of variables used for the study and/or comparisons among groups
Excluded criteria
1. Clinical conditions to contraindicate rapid extubation
2. Preoperative haematocrit 25%
3. Significant coronary disease
4. ß-blocker treatment
5. Chronic pulmonary disease
6. Previous neurologic insult
7. Chronic alcohol or drug abuse
8. Renal failure or hepatic dysfunction
9. Previous personal or family history of malignant hyperthermia
Type of surgery: hip arthroplasty, knee arthroplasty, laminectomy, other orthopaedic
surgery
Baseline characteristics
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TIVA group
1. Age, mean (SD): 75.6 (± 4.2) years
2. Gender, M/F: 3/11
3. ASA grade: ASA I: 1: ASA II: 13
Inhalational maintenance group (isoflurane)
1. Age, mean (SD): 77.3 (± 5) years
2. Gender, M/F: 3/12
3. ASA grade: ASA 1: 2; ASA II: 13
Inhalational maintenance group (desflurane)
1. Age, mean (SD): 77.4 (± 5.1) years
2. Gender, M/F: 4/10




Participants: n = 15; 1 loss (excluded owing to intraoperative complication); 14 analysed
Induction details: propofol 1mg/kg to 2mg/kg, fentanyl 1 µg/kg to 2 µg/kg, vecuronium
0.1 mg/kg
Maintenance details: 60%N2O in O2. Propofol titrated to maintain HR and BP within
20% of baseline. Study authors report mean (SD) infusion rates at 2.18 (± 1.24) mg/
kg/hour
Other information: premedication with oral hydroxyzine 100 mg. Additional fentanyl
at 1 µg/kg at 40-minute intervals depending on length of surgery
Inhalational maintenance group (isoflurane)
Participants: n = 15; 0 losses
Induction details: propofol 1mg/kg to 2mg/kg, fentanyl 1 µg/kg to 2 µg/kg, vecuronium
0.1 mg/kg
Maintenance details: 60% N2O in O2. Isoflurane titrated to maintain HR and BP
within 20% of baseline. Fresh gas flow of 1.5 L/min. Study authors report mean (SD)
concentration isoflurane at 0.33% (± 0.21%)
Other info: premedication and use of fentanyl same as TIVA group
Inhalational maintenance group (desflurane)
Participants: n = 15; 1 loss (owing to sudden vaporizer failure); 14 analysed
Induction details: propofol 1mg/kg to 2mg/kg, fentanyl 1 µg/kg to 2 µg/kg, vecuronium
0.1 mg/kg
Maintenance details: 60% N2O in O2. Desflurane titrated to maintain HR and BP
within 20% of baseline. Fresh gas flow of 1.5 L/min. Study authors report mean (SD)
concentration desflurane 1.59% (± 1.02)
Other information: premedication and use of fentanyl same as TIVA group
Outcomes 1. Psychometric evaluation (recovery of cognitive function, assessed with MMSE at




5. Postoperative analgesic requirements
6. Time to discharge from PACU (using Aldrete; minutes)
7. Time to hospital discharge (days)
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Notes Funding/declarations of interest: supported by Pharmacia and Upjohn
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly allocated to groups; no
additional information
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes assessed by a single investigator whowas
blinded to participants’ group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Few participants losses (1 participant in desflurane
group, and 1 in propofol group); unlikely to influ-
ence outcome data
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk Some differences between groups in numbers for
each type of surgery. Note balance of gender,
with more female participants; balanced between
groups and not a risk of bias within the study
Kim 2015a
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 60
Inclusion criteria
1. ASA I to II, > 65 years of age, scheduled for elective orthopaedic surgery
Exclusion criteria





6. Any cognitive deficiency, hepatic or renal compromise
7. Infectious disease
59Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-
cardiac surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kim 2015a (Continued)
8. Surgery lasting > 3 hours
Type of surgery: orthopaedic surgery (hip replacement, knee replacement, long bone
fracture fixation, spinal surgery)
Baseline characteristics
TIVA group
1. Age, mean (SD): 73.5 (± 7.2) years
2. Gender, M/F: 8/22
3. ASA grade: ASA I: 11; ASA II: 19
Inhalational maintenance group
1. Age, mean (SD): 72.3 (± 6.2) years
2. Gender, M/F: 8/20




Participants: n = 30; 0 losses
Induction details: premedication with midazolam 0.05 mg/kg im. Remifentanil and
propofol based on Minto and Marsh pharmacokinetic model using TCI. Target effect-
site concentration 3 µg/mL propofol, 2.5 ng/mL remifentanil. Rocuronium 1.0 mg/kg
Maintenance details: propofol-remifentanil with 50%O2 and 50%airmix. Target effect-
site concentration 3 µg/mL propofol, 2.5 ng/mL remifentanil. Rocuronium 1.0 mg/kg.
To maintain BIS near 50 (range 40 to 60)
Other information: after surgery fentanyl administration using PCI
Inhalational maintenance group
Participants: n = 30; 2 losses (owing to surgery lasting more than 2 hours); 27 analysed
Induction details: premedication with midazolam 0.05 mg/kg im. Propofol 1.5 mg/kg
to 2.0 mg/kg, 3% to 4 % sevoflurane and 50% O2- air mixture. Rocuronium 1.0 mg/kg
Maintenance details: sevoflurane with 50% O2 and 50% air mix. Adjusted to maintain
BIS near 50 (range 40 to 60)
Other information: fentanyl after surgery same as TIVA group
Outcomes 1. Pain score
2. PONV
3. Duration of time in recovery
Notes Funding/declarations of interest: grants from Chosun University Medical Research
Institute. Study authors declare no competing interests
Study dates: not reported
Note: study has four comparison groups - sevoflurane vs TIVA, with and without
dexmedetomidine. For the review, we have only used the comparison groups without
dexmedetomidine
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of computer-generated randomization
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Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss of 2 participants in the inhalation group; few
losses unlikely to influence outcome data
Selective reporting (reporting bias) Low risk Prospective trial registration (NCT01851005).
Most outcomes were reported, although we noted
that adverse events (secondary outcomes) were not
included in the written report. For the purpose of
our review, MAP was reported but not in terms of
hypotension
Other bias Unclear risk Differences between groups in use of remifentanil
and fentanyl. Also, a higher ratio of female to
male participants; however, this is balanced be-
tween groups
Lindholm 2013
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 200
Inclusion criteria
1. People with AAA or aortic arteriosclerosis obliterans, or both, scheduled for open
abdominal aortic surgery
Excluded criteria
1. < 18 years of age
2. Included in other pharmaceutical studies
3. Abuse of opioids, benzodiazepines, antiepileptic drugs, alcohol, or alpha2-agonists
4. Pregnant and breastfeeding women
5. Family history of malignant hyperthermia
6. Known hypersensitivity for opioids, propofol, or volatile anaesthetics
7. Serious arrhythmias, ventricular fibrillation/tachycardia or tachycardia > 100
beats/min
8. Severe valvular diseases requiring surgical repair before major noncardiac surgery
9. Uncontrolled hypertension
10. Serious psychiatric disease
11. Unstable angina pectoris or MI 30 days before inclusion
12. Acute abdominal aortic surgery
13. Planned laparoscopic AAA surgery
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Type of surgery: open abdominal aortic surgery
Baseline characteristics
TIVA group
1. Age, mean (SD): 67 (± 9) years
2. Gender, M/F: 72/24
3. ASA grade: ASA II: 34; ASA III: 49; ASA IV: 13
Inhalational maintenance group
1. Age, mean (SD): 69 (± 9) years
2. Gender, M/F: 73/24




Participants: n = 100; losses unclearly reported; 96 analysed (PP)
Induction details : premedication with paracetamol. Fentanyl 0.1 mg to 0.3 mg IV, and
propofol 1 mg/kg to 2 mg/kg IV. Vecuronium 0.1 mg/kg, and 0.01 mg/kg to 0.02 mg/
kg based on train-of-four
Maintenance details: propofol 1 mg/kg/hour to 10 mg/kg/hour IV, and remifentanil 0.
1 mg/kg/min to 0.7 mg/kg/min. Aim to maintain BIS 40 to 60
Additional regional anaesthesia: epidural 3 mL/hour to 12 mL/hour (bupivacaine 1 mg/
mL, fentanyl 2 µg/mL, adrenaline 2 µg/mL)
Other information: morphine 1 mg to 10 mg IV as rescue analgesia
Inhalational maintenance group
Participants: n = 100; losses unclearly reported; 97 analysed (PP)
Induction details : premedication with paracetamol as for TIVA. Fentanyl 0.1 mg to 0.
3 mg IV and thiopental sodium 3 mg/kg to 6 mg/kg IV. Vecuronium as for TIVA
Maintenance details: balanced anaesthesia with sevoflurane at 0.7 MAC to 1.5 MAC,
and repeated doses of fentanyl 0.05 mg to 0.1 mg IV. Aim to maintain BIS 40 to 60
Additional regional anaesthesia: epidural 3 mL/hour to 12 mL/hour (bupivacaine 1 mg/
mL, fentanyl 2 µg/mL, adrenaline 2 µg/mL)
Other information: morphine same as TIVA group
Outcomes 1. Troponin T levels on first postoperative day
2. Postoperative complications, to included cognitive dysfunction (at 30 days)
3. Non-fatal coronary events including acute MI
4. Non-thrombotic troponin increase
5. Mortality (at 30 days)
6. Use of inotropic-, vasodilator- , and anaesthetic drugs




10. Fluids and transfusions
11. Postoperative pain
12. Nausea and vomiting
13. SOFA scores at 8 hours and first and second postoperative days
14. Length of ward or ICU stay
15. Length of hospital stay
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Notes Funding/declarations of interest: institution or department funding. One author re-
ceived fees for presentations at Baxter AS Norway
Study dates: February 2008 to February 2012
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomized to groups; no addi-
tional details
Allocation concealment (selection bias) Unclear risk Quote: “after informed consent was given, patients
selected a blank envelope with the randomization
code inside from a box containing envelopes for all
remaining patients to be included.”
Study does not report if envelopes were opaque
and sealed. Unclear if this is a sufficient method to
conceal group allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Postoperative care was blinded.However, study au-
thors do not report who collected data for POCD
Incomplete outcome data (attrition bias)
All outcomes
Low risk Small loss of participant data. Reasons for losses
are unclearly reported, however loss is < 10% and
balanced between groups
Selective reporting (reporting bias) Unclear risk Prospective registration with clinical trials register
(NCT00538421). However, outcomes are not re-
ported in trials register documents; not feasible to
assess risk of selective outcome reporting bias
Other bias Unclear risk Groups differ in use of fentanyl and remifen-
tanil which presents methodological differences
between groups
Liu 2013
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 120
Inclusion criteria
1. People with aMCI, history of spinal surgery, ASA I to II, aged 65 to 75 years
Exclusion criteria
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1. History of general anaesthetic exposure or surgery
2. Neurological diseases that may affect cognitive function (e.g. subdural
haematoma, vascular dementia, frontotemporal dementia)
3. Hypothyroidism
4. Alcoholic dementia




9. Insufficient education to complete the tests
Type of surgery: spinal surgery
Baseline characteristics
TIVA group
1. Age, mean (SD): 69.33 (± 2.90) years
2. Gender, M/F: 24/28
3. ASA grade: all ASA I to II
Inhalational maintenance group
1. Age, mean (SD): 69.56 (± 2.99) years
2. Gender, M/F: 27/28




Participants: n = 60; 8 losses (reasons reported overall, not by group, to include: ’lost to
follow-up’, death, other surgeries before 2-year follow-up time point); 52 analysed
Induction details: midazolam 0.05 mg/kg, sufentanil 0.5 µg/kg, vecuronium 0.5 µg/kg,
propofol 1.0 mg/kg
Maintenance details: propofol 4mg/kg/hour to 6mg/kg/hour continuously, intermittent
vecuronium 0.5 mg/kg. To maintain BIS 40 to 50
Other information: during surgery, patients given lactated Ringer’s solution and het-
astarch. Continuous infusion of sufentanil 0.6 µg/kg/hour, tropisetron 6 µg/kg/hour,
single bolus of sufentanil 0.015 µg/kg and tropisetron 1.5 µg/kg over a 15-minute in-
terval for postoperative pain relief
Inhalational maintenance group
Participants: n = 60; 5 losses (reasons reported overall, not by group, to include: ’lost to
follow-up’, death, other surgeries before 2-year follow-up time point); 55 analysed
Induction details: midazolam 0.05 mg/kg, sufentanil 0.5 µg/kg, vecuronium 0.5 µg/kg,
propofol 1.0 mg/kg
Maintenance details: sevoflurane 2% to 3 % in pure O2. Adjusted to maintain BIS 40
to 50
Other information: fluids and analgesic management etc. same as TIVA group
Outcomes 1. Progression of aMCI. Measured at follow-up of 2 years
Notes Funding/declarations of interest: supported by the Department of Anesthesiology,
Beijing Military General Hospital. The authors have no financial or other conflicts of
interest to disclose
Study dates: January 2007 to January 2009
64Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-
cardiac surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Liu 2013 (Continued)
Note: study has 3 arms: propofol vs sevoflurane vs lidocaine epidural. We have not
included data for the lidocaine comparison arm
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of computer-generated randomization
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Only review outcome of interest is mortality.
Blinding of assessors is not described but lack of
blinding is unlikely to influence mortality data
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk High number of losses, which are reported with
reasons. We have used this as data for mortality
outcome
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. It is not feasible to assess risk of selective out-
come reporting
Other bias Low risk No other sources of bias identified
Longas 2004
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 60
Inclusion criteria
1. Male participants, ASA III
Exclusion criteria
1. Autoimmune deficiency diseases
2. Existing treatment with immunosuppressants or corticosteroids which may affect
the basal immunology profile
3. NYHA III to IV
4. Renal insufficiency
5. Transfusion within the last 3 months or perioperative transfusion
6. Infections prior to intervention
Type of surgery: carotid endarterectomy
Baseline characteristics
TIVA group
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Longas 2004 (Continued)
1. Age, mean (SD): 66 (± 7.1) years
2. Gender, M/F: not reported
3. ASA grade: all patients ASA III
Inhalational maintenance group (sevoflurane MAC 1.0)
1. Age, mean (SD): 65 (7.2) years
2. Gender: not reported
3. ASA grade: all patients ASA III
Inhalational maintenance group (sevoflurane MAC 1.5)
1. Age, mean (SD): 64 (8.1) years
2. Gender: not reported




Participants: n = 20; 0 losses
Induction details: premedication the night before surgery with diazepam 10 mg given
orally, then 30 minutes before surgery with midazolam 0.1 mg/kg im. Induction with
propofol 2 mg/kg, cisatracurium 0.2 mg/kg, and fentanyl 3 µg/kg to 4 µg/kg
Maintenance details: mix of O2 and air, FiO2 of 0.4. Fentanyl 0.05 mg, cisatracurium
0.1 mg/kg IV. Propofol 5 mg/kg/hour. To maintain a BIS 40 to 60
Other information: for postoperative analgesia methadone 0.1 mg/kg, and metamizole
in doses of 2 g IV every 8 hours. Analgesia started 30 minutes before end of surgery
Inhalational maintenance group (sevoflurane MAC 1.0)
Participants: n = 20; 0 losses
Induction details: premedication the night before surgery with diazepam 10 mg given
orally, then 30 minutes before surgery with midazolam 0.1 mg/kg im. Then induction
with propofol 2 mg/kg, cisatracurium 0.2 mg/kg, and fentanyl 3 µg/kg to 4 µg/kg
Maintenance details: mix of O2 and air, FiO2 of 0.4. Fentanyl 0.05 mg, cisatracurium
0.1 mg/kg IV. Sevoflurane MAC 1.0. To maintain a BIS 40 to 60
Other information: postoperative analgesia same as TIVA group
Inhalational maintenance group (sevoflurane MAC 1.5)
Participants: n = 20; 0 losses
Induction details: premedication the night before surgery with diazepam 10 mg given
orally, then 30 minutes before surgery with midazolam 0.1 mg/kg im. Then induction
with propofol 2 mg/kg, cisatracurium 0.2 mg/kg, and fentanyl 3 µg/kg to 4 µg/kg
Maintenance details: mix of O2 and air, FiO2 of 0.4. Fentanyl 0.05 mg, cisatracurium
0.1 mg/kg IV. Sevoflurane MAC 1.5. To maintain a BIS 40 to 60
Other information: postoperative analgesia same as TIVA group
Outcomes 1. Haemodynamic variable
2. Hypertension
3. Hypotension (30% reduction from baseline)
4. Treatment with ephedrine for hypotension
5. Postoperative pain (on VAS)
6. Amnesia in PACU
Notes Funding/declarations of interest: not reported
Study dates: not reported
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Note: the study included a 4th comparison group of remifentanil. We did not include
this group in the review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly allocated to groups; no
additional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to assess risk of selective outcome
reporting
Other bias Low risk No other sources of bias identified
Luntz 2004
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 96
Inclusion criteria
1. Scheduled for elective, unilateral ophthalmic surgery, ≥ 65 years of age, ASA I to
III
Exclusion criteria
1. Obvious cardiovascular complaints (NYHA III to IV)
2. Previous adverse reactions to one of the study drugs
3. Participating in another study
4. History of GA in last 3 months
5. Less than 60% vision in the contralateral eye
Type of surgery: ophthalmic surgery
Baseline characteristics
TIVA group
1. Age, (assumed) mean (SD): 74 (± 7) years
2. Gender: not reported
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3. ASA grade: not reported
Inhalational maintenance group (propofol/sevoflurane)
1. Age, (assumed) mean (SD): 76 (± 6) years
2. Gender: not reported
3. ASA grade: not reported
Inhalational maintenance group (total sevoflurane)
1. Age, (assumed) mean (SD): 77 (± 7) years
2. Gender: not reported
3. ASA grade: not reported
Note: table of baseline characteristics is not reported. Study authors report “There were
no significant differences between the patient groups with regard to age, gender, height,




Participants: n = 32; 0 losses
Induction details: propofol 2 mg/kg, continuous infusion of remifentanil 20 µg/ kg/
hour. Atracurium 0.3 mg/kg to 0.5 mg/kg
Maintenance details: continuous infusion of propofol 4 mg/kg/hour to 8 mg/kg/hour.
Remifentanil at 10 µg/kg/hour
Inhalational maintenance group (propofol/sevoflurane)
Participants: n = 32; 0 losses
Induction details: propofol 2 mg/kg, continuous infusion of remifentanil 20 µg/ kg/
hour. Atracurium 0.3 mg/kg to 0.5 mg/kg
Maintenance details: sevoflurane end-tidal concentration 0.6% to 1.2%. Remifentanil
10µg/kg/hour
Inhalational maintenance group (total sevoflurane)
Participants: n = 32; 0 losses
Induction details : continuous infusion of remifentanil 20 µg/ kg/hour. Atracurium 0.3
mg/kg to 0.5 mg/kg. After 1 minute pre-oxygenation, vaporizer adjusted stepwise up to
8% sevoflurane until eyelash reflex was abolished, then reduced to 5%
Maintenance details: sevoflurane end-tidal concentration 0.6% to 1.2%. Remifentanil
10µg/kg/hour
Outcomes 1. Clinical outcomes (MAP and hypotension, shivering, pain, PONV, duration of




Notes Funding/declarations of interest: supported in part by a grant from Abbott Laborato-
ries, Wiesbaden, Germany
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Use of computer-generated randomization
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
group
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Relevant reported outcome is for hypotension.
Study authors do not report who collected this data
and whether they were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Low risk Baseline characteristics table not reported, but
study authors reported no differences. No other
sources of bias identified
Micha 2016
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 80
Inclusion criteria
1. 60 to 74 years of age, native Greek speakers, of at least preliminary educational
status, tumour resection of > 2 hours duration
Exclusion criteria
1. Not competent in writing
2. Severe impairment of hearing or vision
3. Preoperative cognitive dysfunction (MMSE ≤ 23)
4. Central nervous system (dementia, Parkinson’s, Alzheimer disease) or psychiatric
disease
5. Antidepressant therapy
6. Abuse of drugs or alcohol
7. Assessment with psychometric tests in the past
8. Participants required reoperation during the study period
Type of surgery: tumour resection (non-cardiovascular or neurosurgical)
Baseline characteristics
TIVA group
1. Age, median (IQR): 64 ( 62 to 67) years
2. Gender, M/F: 19/17
3. ASA grade: ASA I: 3; ASA II & III: 33
69Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-
cardiac surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Micha 2016 (Continued)
Inhalational maintenance group
1. Age, median (IQR): 65.62 (62 to 68) years
2. Gender, M/F: 20/17




Participants: n = 40; 4 losses (2 patients had operations cancelled; 2 were haemodynam-
ically unstable); 36 analysed
Induction details: propofol 2 mg/kg, and fentanyl 2 µg/kg
Maintenance details: propofol 6 mg/kg/hour to 10 mg/kg/hour. To maintain BIS 40 to
60
Other information: postoperative analgesia with morphine to achieve a VAS score ≤ 3
Inhalational maintenance groups
Participants: n = 40; 3 losses (no data available at 9 months); 37 analysed = 37
Induction details: propofol 2 mg/kg, and fentanyl 2 µg/kg
Maintenance details: sevoflurane 2% to 3%. To maintain BIS 40 to 60
Other information: postoperative analgesia same as TIVA group
Outcomes 1. Hypotension (MAP ≤ 60 mmHg for > 30 mins)
2. Oxygen saturation ≤ 80% for > 30 mins
3. MMSE (48 hrs postoperatively) with a decrease of ≥ 2 units
4. Delirium using CAM
Notes
1. MMSE was evaluated only when participants’ performance in CAM proved
absence of delirium
2. Cognitive function and BDI also evaluated at 9 months postoperatively
Notes Funding/declarations of interest: not reported
Study dates: June 2010 to July 2013
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly allocated to groups; no
additional details
Allocation concealment (selection bias) Unclear risk Sealed envelopes used; no additional details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
group
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessment of cognitive function completed by
personnel blinded to study groups
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Incomplete outcome data (attrition bias)
All outcomes
High risk Reason for losses in sevoflurane group owing to
loss of data at 9 months; however, data time points
are at 7 days as well as 9 months postoperatively
Selective reporting (reporting bias) Unclear risk Clinical trials registration not reported. Not fea-
sible to assess risk of selective outcome reporting
bias
Other bias Low risk No other sources of bias identified
Moffat 1995
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 40
Inclusion criteria




Type of surgery: cataract extraction and lens implantation
Baseline characteristics
TIVA group
1. Age, mean (range): 72 (60 to 86) years
2. Gender: not reported
3. ASA grade: not reported
Inhalational maintenance group
1. Age, mean (range): 77 (64 to 88) years
2. Gender: not reported




Participants: n = 20; 0 losses
Induction details: premedication with metoclopramide 10 mg 1 hour before surgery.
Topical anaesthesia (1% amethocaine) applied to non-operative eye. Propofol with initial
plasma concentration of 6 µg/mL reducing to 4 µg/mL after 10 minutes. Mix of 70%
N2O in O2 throughout the procedure
Maintenance details: 4 µg/mL propofol TCI
Other information: topical anaesthesia with 1% amethocaine in operative eye before
surgical incision. Airway maintained with LMA
Inhalational maintenance group
Participants: n = 20; 0 losses
Induction details: premedication with metoclopramide 10 mg 1 hour before surgery.
Topical anaesthesia (1% amethocaine) applied to non-operative eye. Induction with
etomidate 0.25 mg/kg and vecuronium 0.075 mg/kg
Maintenance details: Mix of 70% N2O in oxygen, and 0.5% to 1% isoflurane
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Other information: topical anaesthesia with 1% amethocaine in operative eye before
surgical incision. Airway maintained with intubation
Outcomes 1. Haemodynamic measures
2. Recovery times from anaesthesia
3. PONV
4. Ability to converse normally, walk unaided and retain oral fluids
5. Cognitive function assessed using MMSE
Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly allocated to groups; no
additional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk We noted use of different types of airway manage-
ment which was because of the study aim to as-
sess anaesthetic management using neuromuscu-
lar blockade vs no neuromuscular blockade for in-
traocular pressure
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Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 50
Inclusion criteria
1. ASA I or II, > 65 years of age, scheduled for elective laparoscope-assisted surgical
procedures which would last > 3 hours, under combined GA and epidural anaesthesia
Exclusion criteria
1. People with anticoagulation, symptomatic coronary artery disease, cardiac
valvular regurgitation or stenosis, central nervous system or neuromuscular disorders
2. Major or minor tranquillizer medication
3. Psychotic symptoms or cognitive impairment as judged by a psychiatrist




1. Age, mean (SD): 71 (± 8) years
2. Gender, M/F: 13/12
3. ASA grade: ASA I: 7; ASA II: 18
Inhalational maintenance group
1. Age, mean (SD): 71 (± 7) years
2. Gender, M/F: 12/13




Participants: n = 25; 0 losses
Induction details: 100% O2 via face mask for 3 minutes prior to induction. Induction
with propofol using 4 µg/mL TCI. Use of 2% lidocaine solution for injection pain
Maintenance details: 4 µg/mL propofol TCI. Study authors report mean (SD) range
of 1.2 (± 0.2) µg/mL to 2.7 (± 0.2) µg/mL propofol. Use of clinical signs to maintain
anaesthesia
Additional regional anaesthesia: epidural anaesthesia: 6 mL to 8 mL of 1.5% lidocaine,
followed by continuous epidural administration at a rate of 4 mL/hour to 6 mL/hour
throughout surgery
Inhalational maintenance group
Participants: n = 25; 0 losses
Induction details: 100% oxygen via face mask for 3 minutes prior to induction. 5%
sevoflurane and 100% oxygen at 6 L/min until inspired limb-drug concentration was >
4%. Vecuronium 0.1 mg/kg
Maintenance details: sevoflurane with O2/air mix at total gas flow of 3 L/min. Vecuro-
nium 1 mg to 2 mg IV boluses as required. Study authors report mean (SD) range of 0.
9% (± 0.1%) to 1.7% (± 0.4%) sevoflurane
Outcomes 1. Duration of anaesthesia
2. Duration of surgery
3. Intraoperative complications (hypotension, bradycardia, hypertension,
tachycardia, increased salivation)
4. Postoperative delirium (using DRS)
5. Pain (using VAS)
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Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were “randomly assigned by a sealed
envelope technique”. Insufficient information
Allocation concealment (selection bias) Unclear risk Described as “randomly assigned by a sealed enve-
lope technique”. Insufficient information
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Delirium was assessed by a psychiatrist blinded to
intervention group. Data on emergence times was
assessed by anursewhowas blinded to intervention
group
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Low risk No other source of bias identified
Rohan 2005
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 30
Inclusion criteria:
1. Elderly patients (> 65 years of age) presenting for minor urological (rigid
cystoscopy, transurethral resection of bladder mucosal tumour) or gynaecological
surgery (hysteroscopy), requiring GA, and with an anticipated hospital stay of one
night postoperatively
Exclusion criteria
1. Diseases of the central nervous system including pre-existing cognitive
dysfunction (defined as a MMSE < 24)
2. Consumption of phenothiazines or antidepressants
3. Cardiac or neurosurgery
4. Previous neuropsychological testing
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5. Poor comprehension of the language used in processing the tests
6. Patients with alcoholism or addictive drug dependence
Type of surgery: minor urological or gynaecological surgery
Baseline characteristics
TIVA group
1. Age, mean (range): 72.9 (65 to 83) years
2. Gender, M/F: 12/3
3. ASA grade: not reported
Inhalational maintenance group
1. Age, mean (range): 73.8 (67 to 86) years
2. Gender M/F: 11/4




Participants: n = 15; 0 losses
Induction details: 500 mL crystalloid solution, fentanyl 1 µg/kg IV, propofol TCI using
a Deprifusor
Maintenance details: TCI propofol adjusted to maintain adequate depth of anaesthesia,
at discretion of attending anaesthetist. 50% O2 and 50% air
Inhalational maintenance group
Participants: n = 15; 0 losses
Induction details: 500 mL crystalloid solution, fentanyl 1 µg/kg IV. Incremental dose of
sevoflurane by tidal volume inhalation induction technique
Maintenance details: 50% O2 and 50% air. No additional information for maintenance
Outcomes 1. Cognitive dysfunction on the day following surgery
2. S-100β and neuron-specific enolase levels
Notes Funding/declarations of interest: funded entirely from the resources of theDepartment
of Anesthesia, Critical Care and Pain Medicine, Mater Misericordiae Hospital
Study dates: not reported
Note: study also includes an age-matched control group of participants which we did
not include in the review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomized to groups; no addi-
tional details
Allocation concealment (selection bias) Low risk Use of sequentially numbered sealed envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “the investigator who undertook patient
enrolment, neuropsychological tests and blood
tests did not deliver anaesthesia to the patient and,
therefore, was unaware of study group allocation.”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to assess risk of selective outcome
reporting
Other bias Unclear risk No detail on doses of anaesthetic drugs. Unable to
assess whether groups were equivalent
Tan 2009
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 60
Inclusion criteria
1. Undergoing abdominal surgery, > 60 years of age, ASA I to II
Exclusion criteria
1. Neurological abnormalities
2. Regularly taking medication for neuropsychiatric disorders
Type of surgery: abdominal surgery
Baseline characteristics
TIVA group
1. Age, range: 60 to 81 years
2. Gender: not reported
3. ASA grade: not reported
Inhalational maintenance group
1. Age, range: 60 to 81 years
2. Gender: not reported
3. ASA grade: not reported
Note: Study authors do not report a baseline characteristics table. Study authors report




Participants: n = 30; 0 losses
Induction details: propofol IV 1.5 mg/kg to 2 mg/kg, fentanyl 2 µg/kg to 4 µg/kg,
vecuronium 0.1 mg/kg
Maintenance details: propofol IV 100 µg/kg/min to 150 µg/kg/min, fentanyl and ve-
curonium as required
Inhalational maintenance group
Participants: n = 30; 0 losses
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Induction details: propofol IV 1.5 mg/kg to 2 mg/kg, fentanyl 2 µg/kg to 4 µg/kg,
vecuronium 0.1 mg/kg
Maintenance details: 1% to 2 % isoflurane, fentanyl and vecuronium as required
Outcomes 1. POCD, using MMSE before and after surgery (1, 6, 12, 24 and 48 hours after
surgery)




Notes Funding/declarations of interest: not reported
Study dates: not reported
Note: study report is in Chinese. We have used Google translate for essential paragraphs.
We noted that this study was reported by a single author and may not be the original
study report; we checked the study details against other included studies for duplication
but found no duplication
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomized to groups; no addi-
tional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk No baseline characteristics table. Limited informa-
tion in short report, and we noted that this study
was reported by a single author
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Tanaka 2017
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 100
Inclusion criteria
1. > 65 years of age, scheduled for TKA, ASA II or III, BMI > 30 kg/m2
Exclusion criteria
1. Refusal of or failure of regional block
2. Pre-existing neurocognitive disorders (MMSE ≤ 23)
3. Known intolerance to any of drugs used in the study
Type of surgery: total knee arthroplasty
Baseline characteristics
TIVA group
1. Age, mean (SD): 71 (± 5.8) years (taken from clinical trials register documents)
2. Gender, M/F: 16/34 (taken from clinical trials register documents)
3. ASA grade: ASA II: 22; ASA III: 23 (calculated from study report for 45
participants)
Inhalational maintenance group
1. Age, mean (SD): 70 (± 4.0) years (taken from clinical trials register documents)
2. Gender, M/F: 29/21 (taken from clinical trials register documents)





Participants: n = 50; 11 losses (3 withdrawn; other reasons include early hospital dis-
charge, oversedation, respiratory distress, PONV, and pain - not reported by group); 39
analysed
Induction details: femoral nerve block with initial bolus of 30 mL 0.25% ropivacaine
as well as placement of indwelling catheter. Sedation with fentanyl and midazolam
provided for femoral nerve block at discretion of regional anaesthesia team. Induction
with propofol 1 mg/kg, fentanyl 1 µg/kg to 2 µg/kg, rocuronium 0.4 mg/kg, all dosed
according to lean body weight
Maintenance details: propofol. Use of Sedline to maintain PSI 30 to 50
Other information: after surgery, a continuous infusion of 0.2% ropivacaine at 6 mL/
hour was initiated in recovery room and adjusted to maximum of 10 mL/hour for next
48 hours. PCA device to administer IV hydromorphone with standardized dosing and
lock-out period
Inhalational maintenance groups
Participants: n = 50; 10 losses (1 withdrawn; other reasons include early hospital dis-
charge, oversedation, respiratory distress, PONV, and pain - not reported by group); 40
analysed
Induction details: femoral nerve block with initial bolus of 30 mL 0.25% ropivacaine
as well as placement of indwelling catheter. Sedation with fentanyl and midazolam
provided for femoral nerve block at discretion of regional anaesthesia team. Induction
with propofol 1 mg/kg, fentanyl 1 µg/kg to 2 µg/kg, rocuronium 0.4 mg/kg, all dosed
according to lean body weight
Maintenance details: desflurane. Use of Sedline to maintain PSI 30 to 50
Other information: after surgery, a continuous infusion of 0.2% ropivacaine at 6 mL/
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hour was initiated in recovery room and adjusted to maximum of 10 mL/hour for next
48 hours. PCA device to administer IV hydromorphone with standardized dosing and
lock-out period
Outcomes 1. Postoperative delirium (using CAM) at baseline 1, 6, 24 and 48 hours after surgery
2. Cognitive function (20% decrease from baseline to indicate cognitive decline)
using DSST (day 1), Digit Span (day 2), and Trail Making Test (part A and part B; day
2)
3. Wake-up times
4. Length of stay in PACU
5. Pain scores
6. PONV
Note: we interpreted bar charts provided by study authors (from email communication)
for cognitive function tests. In meta-analysis, we used data for Trail Making part A
Notes Funding/declarations of interest: research grant from Baxter Healthcare Corporation
Study dates: October 2010 to August 2014
Note: all participants are obese
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of computer-generated random numbers
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Nurses who administered CAM assessment were
blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk Study authors do not report reasons for losses by
each group, and data is reported inconsistently be-
tween clinical trials register documents and pub-
lished study report. Overall losses are high
Selective reporting (reporting bias) High risk Retrospectively registered with clinical trials regis-
ter (NCT01270620). Not feasible to assess risk of
selective reporting bias from this document. How-
ever, we noted that MMSE was an outcome in the
methods section of the published report but was
not reported in results. In addition, we noted a
difference in data for postoperative delirium, and
length of stay was reported for a different number
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of participants. Overall, we judged risk of selective
reporting bias as high
Other bias Unclear risk We noted a difference in gender balance between
groups; unclear if this is clinically important
Tang 2014
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 220
Inclusion criteria
1. Elderly patient with MCI, ≥ 60 years of age, ASA I to III, scheduled for radical
rectal resection surgery
Exclusion criteria
1. Current diagnosis of dementia (pre-operative MMSE score 23)
2. Current or past psychiatric illness; current use of antidepressant of antianxiety
medication
3. History of drug dependence or alcohol abuse
4. History of coronary artery, peripheral arterial or cerebrovascular disease
5. Severe visual, auditory, or motor disability
6. Acute infection
7. Preoperative haemoglobin 85 g/L
Type of surgery: radical rectal resection surgery
Baseline characteristics
TIVA group
1. Age, mean (SD): 69.6 (± 4.8) years; 41 patients were ≥ 70 years of age
2. Gender, M/F: 26/75
3. ASA grade: not reported
Inhalational maintenance group
1. Age, mean (SD): 70.0 (± 4.3) years; 41 patients were ≥ 70 years of age
2. Gender, M/F: 32/67




Participants: n = 110; 9 losses (declined to participate in follow-up at day 7); 101 analysed
Induction details: midazolam 0.03 mg/kg to 0.04 mg/kg IV, fentanyl 0.002 mg/kg to
0.003 mg/kg IV, vecuronium 0.15 mg/kg to 0.2 mg/kg. Then propofol 1.5 mg/kg to 2
mg/kg IV
Maintenance details: propofol 6 mg/kg/hour to 10 mg/kg/hour. To maintain BIS 30 to
60. Remifentanil 9 µg/kg/hour to 12 µg/kg/hour continuous IV infusion, vecuronium
intermittent IV infusion
Other information: all patients had PCI 150 mL saline with fentanyl 1.5 mg, tropisetron
12 mg, infusion rate 2 mL/hour, with 15-minute lockout
Inhalational maintenance group
Participants: n = 110; 11 losses (declined to participate in follow-up at day 7); 99 analysed
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Induction details: midazolam 0.03 mg/kg to 0.04 mg/kg IV, fentanyl 0.002 mg/kg to 0.
003 mg/kg IV, vecuronium 0.15 mg/kg to 0.2 mg/kg. Then 8% sevoflurane (fresh gas
flow 6 L/min, decreased to 3% to 4% after loss of consciousness with fresh gas flow 1
L/min to 2 L/min)
Maintenance details: sevoflurane 2% to 3%. To maintain BIS 30 to 60. Remifentanil
9 µg/kg/hour to 12 µg/kg/hour continuous IV infusion, vecuronium intermittent IV
infusion
Other information: analgesics same as TIVA group
Outcomes 1. POCD
2. Anaesthesia duration
3. Dose of remifentanil and atropine
4. Hypotension
5. Haemodynamic variables
6. Pain (using VAS)
7. Wound infection
8. Pneumonia
Notes Funding/declarations of interest: study authors report that authors received no specific
grant from any funding agency in the public, commercial or not-for-profit sectors
Study dates: January 2010 to November 2013
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Use of computer-generated, blocked random-allo-
cation sequence
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetist to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “to ensure blinding, neuropsychological
assessment work was carried out by a physician
trained in psychology. Neither the physician nor
the patient knew which anaesthetic had been used
during surgery”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Some loss of participant data at about 10%. It is
unclear whether this loss could influence outcome
data
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
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Other bias Low risk No other sources of bias identified.
Trembach 2012
Methods RCT, parallel design, single-centre
Participants Total number or randomized participants: 99
Included criteria
1. ASA III patients with acute cholecystitis undergoing laparoscopic cholecystectomy
Excluded criteria
1. Not reported (abstract only)
Type of surgery: laparoscopic cholecystectomy




Participants: n = 45; 0 reported losses
Described as propofol-fentanyl TIVA. No additional details in abstract
Inhalational maintenance group
Participants: n = 44; 0 reported losses
Described a VIMA. No additional details in abstract
Outcomes 1. Hypotension (requiring support with phenylephrine)
2. Induction time
3. Time to intubation
4. Time to recovery of consciousness
5. Time to extubation





Notes Funding/declarations of interest: not reported
Study dates: not reported
Very limited detail in abstract
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly assigned to groups; no
additional details
Allocation concealment (selection bias) Unclear risk No details. Abstract only
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details. Abstract only
Incomplete outcome data (attrition bias)
All outcomes
Low risk No details. Abstract only. We have assumed there
were no losses
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk Limited detail in abstract, unable to assess risk of
other biases. Description of inhalational mainte-
nance does not include fentanyl/remifentanil
Tylman 2011
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 50
Inclusion criteria
1. Scheduled for elective colorectal surgery
Exclusion criteria
1. Study authors report that participants with ulcerative colitis and Crohn’s disease
were excluded after randomization. No other exclusion criteria reported
Types of surgery: colorectal surgery for rectal or colon cancer
Baseline characteristics
TIVA group
1. Age, median (25 to 75% range): 63 (59 to 72) years
2. Gender, M/F: 15/10
3. ASA grade: not reported
Inhalational maintenance group
1. Age, median (25 to 75% range): 70 (59 to 78) years
2. Gender, M/F: 16/9




Participants: n = 25; 0 losses
Induction details : propofol TCI 3 µg/mL. Continuous infusion of remifentanil 0.25
µg/kg/min
Maintenance details: propofol 2 µg/mL. Remifentanil 0.15 µg/kg/min
Additional regional anaesthesia: epidural anaesthesia of 5 mg/mL bupivacaine, and 5
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µg/mL epinephrine at rate of 4 mL to 5 mL during surgery. Postoperatively participants
epidural changed to 1 mg/mL bupivacaine, 2 µg/mL fentanyl, 2 µg/mL epinephrine at
rate of 5 mL/hour to 12 mL/hour
Other information: before induction of anaesthesia participants given 1 µg/kg to 2 µg/
kg fentanyl IV, and standard dose of rocuronium
Inhalational maintenance group
Participants: n = 25; 4 losses (did not meet study inclusion criteria); 21 analysed
Induction/maintenance details: sevoflurane with 60% O2 throughout surgery. Concen-
tration not reported. We assume that induction was also with sevoflurane
Additional regional anaesthesia: epidural anaesthesia of 5 mg/mL bupivacaine, and 5
µg/mL epinephrine at rate of 4mL to 5 mL during surgery. Postoperatively participants
epidural changed to 1 mg/mL bupivacaine, 2 µg/mL fentanyl, 2 µg/mL epinephrine at
rate of 5 mL/hour to 12 mL/hour
Other information: fentanyl and rocuronium same as TIVA group
Outcomes 1. Inflammatory markers
2. Blood loss
3. Body temperature
4. Blood glucose levels
5. Length of hospital stay
Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants were randomly assigned to groups; no
additional details
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetist to intervention
groups.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
High risk Loss of participants (all in inhalation group) after
randomization because these participants were di-
agnosed with additional conditions (ulcerative col-
itis and Crohn’s disease). Decision to remove these
participants was to avoid confounding. Post-hoc
decision which is imbalanced between groups
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Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Unclear risk Differences in groups in use of remifentanil and
fentanyl. Also, study authors do not report concen-
tration of sevoflurane. Note limited information in
baseline characteristics table, and lack of inclusion/
exclusion criteria
Zhang 2015
Methods RCT, parallel design, single-centre
Participants Total number of randomized participants: 80
Inclusion criteria
1. Senile gastric cancer patients receiving selective radical surgery
Exclusion criteria
1. Mental health disorder
2. Severe dysfunction of heart, lung, liver, or kidney
3. Spinal deformity
4. Contraindications of epidural anaesthesia
5. History of severe trauma
6. Surgical treatment
Type of surgery: radical surgery for gastric cancer
Baseline characteristics
TIVA group (without epidural)
1. Age, mean (SD): 71.4 (± 5.6) years
2. Gender, M/F: 15/5
3. ASA grade: ASA I: 4; ASA II: 16
Inhalational maintenance group (without epidural)
1. Age, mean (SD): 67.9 (± 7.2) years
2. Gender, M/F: 16/4
3. ASA grade: ASA I: 5; ASA II: 15
TIVA group (with epidural)
1. Age, mean (SD): 69.0 (± 6.6) years
2. Gender, M/F: 15/5
3. ASA grade: ASA I: 3; ASA II: 17
Inhalational maintenance group (with epidural)
1. Age, mean (SD): 70.4 (± 5.9) years
2. Gender, M/F: 14/6
3. ASA grade: ASA I: 4; ASA II: 16
Country: China
Setting: hospital
Interventions TIVA group (without epidural)
Participants: n = 20; 0 losses
Induction details: TCI propofol 4.0 µg/mL, 3 µg/kg to 4 µg/kg fentanyl and 0.2 mg/kg
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cisatracurium IV
Maintenance details: fentanyl IV 0.15 µg/kg/min to 0.35 µg/kg/min, TCI propofol 1.5
µg/mL to 3.0 µg/mL. To maintain BIS 40 to 60
Other information: 30 minutes before end of surgery, 0.6 µg to µg 1 µg fentanyl IV
Inhalational maintenance group (without epidural)
Participants: n = 20; 0 losses
Induction details: 8% sevoflurane at high-flow rate, 8 L/min to 10 L/min. After loss of
consciousness, adjusted to 2 L/min to achieve end-tidal concentration of 2%
Maintenance details: continuous inhalation end-tidal concentration of 1.5% to 3.5%.
Cisastracurium 0.05 mg/kg to 0.1 mg/kg. To maintain BIS 40 to 60
Other info: 30 minutes before end of surgery, 0.6 µg to 1 µg fentanyl IV
TIVA group (with epidural)
Participants: n = 20; 0 losses
Induction details: TCI propofol 4.0 µg/mL, 3 µg/kg to 4 µg/kg fentanyl and 0.2 mg/kg
cisatracurium IV
Maintenance details: fentanyl IV 0.15 µg/kg/min to 0.35 µg/kg/min, TCI propofol 1.
5 µg/mL to 3.0 µg/mL. 30 minutes before skin incision: 10 mL ropivacaine and 2 µg/
mL, fentanyl injected into epidural space
Other info: once epidural puncture was performed, a test dose of 3 mL 2% lidocaine to
confirm level and absence of adverse reactions. 30 minutes before end of surgery, 10 mL
mixed anaesthesia solution
Inhalational maintenance group (with epidural)
Participants: n = 20; 0 losses
Induction details: 8% sevoflurane at high-flow rate, 8 L/min to 10 L/min. After loss of
consciousness, adjusted to 2 L/min. to achieve end-tidal concentration of 2%
Maintenance details: 30 minutes before skin incision: 10 mL ropivacaine and 2 µg/mL
fentanyl injected into epidural space. Continuous inhalation end-tidal concentration of
1.5% to 3.5% sevoflurane. Cisastracurium 0.05 mg/kg to 0.1 mg/kg. BIS 40 to 60
Other info: once epidural puncture was performed, a test dose of 3 mL 2% lidocaine to
confirm level and absence of adverse reactions. 30 minutes before end of surgery, 10 mL
mixed anaesthesia solution
Outcomes 1. Dose of remifentanil
2. Incidence of hypotension (defined as SBP ≤ 90 mmHg or reduction ≥ 20% or
baseline for ≥ 5 minutes)
3. Time to awakening
4. Time to endotracheal tube removal
5. Time to orientation
6. Time to achieve modified Aldrete scores ≥ 9
7. Emergence agitation
Notes Funding/declarations of interest: not reported
Study dates: not reported
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Use of a random number table
Allocation concealment (selection bias) Unclear risk No details
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind anaesthetists to intervention
groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No details
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss of study participants
Selective reporting (reporting bias) Unclear risk Study authors do not report clinical trials registra-
tion. Not feasible to judge risk of selective outcome
reporting
Other bias Low risk No other sources of bias identified
AAA: abdominal aortic aneurysm
aMCI: amnesic mild cognitive impairment
ApoE: apoliproprotein E
ASA: American Society of Anesthesiologists
BDI: Beck Depression Inventory
BIS: bispectral index
BMI: body mass index
BP: blood pressure
CAM: confusion assessment method
DRS: delirium rating scale
DSST: Digit Symbol Substitution Test
FiO2: fraction of inspired oxygen
GA: general anaesthesia
HR: heart rate




ITT: intention to treat
LMA: laryngeal mask airway
MAC: minimum alveolar concentration
MAP: mean arterial pressure
MCI: mild cognitive impairment
M/F: male/female
MI: myocardial infarction
MMSE: Mini-Mental State Examination
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MMT: Mini Mental Test
n: number of randomized participants per group
N2O: nitrous oxide
NYHA: New York Heart Association
O2: oxygen
PACU: postanaesthesia care unit
PCA: patient controlled analgesia
PCI: percutaneous coronary intervention
POCD: postoperative cognitive dysfunction
PONV: postoperative nausea and vomiting
PP: per protocol
PSI: patient state index
RAVLT: Rey Auditory Verbal Learning test
RCT: randomized control trial
SBP: systolic blood pressure
SD: standard deviation
SOFA: Sequential Organ Failure Assessment
T8-T10: epidural given between the 8th and 9th, or the 9th and 10th thoracic vertebrae
TCI: target-controlled infusion
TDT: Trieger Dot Test
TEE: transoesophageal echocardiography
TIVA: total intravenous anaesthesia
TKA: total knee arthroplasty
VAS: visual analogue scale
VIMA: volatile induction and maintenance anaesthesia
vs: versus
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arar 2005 RCT, measuring effects of sevoflurane versus isoflurane versus propofol infusions on postoperative recovery
criteria in geriatric participants. Outcomes measured: time to spontaneous eye opening, extubation, re-
sponse to verbal stimuli, and orientation. Post-hoc decision to exclude studies that did not measure review
outcomes
Arnaoutoglou 2007 RCT, measuring effects of propofol versus sevoflurane on the production of free oxygen radicals during
total knee arthroplasty in elderly participants. Outcomes measured: MDA levels. Post-hoc decision to
exclude studies that did not measure review outcomes
But 2003 Unclear if this is an RCT. Measures effects of sevoflurane versus propofol on hepatic and renal functions in
participants > 65 years of age. Post-hoc decision to exclude studies that did not measure review outcomes
Carles 2008 RCT, measuring effects of sevoflurane versus propofol versus spinal anaesthesia on levels of interstitial
glycolysis metabolites in elderly participants. Post-hoc decision to exclude studies that did not measure
review outcomes
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Doe 2016 RCT, measuring effects of sevoflurane versus propofol on jugular venous bulb oxygenation (SjO2) and
regional oxygen saturation in participants undergoing robotic-assisted laparoscopic prostatectomy. Post-
hoc decision to exclude studies that did not measure review outcomes
Filipovic 2007 RCT, measuring effects of anaesthetics on left ventricular diastolic function in participants aged between
18 and 75. Outcomes measured: haemodynamic parameters. Post-hoc decision to exclude studies that did
not measure review outcomes
Fredman 2002 RCT, measuring the effects of propofol verses sevoflurane on postanaesthesia recovery in geriatric partic-
ipants. Outcomes measured: emergence time, time to orientation, postanaesthesia recovery scores, and
therapeutic interventions. Post-hoc decision to exclude studies that did not measure review outcomes
Gasowska 1999 RCT, measuring effects of halothane versus isoflurane versus propofol on venous admixture in participants
between 28 to 72 years of age. Post-hoc decision to exclude studies that did not measure review outcomes
Gauger 2008 RCT, measuring effects of propofol on postoperative nausea and vomiting in participants undergoing
thyroid and parathyroid operations. Outcomes measured: occurrences of nausea and vomiting. Post-hoc
decision to exclude studies that did not measure review outcomes
Guedes 1988 RCT, measuring effects of propofol versus enflurane on intraocular pressure in elderly participants. Out-
comes measured: haemodynamic parameters. Post-hoc decision to exclude studies that did not measure
review outcomes
Halberg 1996 Unclear if this is anRCT.Apharmaco-economic evaluationof anaesthesia in ambulatory surgery comparing
desflurane verses isoflurane and propofol. Unable to source full text. Post-hoc decision to exclude studies
that did not measure review outcomes. Decision made from information in the abstract
Holst 1993 Unclear if this is an RCT. A comparison of the intraoperative sympatho-adrenergic response and the
postoperative vigilance of a propofol/alfentanil anaesthesia to a conventional isoflurane anaesthesia. Unable
to source full text. Post-hoc decision to exclude studies that did not measure review outcomes. Decision
made from information in the abstract
Hosseinzadeh 2013 RCT, measuring effects of propofol versus isoflurane on incidence of postoperative nausea and vomiting
in participants between 16 to 65 year of age. Post-hoc decision to exclude studies that did not measure
review outcomes
Ionescu 2009 Unclear if this is an RCT. Effects of TIVA versus isoflurane on postoperative nausea and vomiting, and
patient satisfaction, in participants undergoing laparoscopic cholecystectomy. Unable to source full text.
Post-hoc decision to exclude studies that did not measure review outcomes. Decision made from informa-
tion in the abstract
Ito 2012 RCT, measuring effects of TIVA versus desflurane on postoperative emergence in elderly participants.
Outcomesmeasured: presence of spontaneous speech, early recovery time, time to extubation, eye opening,
and squeezing fingers on command. Post-hoc decision to exclude studies that did not measure review
outcomes
Kadoi 2009a RCT, measuring effects of propofol versus sevoflurane on cerebrovascular carbon dioxide reactivity in
elderly participants. Outcomes measured: cerebral circulation. Post-hoc decision to exclude studies that
did not measure review outcomes
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Kim 2015b RCT, measuring effects of propofol versus desflurane on postoperative spirometry in elderly after knee
surgery. Outcomes measured: spirometry parameters. Post-hoc decision to exclude studies that did not
measure review outcomes
Konstantopoulos 2013a RCT, measuring effects of sevoflurane versus propofol on recovery characteristics in older participants.
Outcomesmeasured: haemodynamic stability, recovery characteristics, postoperative nausea and vomiting,
and pain intensity. Post-hoc decision to exclude studies that did not measure review outcomes
Kvarnstrom 2012 RCT, measuring effects of sevoflurane versus propofol on complement activation and the release of inflam-
matory interleukins in participants undergoing major abdominal surgery. Post-hoc decision to exclude
studies that did not measure review outcomes
Malcharek 2015 RCT, measuring effects of desflurane versus propofol on tcMEP amplitudes in participants without PMDs
undergoing CEA. Post-hoc decision to exclude studies that did not measure review outcomes
Manolescu 2012 Unclear if this is an RCT. Evaluation of cardioprotective effects of sevoflurane versus propofol in patients
with cardiac risk, undergoing noncardiac surgery. Unable to source full text. Post-hoc decision to exclude
studies that did not measure review outcomes. Decision made from information in the abstract
Mets 1992 RCT,measuring effects of propofol versus isoflurane in elderly participants undergoing ophthalmic surgery.
Outcomesmeasured: haemodynamic parameters. Post-hoc decision to exclude studies that did not measure
review outcomes
Murray 1994 RCT, measuring effects of isoflurane versus propofol on hepatic glutathione-S-transferase concentrations.
Post-hoc decision to exclude studies that did not measure review outcomes
Mutch 1995 RCT, measuring effects of propofol versus isoflurane in older patients undergoing carotid endarterectomy.
Outcomesmeasured: haemodynamic parameters. Post-hoc decision to exclude studies that did not measure
review outcomes
Ohe 2014 Unclear if this is an RCT. Compares effects of sevoflurane versus propofol on preventing intraoperative
hypothermia. Post-hoc decision to exclude studies that did not measure review outcomes
Oikkonen 1992 RCT, measuring effects of isoflurane versus alfentanil-methohexitone verses propofol on arterial pressure
or heart rate in geriatric participants. Post-hoc decision to exclude studies that did not measure review
outcomes
Passot 2005 RCT, measuring effects of target- versus manually-controlled infusion of propofol and desflurane in elderly
participants undergoing hip fracture surgery. Outcomes measured: haemodynamic parameters. Post-hoc
decision to exclude studies that did not measure review outcomes
Pirttikangas 1996 RCT, measuring effects of propofol versus combined isoflurane in elderly participants undergoing oph-
thalmic surgery. Outcomes measured: immune responses. Post-hoc decision to exclude studies that did
not measure review outcomes
Polarz 1995 RCT, measuring effects of isoflurane versus propofol on participants undergoing ophthalmic surgery.
Outcomes measured: intraocular pressure. Unable to source full text. Post-hoc decision to exclude studies
that did not measure review outcomes
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Sal’nikov 2003 Unclear if this is an RCT. A comparative evaluation of “cerebral oximetry” during anaesthesia with xenon
and other anaesthetics. Unable to source full text. Post-hoc decision to exclude studies that did not measure
review outcomes
Schilling 2007 RCT, measuring effects of propofol versus desflurane in older participants undergoing open thoracic
surgery. Outcomes measured: alveolar inflammatory response to one-lung ventilation. Post-hoc decision
to exclude studies that did not measure review outcomes
Schilling 2011 RCT, measuring effects of propofol versus desflurane versus sevoflurane in older participants undergoing
open thoracic surgery. Outcomes measured: alveolar inflammatory response. Post-hoc decision to exclude
studies that did not measure review outcomes
Schäfer 2002 RCT, measuring effects of propofol versus sevoflurane in participants aged over 50 undergoing cataract
surgery.Outcomesmeasured: intraocular pressure. Post-hoc decision to exclude studies that did notmeasure
review outcomes
Shao 2013 RCT, measuring effects of propofol versus sevoflurane in elderly participants. Outcomes measured: quality
of neuromuscular blockade with cisatracurium. Post-hoc decision to exclude studies that did not measure
review outcomes
Sohn 2008 RCT, measuring effects of propofol versus sevoflurane in elderly participants undergoing total knee arthro-
plasty. Outcomes measured: haemodynamic parameters. Post-hoc decision to exclude studies that did not
measure review outcomes
Sugata 2012 RCT, measuring effects of propofol versus sevoflurane in participants undergoing prone spine surgery.
Outcomes measured: intraocular pressure. Unable to source full text. Post-hoc decision to exclude studies
that did not measure review outcomes
Trifu 2011 RCT, measuring effects of propofol versus sevoflurane in participants aged between 16 and 76 undergoing
elective neurosurgery. Unable to source full text. Outcomes measured: cardiovascular stability, recovery
characteristics, and side effects. Post-hoc decision to exclude studies that did not measure review outcomes
Tufano 2000 RCT, measuring effects of propofol versus sevoflurane in participants aged between 18 and 70. Outcomes
measured: drug consumption, intraoperative responses, and times of recovery. Post-hoc decision to exclude
studies that did not measure review outcomes
Ueda 1999 RCT, measuring effects of sevoflurane versus propofol combined with thoracic epidural anaesthesia on
arterial oxygenation during one-lung ventilation for thoracotomy. Unable to source full text. Outcomes
measured: haemodynamic parameters. Post-hoc decision to exclude studies that did not measure review
outcomes. Decision made from information in the abstract
Wakabayashi 2014 RCT, measuring effects of sevoflurane versus propofol in older participants undergoing oesophagectomy.
Outcomes measured: levels of cytokine and chemokine at the airway epithelium. Post-hoc decision to
exclude studies that did not measure review outcomes
Weilbach 2005 RCT, measuring effects of TIVA versus BA in elderly participants undergoing a cataract operation. Out-
comes measured: patient satisfaction. Post-hoc decision to exclude studies that did not measure review
outcomes
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Wen 2010 RCT,measuring effects of sevoflurane versus propofol on neuromuscular blockade produced by continuous
cisatracurium infusion. Post-hoc decision to exclude studies that did not measure review outcomes
Wormald 2005 RCT, measuring effects of sevoflurane versus propofol on the surgical field. Post-hoc decision to exclude
studies that did not measure review outcomes
Yu 2010a RCT, measuring effects of sevoflurane versus propofol in elderly patients undergoing abdominal surgery.
Outcomesmeasured: haemodynamic parameters. Post-hoc decision to exclude studies that did not measure
review outcomes
Zabolotskikh 2013 Unclear if this is an RCT. Measuring effects of sevoflurane versus propofol on intracerebral and cerebral
perfusion pressure. Post-hoc decision to exclude studies that did not measure review outcomes
Zhang 2014 RCT, measuring effects of propofol versus propofol and sevoflurane versus sevoflurane on immune re-
sponses in patients undergoing surgery for tongue cancer. Post-hoc decision to exclude studies that did




PMDs: pre-existing motor deficits
RCT: randomized control trial
SjO2: jugular venous bulb oxygenation saturation
tcMEP: transcranial electrical motor evoked potential
TIVA: total intravenous anaesthesia
Characteristics of studies awaiting assessment [ordered by study ID]
IRCT2015112925277N1
Methods RCT, parallel design




1. History of allergic reaction to the drug used in this study
2. Pregnancy
3. Drug addiction




Type of surgery: inguinal herniorrhaphy
Country: Iran
Setting: hospital
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Interventions TIVA group
Maintenance details: 100 mg /kg/minute propofol
Inhalational maintenance group








8. Dose of diclofenac postoperatively
Notes Study is completed, but study results are not posted. Study does not specifically recruit elderly participants. Once
published, we would need to ascertain whether mean age of participants is > 60 years of age
McDonagh 2012
Methods RCT, parallel design
Participants Number of randomized participants: 200
Inclusion criteria
1. ≥ 65 years of age, after obtaining IRB approval and informed consent
Exclusion criteria
1. Not fluent in English
2. Severe visual or auditory deficits
3. Diagnosis of dementia
4. Score 18 on the MMSE




Induction details: pre-medicated with midazolam. Induction with propofol; no additional details
Maintenance details: propofol TIVA to maintain BIS 40 to 60
Inhalational maintenance group
Induction details: pre-medicated with midazolam Induction with propofol; no additional details
Maintenance details: isoflurane to maintain BIS 40 to 60
Outcomes 1. Cognitive function at 3 months postsurgery using GDS. Cognitive testing using standardized cognitive
measures
Notes We only have an abstract for this study. No denominator figures for each group. Not clear whether outcome data is
available for immediate postoperative period
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Methods RCT, parallel design
Participants Target number of participants: 94
Inclusion criteria
1. ≥ 60 years of age, with ASA II or III, scheduled for noncardiac and non-neural surgery
Exclusion criteria
1. MMSE score which is too low
2. Chronic alcohol and drug abuse
3. Disturbed renal and liver function
4. History of a cerebrovascular accident
5. Permanent ventricular pacing
6. Preoperative cognitive deficits
7. Lack of co-operation
Type of surgery: noncardiac and non-neural surgery
Country: China





Outcomes 1. Number of participants with POCD as assessed by MMSE score up to 7 days postoperatively
Notes Study is completed, but study results are not posted
Shen 2011
Methods RCT, parallel design
Participants Total number of randomized participants: 60
Inclusion criteria: requires translation
Exclusion criteria: requires translation




Induction details: requires translation
Maintenance details: propofol and fentanyl
Inhalational maintenance group
Induction details: requires translation
Maintenance details: sevoflurane and fentanyl
Outcomes 1. Durations of operation and one-lung ventilation
2. Volume of blood loss during operation
3. Time of spontaneous eye opening
4. Extubation
5. Cognitive function (assessed before operation and at various times after operation using MMSE)
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Shen 2011 (Continued)
Notes Unable to extract detailed data due to paper being written in Chinese. All data extracted from abstract
ASA: American Society of Anesthesiologists
BIS: bispectral index
GDS: Geriatric Depression scale
IRB: institutional review board
MMSE: Mini-Mental State Examination
RCT: randomized control trial
POCD: postoperative cognitive dysfunction
TIVA: total intravenous anaesthesia
Characteristics of ongoing studies [ordered by study ID]
ChiCTR-IOR-16009851
Trial name or title Impact of postoperative cognitive function after sevoflurane- or propofol-anaesthesia in aged cancer patients:
a double-blinded randomized controlled trial
Methods RCT, parallel design
Participants Target number of randomized participants: 220
Inclusion criteria
1. ≥ 65 years and < 86 years of age, male or female of any nationality
2. Presenting for major abdominal malignant tumour resection under GA with estimated duration of
operation > 2 hours
3. Primary malignant tumour
4. Patient and relatives agree to participate and sign informed consents.
Exclusion criteria
1. Refusal to join the study
2. History of depression, schizophrenia, or epilepsy
3. Parkinsons disease, or myasthenia gravis
4. Serious Alzheimers disease
5. Any severe visual or auditory disorders




10. In a critical condition (ASA status IV or V before surgery)
11. History of neurological surgery
12. MMSE < 24
13. History of alcoholism, or drug dependence
Type of surgery: major abdominal malignant tumour resection
Country: China
Setting: hospital
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ChiCTR-IOR-16009851 (Continued)
Interventions TIVA group
Details: propofol; no details
Inhalational maintenance group
Details: sevoflurane; no details
Outcomes 1. POCD (at 7 days and 3 months postoperatively)
2. Quality of recovery
3. Complications after surgery
4. Length of hospital stay
5. EORCT
6. QLQ-C30
Starting date 11 July 2016
Contact information Liang Guo (1159398818@qq.com) or Ling-Hui Pan (plinghui@hotmail.com)
Notes
EUCTR2014-004604-29-DK
Trial name or title Sevoflurane versus standard general anaesthesia in elective open abdominal aortic aneurism surgery
Methods RCT, parallel design
Participants Target number of randomized participants: 24
Inclusion criteria
1. Enrolled for abdominal infrarenal aortic aneurism repair surgery
Exclusion criteria
1. < 18 years of age
2. Included in other pharmaceutical studies
3. Abuse of opioids, benzodiazepines, anti-epileptic drugs, alcohol or alpha 2-agonists
4. pregnant and breastfeeding women
5. Family history of malignant hyperthermia
6. Known hypersensitivity for opioids, propofol or volatile anaesthetics
7. Serious arrhythmia, ventricular tachycardia or tachycardia > 120 beats/min
8. Severe valvular diseases requiring surgical repair before major noncardiac surgery
9. Uncontrolled hypertension
10. Unstable angina pectoris or MI within 30 days of inclusion
11. Requiring acute abdominal aortic aneurysm surgery, or endovascular abdominal aortic aneurysm
surgery
12. Severe uncontrolled psychiatric disease




Details: propofol; no details
Inhalational maintenance group
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EUCTR2014-004604-29-DK (Continued)
Details: sevoflurane; no details
Outcomes 1. Biochemical measurements
2. Need for inotropic support
3. MI
4. Intestinal ischaemia diagnosed with endoscopy, laparoscopy or angiograph during admission
5. Postoperative incidences of ARDS and need for dialysis
6. Need for postoperative respiratory support
7. Days until discharge
8. Days in ICU
9. 30-day mortality
Starting date Not clear from the clinical trials register documents
Contact information Peder Bach (pedebach@rm.dk)
Notes Study does not specifically recruit elderly participants. Once completed, we would need to ascertain whether
mean age of participants is > 60 years of age
NCT01809041
Trial name or title Comparison of intravenous anesthetics to volatile anesthetics on postoperative cognitive dysfunction
Methods RCT, parallel design
Participants Target number of randomized participants: 684
Inclusion criteria
1. Major elective gastrointestinal, gynaecological, prostate or bladder surgery patients, ≥ 60 years of age
2. Laparoscopic surgery expected to last for ≥ 2 hours under GA and the patient will stay in hospital for
≥ 7 days after surgery
3. Lack of serious hearing and vision impairment and be able to read so that neurobehavioral tests can be
performed
Exclusion criteria
1. Not expected to be alive for > 3 months
2. MMSE score ≤ 23
3. History of dementia, psychiatric illness or any diseases of central nervous system
4. Current use of sedatives or antidepressant, alcoholism and drug dependence
5. Previously included in this study (for participants who have second intra-abdominal surgery during the
study period)
6. Difficult to follow up or participants with poor compliance
7. Uncontrolled hypertension (> 180/100 mmHg)




Maintenance details: propofol (50 - 150 µg/kg/min) and remifentanil (0.1 - 0.5 µg/kg/min)
Inhalational maintenance group
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NCT01809041 (Continued)
Maintenance details: sevoflurane at 0.5 to 1.5 MAC plus remifentanil (0.1 - 0.5 µg/kg/min)
Outcomes Number of participants with POCD (at 7 days and 3 months)
Time for bowel function return after surgery
Degree of increase of stress hormones
Length of hospital stay
Starting date March 2013
Contact information Yujuan Li, MD, PhD (yujuan 04@hotmail.com); or Shulin Peng (pslmzk@yahoo.com.cn)
Notes
NCT01995214
Trial name or title Sevoflurane and propofol anaesthesia on postoperative delirium
Methods RCT, parallel design
Participants Target number of randomized participants: 500
Inclusion criteria
1. ASA I to III, ≥ 60 years of age, elective major surgery under GA
Exclusion criteria
1. ASA ≥ IV, < 60 years of age
2. BMI > 30
3. Neurologic disease
4. Cardiac surgery or neurologic surgery
5. Anticonvulsant drugs
6. Chronic analgesics intake
7. Participating in another study




Maintenance details: propofol and remifentanil guided by Narcotrend index monitoring
Inhalational maintenance group
Maintenance details: sevoflurane and remifentanil guided by Narcrotrend index monitoring
Outcomes 1. Postoperative delirium (using CAM at 24 hours, and at 2, 3, and 7 days postoperatively)
2. Length of PACU stay
3. Haemodynamic parameters
4. PONV
5. Quality of recovery (using QOR-40)
6. Postoperative stroke (at 1, 2, 3, and 7 days postoperatively)
Starting date June 2013
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NCT01995214 (Continued)
Contact information Yuke Tian, MD, PhD
Notes
NCT02107170
Trial name or title Effects of anesthetics on postoperative cognitive function of patients undergoing endovascular repair of aortic
aneurysm and endovascular treatment of arteriosclerosis obliterans of lower extremities
Methods RCT, parallel design
Participants Target number of randomized participants: 400
Inclusion criteria
1. 18 to 100 years of age, patients presenting for endovascular repair of aortic aneurysm and endovascular
treatment of arteriosclerosis obliterans of lower extremities
Exclusion criteria
1. Pre-existing delirium
2. Inability to converse





Details: propofol (50 to 150 µg/kg/min) plus remifentanil (0.1 to 0.5 µg/kg/min) during the surgery
Inhalational maintenance group
Details: sevoflurane at 0.5 to 1.5 MAC plus remifentanil (0.1 to 0.5 µg/kg/min) during the surgery
Outcomes 1. Number of participants with POCD (at 7 days and 3 months postoperatively)
2. Changes in plasma levels of VEGF, TGF-1, TNF-α, IL-1β, and IL-6 (a composite outcome measure,
at 3 days postoperatively)
Starting date February 2014
Contact information Tao Zhang, Master of Medicine (zhtao98@aliyun.com)
Notes Study does not specifically recruit elderly participants. Once completed, we would need to ascertain whether
mean age of participants is > 60 years of age
NCT02133638
Trial name or title Sevoflurane decreases the risk of postoperative delirium after cerebral hypoxemia during surgery
Methods RCT, parallel design
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NCT02133638 (Continued)
Participants Target number of randomized participants: 130
Inclusion criteria
1. ASA III to IV, history of arterial vascular disease (arterial hypertension, myocardial ischaemia and/or
cerebral vascular disease), undergoing elective non-cardiac surgery (hemicolectomy, hernioplasty,
laparoscopic cholecystectomy and laparoscopic hysterectomy), 65 to 80 years of age
Exclusion criteria
1. Dementia
2. Stroke or myocardial infarction ≤ 6 months before surgery
3. Oncological disease of T2-4N3M1 stage





Induction details: propofol 2 mg/kg and fentanyl 4 µg/kg
Maintenance details: infusion of propofol 8 mg/kg/hour and boluses of fentanyl 3 µg/kg
Inhalational maintenance group
Induction details: fentanyl 2 µg/kg and a bolus inhalation of 8% sevoflurane in an 8 L/min fresh gas flow
Maintenance details: 1 MAC sevoflurane at a low fresh gas flow of 0.6 to 0.8 L/min in a 60% air-oxygen
mixture supplemented with boluses of fentanyl
Outcomes 1. Regional cerebral oxygenation
2. Peripheral tissue oxygen saturation
3. Non-invasive blood pressure
4. Postoperative delirium (using CAM 24 and 48 hours postoperatively)
5. Plasma concentration of S100b protein
Starting date May 2014
Contact information Yuri V Iljin, Negovsky Reanimatology Research Institute, Moscow, Russia
Notes
NCT02301676
Trial name or title Long term postoperative cognitive dysfunction in the elderly patients
Methods RCT, parallel design
Participants Target number of randomized participants: 190
Inclusion criteria
1. ≥ 60 years of age, scheduled for laparoscopic cholecystectomy under GA
Exclusion criteria
1. Diseases of the central nervous system, including dementia (MMSE < 24)
2. Consumption of major tranquillizers or antidepressants
3. Previous neuropsychological testing
4. Inability to comply and follow procedures or poor comprehension of the language used in the study
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NCT02301676 (Continued)
5. Parkinson’s disease
6. Severe visual or auditory disability
7. Illiteracy
8. Alcoholism (intake of > 5 units of alcohol daily during the last 3 months)
9. Drug dependence
10. Not expected to complete the postoperative tests






Details: sevoflurane; no details
Outcomes 1. POCD (at 2 years postoperatively)
Starting date December 2014
Contact information Seung-Hoon Baek, Pusan National University Yangsan Hospital
Notes
NCT02458547
Trial name or title Effect of anaesthesia technique on outcome after hip fracture surgery in elderly adult patients
Methods RCT, parallel design
Participants Target number of randomized participants: 186
Inclusion criteria
1. > 65 years scheduled for elective or emergency hip fracture surgery
Exclusion criteria
1. Participant refusal
2. Inflammation or wound at puncture site
3. Increased intracranial pressure
4. Bleeding diathesis
5. Allergies to propofol or its ingredients, soybeans or peanuts
6. Participants with altered mental status
7. Illiterate
8. From another country
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NCT02458547 (Continued)
Details: desflurane at age-adjusted MAC of 0.8 to 1.0
Outcomes 1. Measures of pro-inflammatory cytokines
Starting date May 2015
Contact information Not reported
Notes Study may not report outcomes of interest. Because the study includes elderly surgical patients and compares
the anaesthetic agents of interest, we have included this study in our list of ongoing studies
NCT02662257
Trial name or title Impact of anaesthesia maintenance methods on incidence of postoperative delirium
Methods RCT, parallel design
Participants Target number of randomized participants: 1200
Inclusion criteria
1. ≥ 65 years and < 90 years of age
2. Primary malignant tumour
3. Not receiving radiation therapy or chemotherapy before surgery
4. Scheduled to undergo surgery for the treatment of tumours, with an expected duration of ≥ 2 hours,
under GA
5. Agree to participate, and give signed written informed consent
Exclusion criteria:
1. Preoperative history of schizophrenia, epilepsy, parkinsonism or myasthenia gravis
2. Inability to communicate in the preoperative period (coma, profound dementia, language barrier, or
end-stage disease)
3. Critical illness (preoperative ASA ≥ IV)
4. Severe hepatic dysfunction (Child-Pugh class C)
5. Severe renal dysfunction (undergoing dialysis before surgery)
6. Neurosurgery
7. Other reasons that are considered unsuitable for participation by the responsible surgeons or
investigators




Details: propofol adjusted to maintain BIS 40 to 60, with or without 50% nitrous oxide. Remifentanil (ad-
ministered by continuous infusion), sufentanil (administered by intermittent injection/continuous infusion)
, or fentanyl (administered by intermittent injection). Towards the end of surgery, propofol infusion rate will
be decreased and fentanyl/sufentanil will be administered when necessary
Inhalational maintenance group
Details: sevoflurane adjusted to maintain BIS 40 to 60, with or without 50% nitrous oxide. Remifentanil (ad-
ministered by continuous infusion), sufentanil (administered by intermittent injection/continuous infusion)
, or fentanyl (administered by intermittent injection). Towards the end of surgery, sevoflurane inhalational
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concentration will be decreased and fentanyl/sufentanil will be administered when necessary
Outcomes 1. Delirium (using CAM or CAM-ICU, at 7 days postoperatively)
2. Length of hospital stay (up to 30 days)
3. Incidence of non-delirium complications (up to 30 days)
4. Cognitive function (using TICS-m at 30 days)
5. All-cause 30-day mortality
6. Pain score (during first 3 days postoperatively)
7. Cognitive function at 7 days postoperatively
Starting date April 2015
Contact information Dong-Xin Wang, MD, PhD, Peking University FIrst Hospital
Notes Also registered as ChiCTR-IPR-15006209
NCT03165396
Trial name or title Appropriate compatibility of propofol and sevoflurane for orthopaedic surgery of patients with MCI
Methods RCT, parallel design
Participants Target number of randomized participants: 100
Inclusion criteria
1. Scheduled for elective orthopaedic surgery, ASA II, 50 to 75 years
Exclusion criteria
1. Neurological diseases that may affect cognitive function (e.g. subdural haematoma)
2. Hypothyroidism
3. Alcoholic dementia




Details: propofol TCI 2.0 to 2.5 µg/mL
Inhalational maintenance group
Details: 1.3 MAC sevoflurane
Outcomes 1. Evidence of clinically cognitive function decline (using ApoJ, at 7 days; soluble CD14, at 7 days)
2. Cognitive function (using MMSE, at 24 hours and 7 days postoperatively; and MoCA, at 24 hours
and 7 days postoperatively)
Starting date 10 May 2016
Contact information Haiyun Wang (why@126.com) or Yimeng Chen (chenyimeng5525@163.com)
Notes Compares two additional groups using propofol at different doses combined with sevoflurane
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NCT03194074
Trial name or title Early cognitive function in elderly patients after laser laryngeal surgery: des vs prop
Methods RCT, parallel design
Participants Target number of randomized participants: 70
Inclusion criteria
1. Scheduled for laser laryngeal surgery under GA
Exclusion criteria
1. Cardiac, pulmonary, hepatic, or renal dysfunction
2. Epilepsy
3. Uncontrolled hypertension
4. Taking medications that influence the central nervous system
5. Showing obvious alteration of mental status
6. Refusal to participate




Maintenance details: propofol at a rate 75 to 150 µg/kg/min and remifentanil at 0.1 to 0.3 µg/kg/min
maintained throughout surgery
Inhalational maintenance group
Maintenance details: desflurane at end-tidal concentration at 0.7 to 1.0 MAC and remifentanil 0.1 to 0.3 µg/
kg/min
Outcomes 1. Change of MMSE (day before surgery and 30min postoperatively)
2. MMSE scores at 1, 3, and 24 hours postoperatively
Starting date 15 August 2017
Contact information Xia Shen, MD (zlsx@yahoo.com) or Hui Qiao, MD (theyellow@163.com)
Notes Study does not specifically recruit elderly participants. Once completed, we would need to ascertain whether
mean age of participants is > 60 years of age
ApoJ: Apolipoprotein J
ARDS: acute respiratory distress syndrome
ASA: American Society of Anesthesiologists
BIS: Bispectral Index
BMI: body mass index
CAM: confusion assessment method
CD: cluster of differentiation
EORCT QLQ-C30: (quality of life questionnaire for cancer patients)
GA: general anaesthesia
ICU: intensive care unit
IL: interleukin
MAC: minimum alveolar concentration
MCI: mild cognitive impairment
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MI: myocardial infarction
MMSE: Mini-Mental State Examination
MoCA: Montreal Cognitive Assessment
PACU: postanaesthesia care unit
POCD: postoperative cognitive dysfunction
PONV: postoperative nausea and vomiting
QOR-40: quality of recovery questionnaire
RCT: randomized control trial
TGF: transforming growth factor
TCI: target-controlled infusion
TICS-m: Telephone Interview for Cognitive Status-Modified
TIVA: total intravenous anaesthesia
TNF: tumour necrosis factor
VEGF: vascular endothelial growth factor
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D A T A A N D A N A L Y S E S
Comparison 1. TIVA vs Inhalational maintenance




participants Statistical method Effect size
1 Postoperative delirium 5 321 Odds Ratio (M-H, Random, 95% CI) 0.59 [0.15, 2.26]
2 Postoperative cognitive
dysfunction
7 869 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.31, 0.87]
3 Mortality 3 271 Odds Ratio (M-H, Random, 95% CI) 1.21 [0.33, 4.45]
4 Intraoperative hypotension 11 Odds Ratio (M-H, Random, 95% CI) Totals not selected
5 Length of stay in PACU 7 Mean Difference (IV, Random, 95% CI) Totals not selected
6 Length of hospital stay 4 175 Mean Difference (IV, Random, 95% CI) -0.00 [-1.32, 1.32]
Comparison 2. TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)




participants Statistical method Effect size
1 Postoperative delirium
(induction agents; and TCI vs
non-TCI)
5 321 Odds Ratio (M-H, Random, 95% CI) 0.59 [0.15, 2.26]
1.1 Induction with
inhalational agents, and TCI
1 50 Odds Ratio (M-H, Random, 95% CI) 3.12 [0.12, 80.39]
1.2 Induction with
intravenous agents, and non-
TCI
4 271 Odds Ratio (M-H, Random, 95% CI) 0.42 [0.11, 1.67]
2 Postoperative cognitive
dysfunction (induction agents)
7 869 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.31, 0.87]
2.1 Induction with
inhalational agents
2 230 Odds Ratio (M-H, Random, 95% CI) 0.87 [0.50, 1.50]
2.2 Induction with
intravenous agents
5 639 Odds Ratio (M-H, Random, 95% CI) 0.38 [0.20, 0.75]
3 Mortality (induction agents; and
TCI vs non-TCI)
3 271 Odds Ratio (M-H, Random, 95% CI) 1.21 [0.33, 4.45]
3.1 Induction with
inhalational agents, and TCI
1 28 Odds Ratio (M-H, Random, 95% CI) 3.22 [0.12, 86.09]
3.2 Induction with
intravenous agents, and non-
TCI
2 243 Odds Ratio (M-H, Random, 95% CI) 1.01 [0.25, 4.16]
4 Intraoperative hypotension
(induction agents)
11 Odds Ratio (M-H, Random, 95% CI) Totals not selected
4.1 Induction with
inhalational agents
5 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 Induction with
intravenous agents
6 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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5 Postoperative cognitive
dysfunction (TCI vs non-TCI)
7 869 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.31, 0.87]
5.1 TCI 2 294 Odds Ratio (M-H, Random, 95% CI) 0.31 [0.07, 1.38]
5.2 non-TCI 5 575 Odds Ratio (M-H, Random, 95% CI) 0.63 [0.36, 1.10]
6 Intraoperative hypotension (TCI
vs non-TCI)
11 Odds Ratio (M-H, Random, 95% CI) Totals not selected
6.1 TCI 4 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
6.2 non-TCI 7 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
7 Length of stay in the PACU
(TCI vs non-TCI)
7 Mean Difference (IV, Random, 95% CI) Totals not selected
7.1 TCI 2 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
7.2 non-TCI 5 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 3. TIVA vs inhalational maintenance: subgroup analysis, monitoring with processed EEG vs standard
care




participants Statistical method Effect size
1 Postoperative delirium 5 321 Odds Ratio (M-H, Random, 95% CI) 0.59 [0.15, 2.26]
1.1 Monitoring with
processed EEG
3 211 Odds Ratio (M-H, Random, 95% CI) 0.56 [0.04, 7.44]
1.2 Monitoring with standard
care
2 110 Odds Ratio (M-H, Random, 95% CI) 1.00 [0.14, 7.06]
2 Postoperative cognitive
dysfunction
7 869 Odds Ratio (M-H, Random, 95% CI) 0.52 [0.31, 0.87]
2.1 Monitoring with
processed EEG
6 839 Odds Ratio (M-H, Random, 95% CI) 0.47 [0.27, 0.84]
2.2 Monitoring with standard
care
1 30 Odds Ratio (M-H, Random, 95% CI) 1.0 [0.24, 4.20]
3 Intraoperative hypotension 11 Odds Ratio (M-H, Random, 95% CI) Totals not selected
3.1 Monitoring with
processed EEG
6 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3.2 Monitoring with standard
care
5 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4 Length of stay in PACU 7 Mean Difference (IV, Random, 95% CI) Totals not selected
4.1 Monitoring with
processed EEG
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 Monitoring with standard
care
6 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5 Length of hospital stay 4 175 Mean Difference (IV, Random, 95% CI) -0.00 [-1.32, 1.32]
5.1 Monitoring with
processed EEG
1 37 Mean Difference (IV, Random, 95% CI) 2.30 [-0.50, 5.10]
5.2 Monitoring with standard
care
3 138 Mean Difference (IV, Random, 95% CI) -0.27 [-1.40, 0.86]
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Analysis 1.1. Comparison 1 TIVA vs Inhalational maintenance, Outcome 1 Postoperative delirium.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 1 TIVA vs Inhalational maintenance
Outcome: 1 Postoperative delirium
Study or subgroup TIVA
Inhalational
mainte-








Chan 1996 1/29 2/31 24.6 % 0.52 [ 0.04, 6.04 ]
Ishii 2016 2/29 8/30 44.9 % 0.20 [ 0.04, 1.06 ]
Micha 2016 0/36 0/37 Not estimable
Nishikawa 2004 1/25 0/25 15.2 % 3.12 [ 0.12, 80.39 ]
Tanaka 2017 1/39 0/40 15.3 % 3.16 [ 0.12, 79.85 ]
Total (95% CI) 158 163 100.0 % 0.59 [ 0.15, 2.26 ]
Total events: 5 (TIVA), 10 (Inhalational maintenance)
Heterogeneity: Tau2 = 0.34; Chi2 = 3.61, df = 3 (P = 0.31); I2 =17%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours TIVA Favours Inhalational maintenance
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Analysis 1.2. Comparison 1 TIVA vs Inhalational maintenance, Outcome 2 Postoperative cognitive
dysfunction.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 1 TIVA vs Inhalational maintenance
Outcome: 2 Postoperative cognitive dysfunction
Study or subgroup TIVA
Inhalational
mainte-








Egawa 2016 16/72 24/72 21.5 % 0.57 [ 0.27, 1.20 ]
Geng 2017 (1) 2/50 25/100 9.3 % 0.13 [ 0.03, 0.55 ]
Lindholm 2013 4/96 6/97 11.3 % 0.66 [ 0.18, 2.41 ]
Micha 2016 1/36 10/37 5.2 % 0.08 [ 0.01, 0.64 ]
Rohan 2005 7/15 7/15 9.8 % 1.00 [ 0.24, 4.20 ]
Tanaka 2017 19/39 26/40 17.7 % 0.51 [ 0.21, 1.26 ]
Tang 2014 30/101 33/99 25.3 % 0.85 [ 0.47, 1.54 ]
Total (95% CI) 409 460 100.0 % 0.52 [ 0.31, 0.87 ]
Total events: 79 (TIVA), 131 (Inhalational maintenance)
Heterogeneity: Tau2 = 0.18; Chi2 = 10.12, df = 6 (P = 0.12); I2 =41%
Test for overall effect: Z = 2.47 (P = 0.014)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours TIVA Favours Inhalational maintenance
(1) Combined data for isoflurane and sevoflurane groups
109Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-
cardiac surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.3. Comparison 1 TIVA vs Inhalational maintenance, Outcome 3 Mortality.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 1 TIVA vs Inhalational maintenance
Outcome: 3 Mortality
Study or subgroup TIVA
Inhalational
mainte-








Ammar 2016 0/25 0/25 Not estimable
Biboulet 2012 1/14 0/14 15.7 % 3.22 [ 0.12, 86.09 ]
Lindholm 2013 4/96 4/97 84.3 % 1.01 [ 0.25, 4.16 ]
Total (95% CI) 135 136 100.0 % 1.21 [ 0.33, 4.45 ]
Total events: 5 (TIVA), 4 (Inhalational maintenance)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.40, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 TIVA vs Inhalational maintenance, Outcome 4 Intraoperative hypotension.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 1 TIVA vs Inhalational maintenance
Outcome: 4 Intraoperative hypotension
Study or subgroup TIVA
Inhalational
mainte-








Biboulet 2012 14/14 11/14 8.83 [ 0.41, 188.73 ]
Chan 1996 8/29 5/31 1.98 [ 0.56, 6.96 ]
Geng 2017 (1) 3/50 9/100 0.65 [ 0.17, 2.50 ]
Jellish 2003 28/30 26/29 1.62 [ 0.25, 10.45 ]
Longas 2004 (2) 15/20 33/40 0.64 [ 0.17, 2.33 ]
Luntz 2004 17/32 33/64 1.06 [ 0.46, 2.49 ]
Micha 2016 0/36 0/37 Not estimable
Nishikawa 2004 1/25 3/25 0.31 [ 0.03, 3.16 ]
Tang 2014 26/101 35/99 0.63 [ 0.35, 1.16 ]
Trembach 2012 26/45 9/44 5.32 [ 2.08, 13.64 ]
Zhang 2015 (3) 11/40 2/40 7.21 [ 1.48, 35.07 ]
0.1 0.2 0.5 1 2 5 10
Favours TIVA Favours Inhalational maintenance
(1) combined data for isoflurane and sevoflurane groups
(2) hypotension defined as MAP < 30% baseline. Data also available for hypotension requiring vasopressors
(3) combined TIVA groups vs combined inhalational maintenance groups
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Analysis 1.5. Comparison 1 TIVA vs Inhalational maintenance, Outcome 5 Length of stay in PACU.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 1 TIVA vs Inhalational maintenance
Outcome: 5 Length of stay in PACU








N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Celik 2011 50 20.4 (2.7) 50 24.2 (3.8) -3.80 [ -5.09, -2.51 ]
Chan 1996 29 116.4 (28) 31 131.6 (44) -15.20 [ -33.74, 3.34 ]
Demeere 2006 19 53.8 (60.6) 18 44.3 (47.1) 9.50 [ -25.37, 44.37 ]
Epple 2001 62 77.3 (31) 62 93.9 (47.6) -16.60 [ -30.74, -2.46 ]
Jellish 2003 30 79.1 (8.4) 29 63.2 (6.8) 15.90 [ 12.01, 19.79 ]
Juvin 1997 14 213 (87) 15 252 (71) -39.00 [ -97.03, 19.03 ]
Kim 2015a 30 42 (7.3) 28 42.1 (6.7) -0.10 [ -3.70, 3.50 ]
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Analysis 1.6. Comparison 1 TIVA vs Inhalational maintenance, Outcome 6 Length of hospital stay.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 1 TIVA vs Inhalational maintenance
Outcome: 6 Length of hospital stay








N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Ammar 2016 25 10 (4) 25 11 (5) 18.7 % -1.00 [ -3.51, 1.51 ]
Demeere 2006 19 12.3 (4.7) 18 10 (3.99) 16.0 % 2.30 [ -0.50, 5.10 ]
Jellish 2003 30 1.4 (0.2) 29 1.3 (0.2) 57.3 % 0.10 [ 0.00, 0.20 ]
Juvin 1997 14 12 (3) 15 15 (8) 8.0 % -3.00 [ -7.34, 1.34 ]
Total (95% CI) 88 87 100.0 % 0.00 [ -1.32, 1.32 ]
Heterogeneity: Tau2 = 0.79; Chi2 = 5.06, df = 3 (P = 0.17); I2 =41%
Test for overall effect: Z = 0.00 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI
vs non-TCI), Outcome 1 Postoperative delirium (induction agents; and TCI vs non-TCI).
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)
Outcome: 1 Postoperative delirium (induction agents; and TCI vs non-TCI)








1 Induction with inhalational agents, and TCI
Nishikawa 2004 1/25 0/25 15.2 % 3.12 [ 0.12, 80.39 ]
Subtotal (95% CI) 25 25 15.2 % 3.12 [ 0.12, 80.39 ]
Total events: 1 (TIVA), 0 (Inhalational)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
2 Induction with intravenous agents, and non-TCI
Chan 1996 1/29 2/31 24.6 % 0.52 [ 0.04, 6.04 ]
Ishii 2016 2/29 8/30 44.9 % 0.20 [ 0.04, 1.06 ]
Micha 2016 0/36 0/37 Not estimable
Tanaka 2017 1/39 0/40 15.3 % 3.16 [ 0.12, 79.85 ]
Subtotal (95% CI) 133 138 84.8 % 0.42 [ 0.11, 1.67 ]
Total events: 4 (TIVA), 10 (Inhalational)
Heterogeneity: Tau2 = 0.19; Chi2 = 2.26, df = 2 (P = 0.32); I2 =11%
Test for overall effect: Z = 1.23 (P = 0.22)
Total (95% CI) 158 163 100.0 % 0.59 [ 0.15, 2.26 ]
Total events: 5 (TIVA), 10 (Inhalational)
Heterogeneity: Tau2 = 0.34; Chi2 = 3.61, df = 3 (P = 0.31); I2 =17%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 1.24, df = 1 (P = 0.27), I2 =19%
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Analysis 2.2. Comparison 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI
vs non-TCI), Outcome 2 Postoperative cognitive dysfunction (induction agents).
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)
Outcome: 2 Postoperative cognitive dysfunction (induction agents)








1 Induction with inhalational agents
Rohan 2005 7/15 7/15 9.8 % 1.00 [ 0.24, 4.20 ]
Tang 2014 30/101 33/99 25.3 % 0.85 [ 0.47, 1.54 ]
Subtotal (95% CI) 116 114 35.1 % 0.87 [ 0.50, 1.50 ]
Total events: 37 (TIVA), 40 (Inhalational)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.05, df = 1 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.51 (P = 0.61)
2 Induction with intravenous agents
Egawa 2016 16/72 24/72 21.5 % 0.57 [ 0.27, 1.20 ]
Geng 2017 (1) 2/50 25/100 9.3 % 0.13 [ 0.03, 0.55 ]
Lindholm 2013 4/96 6/97 11.3 % 0.66 [ 0.18, 2.41 ]
Micha 2016 1/36 10/37 5.2 % 0.08 [ 0.01, 0.64 ]
Tanaka 2017 19/39 26/40 17.7 % 0.51 [ 0.21, 1.26 ]
Subtotal (95% CI) 293 346 64.9 % 0.38 [ 0.20, 0.75 ]
Total events: 42 (TIVA), 91 (Inhalational)
Heterogeneity: Tau2 = 0.22; Chi2 = 6.62, df = 4 (P = 0.16); I2 =40%
Test for overall effect: Z = 2.79 (P = 0.0052)
Total (95% CI) 409 460 100.0 % 0.52 [ 0.31, 0.87 ]
Total events: 79 (TIVA), 131 (Inhalational)
Heterogeneity: Tau2 = 0.18; Chi2 = 10.12, df = 6 (P = 0.12); I2 =41%
Test for overall effect: Z = 2.47 (P = 0.014)
Test for subgroup differences: Chi2 = 3.37, df = 1 (P = 0.07), I2 =70%
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(1) Combined data for isoflurane and sevoflurane groups
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Analysis 2.3. Comparison 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI
vs non-TCI), Outcome 3 Mortality (induction agents; and TCI vs non-TCI).
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)
Outcome: 3 Mortality (induction agents; and TCI vs non-TCI)








1 Induction with inhalational agents, and TCI
Biboulet 2012 1/14 0/14 15.7 % 3.22 [ 0.12, 86.09 ]
Subtotal (95% CI) 14 14 15.7 % 3.22 [ 0.12, 86.09 ]
Total events: 1 (TIVA), 0 (Inhalational)
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.49)
2 Induction with intravenous agents, and non-TCI
Ammar 2016 0/25 0/25 Not estimable
Lindholm 2013 4/96 4/97 84.3 % 1.01 [ 0.25, 4.16 ]
Subtotal (95% CI) 121 122 84.3 % 1.01 [ 0.25, 4.16 ]
Total events: 4 (TIVA), 4 (Inhalational)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
Total (95% CI) 135 136 100.0 % 1.21 [ 0.33, 4.45 ]
Total events: 5 (TIVA), 4 (Inhalational)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.40, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Chi2 = 0.40, df = 1 (P = 0.53), I2 =0.0%
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Analysis 2.4. Comparison 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI
vs non-TCI), Outcome 4 Intraoperative hypotension (induction agents).
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)
Outcome: 4 Intraoperative hypotension (induction agents)








1 Induction with inhalational agents
Biboulet 2012 14/14 11/14 8.83 [ 0.41, 188.73 ]
Nishikawa 2004 1/25 3/25 0.31 [ 0.03, 3.16 ]
Tang 2014 26/101 35/99 0.63 [ 0.35, 1.16 ]
Trembach 2012 26/45 9/44 5.32 [ 2.08, 13.64 ]
Zhang 2015 (1) 11/40 2/40 7.21 [ 1.48, 35.07 ]
2 Induction with intravenous agents
Chan 1996 8/29 5/31 1.98 [ 0.56, 6.96 ]
Geng 2017 (2) 3/50 9/100 0.65 [ 0.17, 2.50 ]
Jellish 2003 28/30 26/29 1.62 [ 0.25, 10.45 ]
Longas 2004 (3) 15/20 33/40 0.64 [ 0.17, 2.33 ]
Luntz 2004 17/32 33/64 1.06 [ 0.46, 2.49 ]
Micha 2016 0/36 0/37 Not estimable
0.01 0.1 1 10 100
Favours TIVA Favours inhalational
(1) combined TIVA groups vs combined inhalational maintenance groups
(2) combined data for isoflurane and sevoflurane groups
(3) hypotension defined as MAP < 30% baseline. Data also available for hypotension requiring vasopressors
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Analysis 2.5. Comparison 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI
vs non-TCI), Outcome 5 Postoperative cognitive dysfunction (TCI vs non-TCI).
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)
Outcome: 5 Postoperative cognitive dysfunction (TCI vs non-TCI)









Egawa 2016 16/72 24/72 21.5 % 0.57 [ 0.27, 1.20 ]
Geng 2017 (1) 2/50 25/100 9.3 % 0.13 [ 0.03, 0.55 ]
Subtotal (95% CI) 122 172 30.7 % 0.31 [ 0.07, 1.38 ]
Total events: 18 (TIVA), 49 (Inhalational)
Heterogeneity: Tau2 = 0.86; Chi2 = 3.40, df = 1 (P = 0.07); I2 =71%
Test for overall effect: Z = 1.54 (P = 0.12)
2 non-TCI
Lindholm 2013 4/96 6/97 11.3 % 0.66 [ 0.18, 2.41 ]
Micha 2016 1/36 10/37 5.2 % 0.08 [ 0.01, 0.64 ]
Rohan 2005 7/15 7/15 9.8 % 1.00 [ 0.24, 4.20 ]
Tanaka 2017 19/39 26/40 17.7 % 0.51 [ 0.21, 1.26 ]
Tang 2014 30/101 33/99 25.3 % 0.85 [ 0.47, 1.54 ]
Subtotal (95% CI) 287 288 69.3 % 0.63 [ 0.36, 1.10 ]
Total events: 61 (TIVA), 82 (Inhalational)
Heterogeneity: Tau2 = 0.10; Chi2 = 5.34, df = 4 (P = 0.25); I2 =25%
Test for overall effect: Z = 1.64 (P = 0.10)
Total (95% CI) 409 460 100.0 % 0.52 [ 0.31, 0.87 ]
Total events: 79 (TIVA), 131 (Inhalational)
Heterogeneity: Tau2 = 0.18; Chi2 = 10.12, df = 6 (P = 0.12); I2 =41%
Test for overall effect: Z = 2.47 (P = 0.014)
Test for subgroup differences: Chi2 = 0.78, df = 1 (P = 0.38), I2 =0.0%
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(1) Combined data for isoflurane and sevoflurane groups
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Analysis 2.6. Comparison 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI
vs non-TCI), Outcome 6 Intraoperative hypotension (TCI vs non-TCI).
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)
Outcome: 6 Intraoperative hypotension (TCI vs non-TCI)









Biboulet 2012 14/14 11/14 8.83 [ 0.41, 188.73 ]
Geng 2017 (1) 3/50 9/100 0.65 [ 0.17, 2.50 ]
Nishikawa 2004 1/25 3/25 0.31 [ 0.03, 3.16 ]
Zhang 2015 (2) 11/40 2/40 7.21 [ 1.48, 35.07 ]
2 non-TCI
Chan 1996 8/29 5/31 1.98 [ 0.56, 6.96 ]
Jellish 2003 28/30 26/29 1.62 [ 0.25, 10.45 ]
Longas 2004 (3) 15/20 33/40 0.64 [ 0.17, 2.33 ]
Luntz 2004 17/32 33/64 1.06 [ 0.46, 2.49 ]
Micha 2016 0/36 0/37 Not estimable
Tang 2014 26/101 35/99 0.63 [ 0.35, 1.16 ]
Trembach 2012 26/45 9/44 5.32 [ 2.08, 13.64 ]
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Favours TIVA Favours inhalational
(1) combined data for isoflurane and sevoflurane groups
(2) combined TIVA groups vs combined inhalational maintenance groups
(3) hypotension defined as MAP < 30% baseline. Data also available for hypotension requiring vasopressors
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Analysis 2.7. Comparison 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI
vs non-TCI), Outcome 7 Length of stay in the PACU (TCI vs non-TCI).
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 2 TIVA vs inhalational maintenance: subgroup analysis (induction agents; and TCI vs non-TCI)
Outcome: 7 Length of stay in the PACU (TCI vs non-TCI)





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 TCI
Demeere 2006 19 53.8 (60.6) 18 44.3 (47.1) 9.50 [ -25.37, 44.37 ]
Kim 2015a 30 42 (7.3) 28 42.1 (6.7) -0.10 [ -3.70, 3.50 ]
2 non-TCI
Celik 2011 50 20.4 (2.7) 50 24.2 (3.8) -3.80 [ -5.09, -2.51 ]
Chan 1996 29 116.4 (28) 31 131.6 (44) -15.20 [ -33.74, 3.34 ]
Epple 2001 62 77.3 (31) 62 93.9 (47.6) -16.60 [ -30.74, -2.46 ]
Jellish 2003 30 79.1 (8.4) 29 63.2 (6.8) 15.90 [ 12.01, 19.79 ]
Juvin 1997 14 213 (87) 15 252 (71) -39.00 [ -97.03, 19.03 ]
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Analysis 3.1. Comparison 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with
processed EEG vs standard care, Outcome 1 Postoperative delirium.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with processed EEG vs standard care
Outcome: 1 Postoperative delirium








1 Monitoring with processed EEG
Ishii 2016 2/29 8/30 44.9 % 0.20 [ 0.04, 1.06 ]
Micha 2016 0/36 0/37 Not estimable
Tanaka 2017 1/39 0/40 15.3 % 3.16 [ 0.12, 79.85 ]
Subtotal (95% CI) 104 107 60.2 % 0.56 [ 0.04, 7.44 ]
Total events: 3 (TIVA), 8 (Inhalational)
Heterogeneity: Tau2 = 2.06; Chi2 = 2.20, df = 1 (P = 0.14); I2 =55%
Test for overall effect: Z = 0.44 (P = 0.66)
2 Monitoring with standard care
Chan 1996 1/29 2/31 24.6 % 0.52 [ 0.04, 6.04 ]
Nishikawa 2004 1/25 0/25 15.2 % 3.12 [ 0.12, 80.39 ]
Subtotal (95% CI) 54 56 39.8 % 1.00 [ 0.14, 7.06 ]
Total events: 2 (TIVA), 2 (Inhalational)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.75, df = 1 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.00 (P = 1.0)
Total (95% CI) 158 163 100.0 % 0.59 [ 0.15, 2.26 ]
Total events: 5 (TIVA), 10 (Inhalational)
Heterogeneity: Tau2 = 0.34; Chi2 = 3.61, df = 3 (P = 0.31); I2 =17%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.73), I2 =0.0%
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Analysis 3.2. Comparison 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with
processed EEG vs standard care, Outcome 2 Postoperative cognitive dysfunction.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with processed EEG vs standard care
Outcome: 2 Postoperative cognitive dysfunction








1 Monitoring with processed EEG
Egawa 2016 16/72 24/72 21.5 % 0.57 [ 0.27, 1.20 ]
Geng 2017 (1) 2/50 25/100 9.3 % 0.13 [ 0.03, 0.55 ]
Lindholm 2013 4/96 6/97 11.3 % 0.66 [ 0.18, 2.41 ]
Micha 2016 1/36 10/37 5.2 % 0.08 [ 0.01, 0.64 ]
Tanaka 2017 19/39 26/40 17.7 % 0.51 [ 0.21, 1.26 ]
Tang 2014 30/101 33/99 25.3 % 0.85 [ 0.47, 1.54 ]
Subtotal (95% CI) 394 445 90.2 % 0.47 [ 0.27, 0.84 ]
Total events: 72 (TIVA), 124 (Inhalational)
Heterogeneity: Tau2 = 0.23; Chi2 = 9.55, df = 5 (P = 0.09); I2 =48%
Test for overall effect: Z = 2.54 (P = 0.011)
2 Monitoring with standard care
Rohan 2005 7/15 7/15 9.8 % 1.00 [ 0.24, 4.20 ]
Subtotal (95% CI) 15 15 9.8 % 1.00 [ 0.24, 4.20 ]
Total events: 7 (TIVA), 7 (Inhalational)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Total (95% CI) 409 460 100.0 % 0.52 [ 0.31, 0.87 ]
Total events: 79 (TIVA), 131 (Inhalational)
Heterogeneity: Tau2 = 0.18; Chi2 = 10.12, df = 6 (P = 0.12); I2 =41%
Test for overall effect: Z = 2.47 (P = 0.014)
Test for subgroup differences: Chi2 = 0.89, df = 1 (P = 0.35), I2 =0.0%
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(1) Combined data for isoflurane and sevoflurane groups
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Analysis 3.3. Comparison 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with
processed EEG vs standard care, Outcome 3 Intraoperative hypotension.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with processed EEG vs standard care
Outcome: 3 Intraoperative hypotension








1 Monitoring with processed EEG
Biboulet 2012 14/14 11/14 8.83 [ 0.41, 188.73 ]
Geng 2017 (1) 3/50 9/100 0.65 [ 0.17, 2.50 ]
Longas 2004 (2) 15/20 33/40 0.64 [ 0.17, 2.33 ]
Micha 2016 0/36 0/37 Not estimable
Tang 2014 26/101 35/99 0.63 [ 0.35, 1.16 ]
Zhang 2015 (3) 11/40 2/40 7.21 [ 1.48, 35.07 ]
2 Monitoring with standard care
Chan 1996 8/29 5/31 1.98 [ 0.56, 6.96 ]
Jellish 2003 28/30 26/29 1.62 [ 0.25, 10.45 ]
Luntz 2004 17/32 33/64 1.06 [ 0.46, 2.49 ]
Nishikawa 2004 1/25 3/25 0.31 [ 0.03, 3.16 ]
Trembach 2012 26/45 9/44 5.32 [ 2.08, 13.64 ]
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(1) combined data for isoflurane and sevoflurane groups
(2) hypotension defined as MAP < 30% baseline. Data also available for hypotension requiring vasopressors
(3) combined TIVA groups vs combined inhalational maintenance groups
123Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-
cardiac surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.4. Comparison 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with
processed EEG vs standard care, Outcome 4 Length of stay in PACU.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with processed EEG vs standard care
Outcome: 4 Length of stay in PACU





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Monitoring with processed EEG
Demeere 2006 19 53.8 (60.6) 18 44.3 (47.1) 9.50 [ -25.37, 44.37 ]
2 Monitoring with standard care
Celik 2011 50 20.4 (2.7) 50 24.2 (3.8) -3.80 [ -5.09, -2.51 ]
Chan 1996 29 116.4 (28) 31 131.6 (44) -15.20 [ -33.74, 3.34 ]
Epple 2001 62 77.3 (31) 62 93.9 (47.6) -16.60 [ -30.74, -2.46 ]
Jellish 2003 30 79.1 (8.4) 29 63.2 (6.8) 15.90 [ 12.01, 19.79 ]
Juvin 1997 14 213 (87) 15 252 (71) -39.00 [ -97.03, 19.03 ]
Kim 2015a 30 42 (7.3) 28 42.1 (6.7) -0.10 [ -3.70, 3.50 ]
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Analysis 3.5. Comparison 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with
processed EEG vs standard care, Outcome 5 Length of hospital stay.
Review: Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery
Comparison: 3 TIVA vs inhalational maintenance: subgroup analysis, monitoring with processed EEG vs standard care
Outcome: 5 Length of hospital stay





N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Monitoring with processed EEG
Demeere 2006 19 12.3 (4.7) 18 10 (3.99) 16.0 % 2.30 [ -0.50, 5.10 ]
Subtotal (95% CI) 19 18 16.0 % 2.30 [ -0.50, 5.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.61 (P = 0.11)
2 Monitoring with standard care
Ammar 2016 25 10 (4) 25 11 (5) 18.7 % -1.00 [ -3.51, 1.51 ]
Jellish 2003 30 1.4 (0.2) 29 1.3 (0.2) 57.3 % 0.10 [ 0.00, 0.20 ]
Juvin 1997 14 12 (3) 15 15 (8) 8.0 % -3.00 [ -7.34, 1.34 ]
Subtotal (95% CI) 69 69 84.0 % -0.27 [ -1.40, 0.86 ]
Heterogeneity: Tau2 = 0.43; Chi2 = 2.69, df = 2 (P = 0.26); I2 =26%
Test for overall effect: Z = 0.47 (P = 0.64)
Total (95% CI) 88 87 100.0 % 0.00 [ -1.32, 1.32 ]
Heterogeneity: Tau2 = 0.79; Chi2 = 5.06, df = 3 (P = 0.17); I2 =41%
Test for overall effect: Z = 0.00 (P = 1.0)
Test for subgroup differences: Chi2 = 2.78, df = 1 (P = 0.10), I2 =64%
-10 -5 0 5 10
Favours TIVA Favours inhalational
A D D I T I O N A L T A B L E S
Table 1. Study data reported in different formats






Gursoy 2015 Using MMT (higher scores in-
dicate improved cognitive func-
tion); 24 hours
Mean (SD): 24.5 (± 2.4); n = 30 Mean (SD): 23.7 (± 3.1); n = 30
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Table 1. Study data reported in different formats (Continued)
Moffat 1995 UsingMMSE (higher scores in-
dicate improved cognitive func-
tion); 2 hours
Mean (range): 28 (25 to 30); n
= 20
Mean (range): 27 (25 to 30); n
= 20
Tan 2009 UsingMMSE (higher scores in-
dicate improved cognitive func-
tion); 24 hours







Lindholm 2013 Episodes lasting > 2 minutes Median (25 to 75%percentiles)
: 4 (2 to 6)
Median (25 to 75% percentiles)
: 5 (2 to 6)






Lindholm 2013 Number of days Median (25 to 75%percentiles)
: 9 (8 to 12) days; n = 96
Median (25 to 75% percentiles)
: 9 (8 to 12) days; n = 97
Tylman 2011 Number of days Median (25 to 75%percentiles)
: 8 (6 to 12) days; n = 25
Median (25 to 75% percentiles)
: 8 (6 to 10) days; n = 21
*data as reported by study authors;
n: number of analysed participants
MMSE: mini-mental state examination
MMT: mini-mental test
SD: standard deviation
TIVA: total intravenous anaesthesia
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Anesthesia, Intravenous] explode all trees
#2 MeSH descriptor: [Anesthesia, Inhalation] explode all trees
#3 MeSH descriptor: [Anesthetics, Inhalation] explode all trees
#4 MeSH descriptor: [Anesthetics, Intravenous] explode all trees
#5( an?esthe* near/2 (iv or intravenous or inhalation* or volatile)) or (TIVA or propofol or halothane or enflurane or isoflurane or
desflurane)
#6 #1 or #2 or #3 or #4 or #5
#7 MeSH descriptor: [Geriatrics] explode all trees
#8 MeSH descriptor: [Aged] explode all trees
#9 (Geriatric* or Elder* or old-age or pensioner*) or ((aging or aged or elderly or senior or old) near/2 (wom?n or m?n or lady or ladies
or adult* or citizen* or population* or people or person))
#10 #7 or #8 or #9
#11 #6 and #10
Appendix 2. MEDLINE (Ovid) search strategy
1. Anesthesia, Intravenous/ or Anesthesia, Inhalation/ or (an?esthe* adj2 (iv or intravenous or inhalation* or volatile)).mp. or
(TIVA or propofol or halothane or enflurane or isoflurane or desflurane).mp.
2. (Geriatric* or Elder* or old-age* or pensioner*).ti,ab.
3. ((Aging or aged or senior or old*) adj2 (wom#n or m#n or lady or ladies or adult* or citizen* or population*1 or people or
person)).ti,ab.
4. exp Aged/ or exp geriatrics/
5. 2 or 3 or 4
6. 1 and 5
7. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab.
or trial.ab. or groups.ab.) not (animals not (humans and animals)).sh.
8. 6 and 7
Appendix 3. Embase (Ovid) search strategy
1. intravenous anesthesia/ or inhalation anesthesia.mp. or (an?esthe* adj2 (iv or intravenous or inhalation* or volatile)).mp. or
(TIVA or propofol or halothane or enflurane or isoflurane or desflurane).mp. [mp=title, abstract, heading word, drug trade name,
original title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word]
2. (geriatric* or elder* or old-age* or pensioner*).ti,ab.
3. ((aging or aged or senior or old*) adj2 (wom#n or m#n or lady or ladies or adult* or citizen* or population*1 or people or
person)).ti,ab.
4. aged/ or geriatrics/
5. 2 or 3 or 4
6. 1 and 5
7. ((crossover procedure or double blind procedure or single blind procedure).sh. or (crossover* or cross over*).ti,ab. or
placebo*.ti,ab,sh. or (doubl* adj blind*).ti,ab. or (controlled adj3 (study or design or trial)).ti,ab. or allocat*.ti,ab. or trial*.ti,ab. or
randomized controlled trial.sh. or random*.ti,ab.) not ((exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/
or (human or humans).ti.))
8. 6 and 7
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Appendix 4. PsycINFO (EBSCO) search strategy
S1 MM “Anesthesiology”
S2 ((an?esthe* N2 (iv or intravenous or inhalation* or volatile))
S3 TIVA or propofol or halothane or enflurane or isoflurane or desflurane
S4 S1 OR S2 OR S3
S5 MM “Geriatrics”
S6 Geriatric* or Elder* or old-age or pensioner*
S7 ((aging or aged or elderly or senior or old) N2 (wom?n or m?n or lady or ladies or adult* or citizen* or population* or people or
person))
S8 S5 OR S6 OR S7
S9 ((MM “Randomized Controlled Trials”) OR (MM “Random Assignment”) OR (MH “Clinical Trials”) OR (MH “Placebos”)) OR
(random* or (trial* and (clinical or controlled)) or multicenter or prospective)
S10 S4 AND S8 AND S9
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We made the following changes to the published protocol (Miller 2016).
1. Authors: we added additional authors during the review, Michael W Pritchard and Oliver J Schofield Robinson.
2. Title: we edited it to make it clear that our inclusion criteria was ’non cardiac’ surgery.
3. Objectives: we edited the wording of our review objective to reflect our intention at protocol to only include interventions that
were propofol-based TIVA.
4. Inclusion criteria: we excluded studies in which the inclusion criteria specified a participant age range of 18 to 65 years because
we believed these studies were not aiming to specifically recruit elderly patients; we found that these studies had a mean age for
participants of < 60 years and therefore this decision did not affect choice of included studies. We found a large number of studies
that compared intravenous versus inhalational anaesthetic agents, but only measured outcomes which were outside the scope of this
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review, e.g. biochemical parameters. We therefore added an exclusion criteria to the review: to exclude studies that did not measure
our review outcomes. We reported these studies in Characteristics of excluded studies.
5. In the protocol, we stated that our final choice of fixed-effect or random-effects statistical model was influenced by the level of
identified heterogeneity and the number of studies. We selected to use a random-effects statistical model; this decision was made
because a random-effects model is more appropriate for analysis of studies in which differences (for example, in types of surgery) were
most likely.
6. Dealing with missing data: we did not contact authors to request missing data (except for in Tanaka 2017). In the case that study
participants were lost at follow-up, we included data as analysed by study authors. We did not impute missing values with
replacement values. In the case of missing statistics, we did not impute missing values with replacement values. We reported data in
the format presented by study authors, and if it was in a format that was not comparable to other data that could be pooled (e.g.
median values), we reported these data separately in additional tables. We found high statistical heterogeneity in included studies and
noted inconsistencies in visual inspection of results; imputing appropriate values was not appropriate because of heterogeneity. We
used sensitivity analysis to explore the effect of including studies in which attrition was high and unbalanced between groups.
7. ’Summary of findings’ table and GRADE: only one review author used GRADEpro software to create a ’Summary of findings’
table. This was checked and approved by a second review author.
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